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Abstract
Apoptosis is an important form of cell death induced by anti-cancer drugs and 
chemicals. The biochemical mechanisms of chemical-induced apoptosis remain, 
however, largely unknown, and the major biochemical events in this model of 
apoptosis are poorly characterised.
In this study, apoptosis, induced in human monocytic THP.l cells by etoposide and 
N-tosyl-L-phenylalanyl chloromethyl ketone and in leukaemic U937 cells by 
etoposide, was accompanied by the release of mitochondrial cytochrome c, activation 
of caspases, proteolysis of poly(ADP-ribose) polymerase (PARP)? DNA 
fragmentation, externalisation of phosphatidylserine (PS), and reduction in 
mitochondrial membrane potential (AVm)- Time course studies demonstrated that 
activation of caspases occurred prior to both PS externalisation and reduction in A\|/m. 
This was further supported by the observation that the caspase inhibitor, 
benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethyl ketone (Z-VAD.FMK) 
inhibited all the ultrastructural and biochemical characteristics of apoptosis except the 
release of cytochrome c. The execution phase of apoptosis may thus be initiated by 
the translocation of cytochrome c to the cytosol, where it interacts with dATP and 
apoptotic-protease activating factor-1, resulting in activation of the initiator caspase-9, 
which in turn activates effector caspases, such as -3 and -7. Cytochrome c release was 
a later event in non-apoptotic cell death occurring after commitment to cell death and 
without caspase activation. Thus its release may represent a commitment to cell death 
in chemical-induced apoptosis.
This study also showed that in cells triggered into apoptosis the plasma membrane 
changes leading to recognition and phagocytosis may be uncoupled from other 
features of apoptosis by using the mitochondrial inhibitors, antimycin A and 
oligomycin. These inhibitors blocked increased plasma membrane permeability, PS 
externalisation and recognition by two classes of phagocytes but not activation of 
caspases-3 and -7, PAR? cleavage or DNA fragmentation in THP.l cells. PS 
externalisation was also dissociated from caspase activation in U937 cells. Thus cell 
surface changes governing safe clearance of apoptotic cells may be regulated by an 
independent pathway to those mediated by caspases. This finding may have 
important consequences for attempts to manipulate cell death for therapeutic gain in 
vivo.
Finally, this study demonstrated that in chemical-induced apoptosis caspases 
functioned solely as executioners and activation of caspases occurred after 
commitment to cell death, through post-mitochondrial activation pathway(s). Z- 
VAD.FMK inhibited apoptosis at a stage after this commitment by blocking the post- 
mitochondrial activation cascade of caspases. This contrasted to its effect in death 
receptor-mediated apoptosis in U937 cells, where Z.VAD.FMK inhibited apoptosis 
prior to commitment to cell death induced by tumour necrosis factor-a.
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Chapter 1 Introduction
1.1 Defining apoptosis
Apoptosis, a term derived from a Greek word describing the dropping off of leaves from 
trees, is a basic form of cell death often observed when single cells are deleted in the 
midst of living tissues (Kerr et al., 1972). Initially, the defining characteristics of 
apoptosis were essentially morphological. These include loss of cell volume, dilatation of 
endoplasmic reticulum, compaction of cytoplasmic organelles, loss of specialised surface 
structures such as junctional complexes and microvilli, blebbing into a collection of 
membrane-bounded bodies of various sizes which are often found inside the viable 
neighbouring cells, as well as the distinctive condensation of chromatin into crescentic 
accumulation at the nuclear periphery (Kerr, 1971; Kerr et al., 1972; Wyllie et al., 1980; 
reviewed by Arends and Wyllie, 1991). Based on these morphological features, it is 
suggested that apoptosis is an active, inherently programmed phenomenon (Kerr et al., 
1972). It is, however, not always the case that all the above morphological features are 
observed altogether in one particular cell undergoing apoptosis. In fact, time-lapse 
studies show that the initial cell shrinkage and fragmentation occur in a matter of minutes, 
whereas the phagocytosed remnants may remain recognisable within tissues for several 
hours, by virtue of their condensed chromatin fragments (Arends and Wyllie, 1991). 
Moreover, apoptosis occurs only in scattered individual cells thus making its biochemical 
analysis very difficult (Kerr, 1971). Perhaps due to these reasons, the incidence and 
biological significance of apoptosis have been appreciated only comparatively recently 
(Wyllie, 1988; Raff, 1992).
Apoptosis is now known to be involved in regulating cell numbers in many normal tissues 
and be accountable for extensive spontaneous cell loss in malignant neoplasms (reviewed 
by Wyllie, 1992 and 1993). It is also implicated in both physiological involution and 
atrophy of various tissues and organs (Kerr, 1971; Kerr et al., 1972). In the ontogeny of 
the immune system apoptosis occurs in deletion of autoreactive T lymphocyte clones 
during thymic maturation (Kisielow et al., 1988; Smith et al., 1989) and in B lymphocyte 
deletion in germinal centres (Liu et al., 1989). Apoptosis also plays a vital role in many 
normal embryonic processes of animal development such as the formation of the lumina 
of tubular structures, the development of limbs, and involution of phylogenetic vestiges 
(reviewed by Clarke, 1990; Jacobson et al., 1997).
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Apoptosis, a mode of cell death distinct from necrosis, is often interchangeably referred to 
as programmed cell death. Programmed cell death was well recognised in the 19th 
century and was a focus of interest in early developmental biology (reviewed by Clarke 
and Clarke, 1996; Lockshin, 1997). It has an obvious meaning when applied to cell 
deletion occurring as part of developmental processes, such as rearrangement of cells in 
forming the avian limb as mentioned above, and apoptosis appears to be the major form 
of cell death. However, there are many other instances in which programmed cell death 
occurs by a morphology other than apoptosis, notably cell death in interdigital membranes 
of the feet of chick embryo in forming the interdigital clefts (reviewed by Clarke, 1990; 
Majno and Idris, 1995; Schwartz, 1995). Likewise, apoptosis can occur in cells when 
challenged with many unphysiological stumuli including some toxic chemicals and 
ionising radiation (reviewed by Arends and Wyllie, 1991; Trump et al., 1997), suggesting 
that at least in some situations apoptosis is not programmed but is the cells’ response to 
changes in their local environment. Furthermore, there is a conceptual confusion due to 
the fact that two different programs are involved in apoptosis, one is to carry out the death 
process while the other is to trigger the activation of this death process, and that both 
programs appear to be genetically regulated. Two programs are thus defined by two 
different concepts. The genetic program of programmed cell death is a clock specifying 
the time for cell death to occur, whereas the genetic program of apoptosis specifies the 
machinery to execute death process which eventually brings about the morphological 
features of apoptosis. Therefore, apoptosis refers to a morphology while programmed cell 
death describes a process. For these reasons, the term apoptosis is used throughout this 
thesis as defined by the morphological criteria.
1.2 Morphological and biochemical features
As described earlier, apoptosis involves a distinct morphological process which may 
occur in three discrete stages (Kerr et al., 1972; Wyllie, 1988; Arends and Wyllie, 1991). 
In the first, there is reduction in nuclear size, condensation of chromatin, loss of cell to 
cell contact and dilatation of the endoplasmic reticulum. Cell membranes are still intact 
as cells within tissues do not evoke inflammatory reaction. The second stage mainly 
comprises breaking up of the cell into a number of membrane-bound “apoptotic bodies”, 
some containing nuclear fragments, and most of the apoptotic bodies are phagocytosed by 
neighbouring cells or macrophages. In the third stage, there is progressive degeneration 
of residual nuclear and cytoplasmic structures. Cell membranes disappear and organelles
3
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become unrecognisable. The majority of apoptotic cells seen under the light microscope 
are in fact in the latter two stages. It is estimated that within tissues the whole process is 
completed in less than ten hours (Arends and Wyllie, 1991). This relatively short period 
indicates that high rates of apoptosis produce only small increases in the proportion of 
apoptotic cells recognisable in tissue sections. Swift clearance of apoptotic cells also 
protects surrounding tissues from exposure to injurious contents leaking from dying cells, 
which is inevitable in accidental cell death culminating in necrosis.
The characteristic morphologic condensation of chromatin in apoptosis is often associated 
with DNA fragmentation. Initially, DNA is cleaved to 200-300 and 30-50 kilobase pair­
sized fragments, which in terms of higher-order chromatin structure may represent loops 
and rosettes of DNA (Brown et al., 1993; Cohen et al., 1994). The large kilobase pair- 
sized fragments are then further degraded to form internucleosomal DNA fragments of 
180-200 basepair in length. These internucleosomal fragments, demonstrated as a DNA 
ladder by agarose gel electrophoresis, were originally considered as a biochemical 
hallmark of apoptosis (Wyllie, 1980). The formation of intemucleosome-sized DNA 
fragments is now considered as a late event in apoptosis, which may be dissociated from 
early more critical changes (G. Cohen et al., 1992).
Another biochemical feature associated with apoptosis is the degradation of a set of 
cellular proteins. Proteolysis of nuclear proteins such as lamins (Kaufinann, 1989; 
Oberhammer et al., 1994), poly (ADP-ribose) polymerase (PARP) (Kaufrnann, 1989; 
Kaufinann et al., 1993), DNA-dependent protein kinase (DNA-PK) (Casciola-Rosen et 
al., 1995; Song et al., 1996) and U1 small ribonucleoprotein (Ul-70 kDa) (Casciola- 
Rosen et al., 1994; Tewari et al., 1995a) has consistently been observed in cells 
undergoing apoptosis induced by diverse apoptotic stimuli in a variety of cell systems. 
Although the precise biological significance of these proteolytic cleavages and their 
relationship with the ensuing apoptotic morphology are yet unknown, it is believed that 
degradation of these nuclear proteins contributes to the collapse of the nucleus and 
condensation of the chromatin. Of particular interest is the DNA repair enzyme PARP 
(Satoh and Lindahl, 1992) which is cleaved early during apoptosis in a number of cell 
systems and its cleavage is thus proposed as another biochemical marker of apoptosis 
(Kaufinann et al., 1993).
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1.3 Apoptosis and diseases
Apoptosis is a fundamental form of cell death which plays a major role in the 
development and homeostasis of multicellular organisms, as described earlier. It is also 
imperative for host survival as it provides a simple way to eliminate misplaced, damaged 
or infected cells. Disturbances in apoptosis have therefore been implicated in 
pathogenethesis of a variety of human diseases including cancer, acquired 
immunodeficiency syndrome (AIDS), autoimmune diseases and some neurodegenerative 
disorders (reviewed by Thompson, 1995). These diseases either occur as a result of 
increased apoptosis or are associated with the inhibition of apoptosis, as shall be 
described below.
1.3.1 Diseases where apoptosis is inhibited
1.3.1.1 Cancer
The observation that most, if not all, mammalian nucleated cells undergo apoptosis when 
deprived of exogenous signals and /or intercellular contacts has led to the notion that 
survival of a cell depends on the presence of signals produced by other cells, and in 
addition, its survival may require continuous suppression of apoptotic process (reviewed 
by Raff, 1992). Dependence of normal cells on environment-specific factors to maintain 
their viability may serve to prevent normal cells from surviving in non-physiological 
sites. Metastatic tumour cells have, however, circumvented this homeostatic mechanism 
and can survive at sites distinct from the tissues in which they arise. Consistent with the 
early suggestion that hyperplasia might result from decreased apoptosis rather than 
increased mitosis (Kerr et al., 1972), cells from a wide variety of human malignancies 
show a decreased ability to undergo apoptosis in response to several physiological stimuli 
(Hoffinan and Liebermann, 1994). Recent studies on the molecular bases for the 
decreased apoptosis in tumour cells have suggested the involvement of several critical 
genes in the regulation of apoptosis (reviewed by Wyllie, 1992; Reed, 1994; Thompson, 
1995).
The gene bcl-2 was first discovered because of its involvement in B cell malignancies, 
where translocations between chromosomes 14 and 18 activates the gene in the majority 
of follicular non-Hodgkin’s lymphomas (Tsujimoto et al., 1985). Though originally 
viewed as an oncogene, Bcl-2 protein is found to have little ability to promote cell cycle 
or cell proliferation (reviewed by Adams and Cory, 1998). Studies using immature B
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cells that are dependent on the cytokine, interleukin-3, for their growth and survival in 
culture show that stable transfer of bcl-2 gene permits prolonged cell survival in the 
absence of the cytokine, but with no effect on cell proliferation (Vaux et al., 1988). 
Further studies demonstrate that Bcl-2 is capable of both promoting B cell survival and 
follicular lymphoprolifcraliun in transgenic mice (McDonnell et al., 1989) and blocking 
apoptosis in growth factor-deprived haemopoietic cell lines (Hockenbery et al., 1990; 
Nunez et al., 1990). Moreover, in contrast to the prolonged cell survival and anti- 
apoptotic potential observed when elevations in the levels of Bcl-2 protein are achieved 
through gene transfer methods, antisense-mediated reductions in Bcl-2 expression have 
been shown to accelerate apoptosis following growth factor withdrawal (Reed et al., 
1990a). In addition, over-expression of Bcl-2 can prevent or markedly reduce apoptosis 
induced by a wide variety of stimuli (reviewed by Nunez and Clarke, 1994; Kroemer, 
1997; Adams and Cory, 1998). In all cases where examined, Bcl-2 appears to block a 
relatively early event associated with apoptotic cell death in that none of the characteristic 
morphological changes such as cell shrinkage, chromatin condensation, and nuclear 
fragmentation occurred, and DNA degradation was markedly reduced or prevented 
(reviewed by Reed, 1994). This suggests that Bcl-2 blocks a final common pathway 
leading to apoptotic cell death, although the mechanisms underlying the inhibition are not 
fully understood yet. The observation that Bcl-2 blocks apoptosis induced by many 
chemotherapeutic drugs as well as y-irradiation (Miyashita and Reed, 1992; Strasser et al., 
1994) may provide some clues, as these stimuli all induce DNA damage either directly or 
indirectly. The protection afforded by Bcl-2 does not involve reductions in drug-induced 
damage to DNA, increased rates of DNA repair, or changes in cell cycle kinetics (Fisher 
et al., 1993; Walton et al., 1993). Thus, Bcl-2 appears to act downstream of all of these 
events, perhaps by preventing the occurrence of damaged DNA from being translated into 
a signal for activation of the apoptotic program, or by blocking the action of individual 
components of the program after its activation or both.
There is increasing evidence that the tumour suppressor gene p53 may be involved in this 
pathway. The protein product of the p53 gene has been implicated in maintaining 
genomic stability, and in response to drug-induced DNA damage two cellular response to 
p53 activation are well described, i.e. growth arrest (in cell cycle stages Gj and G2) and 
apoptosis (reviewed by Levine, 1997; Evan and Littlewood, 1998). It is thus tempting to 
speculate that a functional connection between p53 and Bcl-2 may exist. It has indeed
6
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been shown that over-expression of Bcl-2 blocks p53-induced apoptosis in several cell 
systems (Wang et al., 1993; Chiou et al., 1994). However, this is by no means to suggest 
that p53 is the only mediator in regulation of apoptosis by Bcl-2 since studies using p53 
knock-out mice have shown that p53 is required for induction of apoptosis by some 
stimuli such as y-irradiation and the anti-cancer drug etoposide but not by glucocorticoids 
and Ca^-ionophores in thymocytes (Lowe et al., 1993; Clarke et al., 1993), and yet Bcl-2 
is very effective in blocking glucocorticoids and Ca^-ionophore-induced cell death 
(Sentman et al., 1991; Miyashita and Reed, 1992).
Studies investigating other genes required for apoptosis in the absence of p53 suggest that 
some oncogenes are involved in regulating the induction of apoptosis, in cooperating with 
Bcl-2. c-Myc is a key regulator of cell growth and differentiation and Myc oncoproteins 
are commonly activated in human cancer (reviewed by Packam and Cleveland, 1995; 
Evan and Littlewood, 1998). It has been shown that expression of c-myc induces 
apoptosis in several systems (Evan et al., 1992; Shi et al. 1992). Gene transfer 
experiments have shown that Bcl-2 blocks apoptosis induced by c-myc (Bissonnette et al., 
1992; Fanidi et al., 1992), indicating that Bcl-2 suppresses apoptotic signals that occur 
with transformation. It also suggests that, as c-Myc stimulates both mitogenesis and 
apoptosis, concomitant expression of Bcl-2 can attenuate the apoptotic influence of c-myc, 
thus reinforcing the proliferative effects of c-myc and leading to a further selective growth 
advantage of tumour cells. Bcl-2 has also been shown to co-operate with members of the 
ras oncogene family in malignant transformation of rat embryonic fibroblasts (Reed et al., 
1990b). Consistent with the above experimental observations, the presence of either the 
Bcl-2 protein or bcl-2 gene rearrangement has clinically been associated with a poor 
prognosis in patients with prostatic cancer (McDonnell et al., 1992), non-Hogkin’s 
lymphomas (Yunis et al., 1989), and acute myeloid leukaemia (Campos et al., 1993).
1.3.1.2 Autoimmune disorders
Apoptosis is responsible for the removal of potentially autoreactive lymphocytes during 
development as well as for the removal of excess cells after the completion of an immune 
response (reviewed by Golstein et al., 1991; J. Cohen et al., 1992). Disregulation of 
apoptosis has been implicated in the aetiology of autoimmune diseases. Studies in murine 
models have shown that one molecule critical in regulating apoptosis in lymphocytes 
involves the cell surface receptor CD95 (also known as Fas or Apo-1), a member of the
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tumour necrosis factor (TNF) receptor family (reviewed by Nagata and Golstein, 1995; 
Nagata, 1997). Stimulation of CD95 on activated lymphocytes can induce apoptosis. 
Two forms of hereditary autoimmune diseases have been attributed to alterations in 
CD95-mediated apoptosis (Watanabe-Fukunaga et al., 1992; Suda et al., 1993). Mice 
carrying homozygous mutations in Ipr (lymphoproliferation) develop a fatal autoimmune 
disorder by 6 months of age, resembling human systemic lupus erythematosus, whereas 
mutations in gld (generalised lymphoproliferative disease) also result in a similar illness 
(Cohen and Eisenberg, 1991). Genetic and molecular analyses of Ipr and gld mutations 
have shown that they are loss-of-function mutations in genes encoding CD95 and CD95 
ligand, respectively (Watanabe-Fukunaga et al., 1992; Takahashi et al., 1994). A lupus­
like autoimmune disease has also been reported in transgenic mice constitutively over­
expressing Bcl-2 in their B cells (Strasser et al., 1991).
Children carrying a defect in the CD95 gene have also been identified with most of these 
patients carrying a heterozygous mutation (Fisher et al., 1995; Rieux-Laucat et al., 1995). 
T cells from the patients do not undergo apoptosis upon activation. The patients show 
phenotypes (autoimmune lymphoproliferative syndrome) that bear marked similarity to 
those of Ipr mice, including lymphadenopathy, splenomegaly, and 
hypergammaglobulinemia. Some patients show autoimmune conditions such as 
haemolytic anaemia, thrombocytopenia, and neutropenia by producing autoantibodies 
against red blood cells and platelets. It should be pointed out that the studies into the role 
of apoptosis in the development of autoimmune diseases in humans are still in an early 
stage although alterations in the susceptibility of lymphocytes to die by apoptosis in vitro 
have been reported in several other diseases (reviewed by Thompson, 1995).
1.3.1.3 Viral infections
Apoptosis can occur in cells infected by viruses (Levine et al., 1993) and this may serve 
as a cellular defence mechanism to prevent viral multiplication. In addition, cytotoxic T 
cells act to prevent viral spread by recognising and killing cells exhibiting viral peptides 
associated with cell surface major histocompatibility complex (MHC) class I molecules 
(Henkart, 1994). Cytotoxic T cells induce apoptosis by either activating the death 
receptor, e.g. CD95, on the surface of the target cell or producing proteases, e.g. 
granzyme B, which activate the cell death program from within the cells (reviewed by J. 
Cohen et al., 1992; Nagata and Golstein, 1995; Froelich et al., 1998). Several studies
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have shown, however, that many viruses circumvent the host defences by interfering with 
the natural apoptotic processes that are activated in the host cells. For example, the 
adenovirus E1B 19 kDa protein that is required to establish an effective adenoviral 
infection blocks apoptosis directly and its function can be replaced in adenovirus by Bcl-2 
(Rao et al., 1992; Boyd et al., 1994). Other viral genes have also been reported to inhibit 
apoptosis. Cowpox virus effectively inhibits apoptosis in a number of different systems 
(Miura et al., 1993 and 1995; Chinnaiyan et al., 1996; Srinivasula et al., 1996a). One of 
the viral genes necessary for this inhibition, crmA (a cytokine response modifier gene), 
encodes a serpin that effectively inhibits apoptosis-specific proteases (Ray et al., 1992), 
now known as caspases (see below). CrmA has also been shown to inhibit the 
development of an inflammatory response in virally infected cells (Gagliardini et al., 
1994). The protein products of baculovirus p35 and the inhibitor of apoptosis {LAP) genes 
can inhibit apoptosis induced by a wide variety of stimuli (Clem et al., 1991 and 1994; 
Liston et al., 1996). Further studies show that both P35 and LAP proteins act as specific 
inhibitors of caspases (Bump et al., 1995; Hawkins et al., 1996; Deveraux et al., 1997;
Roy et al., 1997). The prevention of apoptosis is also vital for the establishment of viral 
latency as indicated by an observation that Epstein-Barr virus (EBV) enhances the 
survival of infected B cells (Gregory et al., 1991). The survival effect may be conferred 
by expression of a single EBV latent protein LMP-1, which specifically up-regulates the 
expression of Bcl-2, thus providing a survival advantage to latently infected cells 
(Henderson et al., 1991).
1.3.2 Diseases associated with excessive apoptosis
Excessive apoptosis can result from both intra-and extra-cellular changes that enhance the 
accretion of signals that induce apoptosis or that decrease the threshold of the induction of 
apoptosis. Several clinical conditions are believed to be associated with the increase in 
apoptosis.
13.2.1 AIDS
Lymphopenia and immunodeficiency in patients with AIDS, induced by the human 
immunodeficiency virus (HIV), may be linked to an enhanced susceptibility of the CD4+ 
helper T lymphocyte population to death by apoptosis (Ameisen and Capron, 1991; 
Gougeon and Montagnier, 1993). In vitro activation of CD4+ T cells from asymptomatic 
HTV-infected individuals by mitogens induces apoptosis (Groux et al., 1992). In addition,
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specific CD4+ T cell death is observed upon activation of T cells by the MHC class II- 
dependent bacterial superantigens. Although the mechanism underlying the increased 
susceptibility is not fully understood yet, the binding of CD4 receptor by the glycoprotein 
gpl20 of the virus is believed to prime normal CD4+ T cells for apoptosis in response to 
subsequent T cell receptor stimulation. Both CD4+ T cells from normal and from HIV- 
infected individuals have indeed been shown to undergo apoptosis in vitro if cell surface 
CD4 is crosslinked before engagement of T cell receptors (Newell et al., 1990; Banda et 
al., 1993). Thus, it is possible that gpl20 promotes apoptosis by its interaction with CD4. 
It has also been suggested that interference of signal transduction by HTV can result in the 
induction of apoptosis in T lymphocytes, perhaps by inducing oxidative stress or an 
abortive cell cycle (reviewed by Orrenius, 1995). As CD4+ T cells play an important role 
in establishing protective immunity against a wide variety of viral infections, 
development of chronic HTV infection may therefore depend on virally mediated 
depletion of CD4+ T cells and the concomitant loss of a protective cell-mediated immune 
response in host.
1.3.2.2 Neurodegenerative disorders
Many neurological diseases are characterised by the gradual loss of specific sets of 
neurons (reviewed by Isacson, 1993). These disorders includes Alzheimer’s disease, 
Parkinson’s disease, amyotrophic lacteral sclerosis (ALS), retinitis pigmentosa, spinal 
muscular atrophy, and several forms of cerebellar degeneration. The cell loss in these 
diseases does not provoke an inflammatory response and appears to be accomplished by 
apoptosis (reviewed by Desmukh and Johnson, 1997). Oxidative stress, calcium toxicity, 
mitochondrial defects, excitatory toxicity, and deficiency of survival factors have all been 
speculated to contribute to the pathogenesis of these diseases by increasing susceptibility 
of neurons to apoptosis (reviewed by Choi, 1992; Orrenius, 1995). In support of this 
view, the anti-apoptotic Bcl-2 protein has been shown to protect a central neural cell line 
from apoptosis induced by diverse stimuli (Zhong et al., 1993; Offen et al., 1997).
Most cases of early-onset familial Alzheimer’s disease are caused by mutations in genes 
encoding the presenilin 1 and 2 proteins (reviewed by Hardy, 1997). The resultant mutant 
proteins have been shown to induce an increased production of P-amyloid, a peptide 
progressively accumulated in plaques in patients with Alzheimer’s disease (Scheuner et 
al., 1996; Duff et al., 1996). In vitro studies have shown that in neurons apoptosis is
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induced by P-amyloid (Loo et al., 1993), suggesting that excessive apoptosis may occur in 
vivo leading to gradual depletion of neurons and subsequent development of the disease. 
The antioxidant and free radical scavenger vitamin E inhibits p-amyloid-induced cell 
death (Behl et al., 1992), indicating the involvement of reactive oxygen species (ROS) in 
apoptosis. In addition, evidence from human brain studies and animal transgenic 
experiments supports a role of apoptosis in Alzheimer’s disease (reviewed by Dragunow 
et al., 1997), although clinical significance of these findings still remains to be further 
substantiated.
Parkinson’s disease is another form of neurodegenerative disorder characterised by 
progressive cell loss confined mostly to dopamine neurons of the substantia nigra 
(reviewed by Burke and Khulodilov, 1998). Characterisation of cell death reveals 
morphological and biochemical features of apoptosis in both nigral neurons of patients 
with Parkinson’s disease (Anglade et al., 1997) and neural cell lines (Ziv et al., 1994; 
Walkinshaw and Waters, 1995). Cells over-expressing Bcl-2 show a marked resistance to 
cell death (Offen et al., 1997), suggesting that apoptosis may contribute to the 
development of the disease. The accumulation of ROS generated during altered 
metabolism of the natural neurotransmitter dopamine may be responsible for the increased 
apoptosis in neurons as the treatment with an antioxidant inhibits the cell death (Ziv et al., 
1994).
The spinal muscular atrophies (SMAs), characterised by spinal cord motor neuron 
depletion, are a group of recessive neurodegenerative disorders of childhood. One of the 
genes linked to these disorders has been isolated recently, which encodes neuronal 
apoptosis inhibitory protein (NAIP), a homologue to the baculovirus inhibitor of 
apoptosis protein (Roy et al., 1995; Liston et al., 1996). It has been shown that the gene is 
partly deleted in individuals with SMAs, suggesting that the lack of suppression of 
apoptosis by NAIP results in motor neurons more susceptible to apoptosis.
Retinal degeneration associated with retinitis pigmentosa, a condition leading to 
progressive blindness, may result from mutations in any one of the three photoreceptor- 
specific genes encoding rhodopsin, the p subunit of cyclic guanosine monophosphate 
phosphodiesterase, and peripherin, respectively (Portera-Cailliau et al., 1994). All three 
mutations lead to photoreceptor apoptosis in animal models (Chang et al., 1993; Portera-
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Cailliau et al., 1994). Although the initiating mechanisms of apoptosis associated with 
these conditions are not known yet, accumulation of the mutant protein with 
dysfunctional structure may result in an increased apoptosis (Rao et al., 1994).
1.3.2.3 Blood cell disorders
Mature blood cells are continuously being produced from haemotopoietic stem cells in the 
bone marrow. Several haematological diseases are, however, associated with a decreased 
production of blood cells. These disorders include anaemia resulting from chronic 
diseases, aplastic anaemia, chronic neutropenia, and the myelodysplastic syndromes, 
which are associated with increased apoptotic cell death within the bone marrow (Yuan et 
al., 1993a; reviewed by Yoshida, 1993). The diseases could result from the activation of 
genes promoting apoptosis, deficiencies in haematopoietic survival factors or the direct 
effects of toxins. In support of this view, several haematopoietic growth factors have 
been shown to increase the production of individual types of blood cells (reviewed by 
Fleischman, 1993). For instance, erythropoietin is used to increase red blood cell 
production in patients with anaemia caused by renal failure and other chronic conditions. 
Granulocyte-macrophage colony-stimulating factor (GM-CSF), macrophage CSF, and 
granulocyte CSF have all been used to promote the recovery of macrophages and 
granulocytes following chemotherapy for cancer (reviewed by Thompson, 1995).
1.3.2.4 Myocardial infarction and stroke
Myocardial infarction and stroke are two common disorders all caused by an acute loss of 
blood flow (ischemia). In both disorders, cells within the central area of ischemia appear 
to die rapidly resulting in necrosis. Cells outside of the central ischemic region, however, 
die over a prolonged time period, morphologically by apoptosis (Cohen, 1993). Ischemia 
of both neurons and cardiac myocytes in culture result in the induction of apoptosis 
(Rosenbaun et al., 1994; Tanaka et al., 1994). Agents known to be inhibitors of apoptosis 
in vitro have been shown to limit infarct size in vivo. For example, use of apoptosis- 
specific protease inhibitors reduces ischemic and excitotoxic neuronal damage in mice 
(Hara et ah, 1997). Thus, it is likely that apoptosis plays an important role in the 
development of these diseases.
1.4 Evolutionarily conserved mechanism of apoptosis
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The observation that apoptosis is often accompanied by the distinct morphological 
changes has led to the idea that there must be a set of biochemical events that characterise 
the apoptotic program. Furthermore, there is increasing evidence that apoptosis occurs by 
a mechanism that has been at least partially conserved throughout animal evolution. 
Indeed, much of our current knowledge about the molecular basis of the death program 
came initially from genetic studies in the nematode Caenorhabditis elegans. During the 
development of the C. elegans hermaphrodite, 1090 cells are generated, of which 131 
undergo apoptosis as a result of programmed cell death (reviewed by Ellis et al., 1991). 
Genetic analyses of C. elegans have identified genes that function in apoptosis and 
ordered these genes into a genetic pathway, which led to the finding that similar genes 
operate during apoptosis in other organisms, including mammals.
1.4.1 Genes required for cell death during the development of the C. elegans
Cell death by apoptosis in the development of C. elegans may be divided into four stages, 
including the decision of whether a particular cell will die, the death process of the cell, 
the engulfinent of the dead cell by phagocytes, and the degradation of the engulfed corpse 
(reviewed by Steller, 1995). A variety of single-gene mutations that have specific effects 
in each of these stages during cell death have been identified, which define a number of 
genes required not only to cause cell death but also to protect cells from dying (reviewed 
by Metzstein et al., 1998).
The activity of the gene ced-9 (ced, cell death defective) protects most, if not all, cells 
from undergoing programmed cell death during C. elegans development. A dominant 
gain-of-function mutation in ced-9 suppresses all normal programmed cell death, whereas 
recessive loss-of-function mutations in ced-9 cause many normally living cells to undergo 
apoptosis and are lethal to C. elegans (Hengartner et al., 1992). These observations 
suggest that the protein product of ced-9 acts as a gatekeeper to prevent cells from 
activating the cell death program.
Three other C. elegans genes, egl-1 (egl, egg-laying defective), ced-4 and ced-3 seem to 
be required for all somatic cell death to occur. Loss-of-function mutations in egl-1, ced-4 
or ced-3 lead to the survival of the cells that normally undergo apoptosis during wild-type 
development (Ellis and Horvitz, 1986; Conradt and Horvitz, 1998). The gene egl-1 
encodes a protein that interacts with Ced-9 protein, and gain-of-function mutations in egl-
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1 cause the two hermaphrodite-specific neurons (HSNs), which are required for egg 
laying, to undergo apoptosis inappropriately (Conradt and Horvitz, 1998). A loss-of- 
function mutation in egl-1 prevents not only the ectopic death of the HSNs but also 
apoptosis in most cells otherwise undergoing programmed cell death. On the other hand, 
recessive loss-of-function mutations in ced-3 and ced-4 prevent all 131 cells from 
undergoing programmed cell death during C. elegans hermaphrodite development 
(reviewed by Yuan, 1996). Such mutations can also prevent the excess cell death and 
lethality in ced-9 loss-of-function mutant animals (Hengartner et al., 1992), indicating that 
ced-3 and ced-4 function genetically downstream of ced-9. In addition, mutations in 
either ced-3 or ced-4 are sufficient to eliminate all programmed cell death, suggesting that 
the functions of these two genes are not redundant (Ellis and Horvitz, 1986). Thus, the 
Ced-3 and Ced-4 proteins may well represent the machinery that carry out the execution 
of the cell death program within the dying cells.
Further genetic studies suggest that ced-4 acts upstream of ced-3 since cell death induced 
by ced-4 over-expression is greatly reduced in the absence of activity of cell death 
protease Ced-3 (Shaham and Horvitz, 1996). It has recently been shown that interaction 
of Ced-4 with Ced-3 results in the activation of Ced-3 and the initiation of cell death 
(Seshagiri and Miller, 1997; Chinnaiyan et al., 1997a and b). It has also been shown that 
Ced-9 protein functions to negatively regulate the cell death by binding to Ced-4 protein 
(Chinnaiyan et al., 1997b; Spector et al., 1997; Wu et al., 1997), thus preventing the 
activation of Ced-3 (Hengartner, 1997). However, these observations do not exclude the 
possibility that ced-9 may also employ other mechanism(s) in suppressing apoptosis apart 
from inhibiting the activation of ced-4 and ced-3. Indeed, recent studies show that Ced-9 
can also directly inhibit the activity of Ced-3 protease in C. elegans (Xue and Horvitz, 
1997). By contrast, loss of egl-1 function, while preventing somatic cell death as does 
loss of ced-4 or ced-3 function, does not prevent the cell death and lethality caused by loss 
of ced-9 function (Conradt and Horvitz, 1998), suggesting that egl-1 may act genetically 
upstream of ced-9. As Egl-1 protein binds to the Ced-9 protein, it has been proposed that 
Egl-1 acts by releasing Ced-4 from Ced-9 thus functioning as a negative regulator of Ced- 
9 (Metzstein et al., 1998).
1.4.2 Mammalian homologues of the cell death genes
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The molecular characterisation of C elegans cell death genes has significantly 
contributed to the understanding of some of the biochemical mechanisms underlying 
apoptosis in mammals. The discovery that ced-3 encodes a protease homologous to 
mammalian interleukin-Ip converting enzyme (ICE) (Yuan et al., 1993b) was 
instrumental in identifying a role of mammalian Ced-3-like proteases in the regulation of 
apoptosis. To date, there are at least 13 mammalian Ced-3/ICE-related proteases 
identified (reviewed by Thomberry and Lazebnik, 1998), and a unified nomenclature for 
these proteases has been established after the name caspase, with the “c” denoting a 
cysteine protease and the “aspase” referring to the unique ability of these proteases to 
cleave specifically after an aspartic acid residue (Alnemri et al., 1996). Another 
mammalian protein related to the Ced-4 protein, Apaf-1 (Apaf, apoptotic protease 
activating factor), appears to be critically involved in a pathway leading to the activation 
of some of these caspases (Zou et al., 1997, see below). Cloning of the ced-9 gene shows 
that it encodes a 280-amino acid protein containing sequence and structural similarities to 
the mammalian Bcl-2 protein (Hengartner and Horvitz, 1994). This discovery, together 
with the findings that human Bcl-2 can block programmed cell death in C. elegans, thus 
functionally replacing Ced-9 (Vaux et al., 1992), suggests that at least some of molecular 
mechanisms of apoptosis are evolutionarily conserved. In addition, Egl-1 has functional 
and molecular similarity to the “BH3-only” (BH, Bcl-2 homology domain) subfamily of 
Bcl-2-like proteins (reviewed by Adams and Cory, 1998; Metzstein et al., 1998). BH3- 
only proteins have been shown to induce apoptosis when over-expressed in mammalian 
cell systems (Conradt and Horvitz, 1998).
The structural and functional similarities between C. elegans Ced-9, Ced-4, Ced-3 and 
Egl-1 proteins and their respective mammalian counterparts strongly suggest an 
evolutionary conservation of a genetic pathway of apoptosis in multicellular organisms. It 
is likely that additional mammalian apoptosis-regulating genes will be identified that may 
share similarities with other C. elegans cell death genes. However, the situations in 
mammals are much more complicated, for instances, instead of ced-9, ced-4, ced-3 and 
egl-1, there are already many more M-2-related genes (Adams and Cory, 1998) and 
many more caspase-ioidXod genes (Thomberry and Lazebnik, 1998) reported in 
mammalian cells. Furthermore, it is also expected that some other critical biochemical 
events may be involved in mammalian cell death whereas they may not be important in C. 
elegans cell death, as will be described below.
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1.5 Major biochemical events of apoptosis in mammalian cells
The evolutionary conservation of the molecular machinery responsible for apoptosis, as 
described above, also suggests that apoptosis occurs through the activation of an intrinsic 
cell suicide program. The basic machinery to execute apoptosis appears to be 
constitutively present in almost all mammalian cells, but the activation of the cell death 
program may be carefully regulated by many different signals of both intra- and extra­
cellular origin (reviewed by Steller, 1995; Wyllie, 1995). These diverse signals may 
function to either suppress or promote the activation of the death program. Apoptotic cell 
death thus occurs in two phases, an initial commitment phase followed by the execution 
phase (reviewed by Eamshaw, 1995). Upon receiving a signal which can be either 
external or internal, the cell responds to it. The length of time for decision making 
between life and death varies enormously, thus making it extremely difficult for the 
biochemical characterisation of the molecular events involved in this phase. Once cells 
become committed to death, there occurs a transition to an execution phase. This 
execution phase, characterised by a series of distinct morphological and biochemical 
changes of apoptotic phenotype, is brief and decisive (Eamshaw, 1995). As a result, the 
cell has ceased its existence as an integral unit.
The understanding of the elaborate sequence of biochemical events during the execution 
phase of apoptosis has so far been dominated by three major observations. Firstly, 
apoptosis is the outcome of a systematic dismantling cascade of key cellular components 
and activation of caspases appears to be primarily responsible for this to occur. Secondly, 
many important apoptosis-related molecules, e.g. Bcl-2 and cytochrome c, are localised in 
mitochondria. Alterations in mitochondrial function and structure also occur during the 
induction of apoptosis, thus suggesting that mitochondria co-ordinate the apoptotic 
process in execution phase. Finally, both activation of caspases and mitochondrial 
changes have been implicated in resulting in the plasma membrane changes in cells 
undergoing apoptosis, which lead to the recognition and phagocytosis thus completing the 
elimination of dead cells. However, many questions remain unresolved, for example, 
how these events are regulated and what the temporal relationships between these events 
are and so on. Below is a literature review on the background of these individual events 
and their biological significance in apoptosis.
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1.5.1 Activation of caspases
Apoptosis is accompanied by a cascade of proteolysis of a set of cellular proteins 
resulting in disassembly of the cell. This cascade is centred on the activation of caspases, 
which is triggered in response to proapoptotic signals through several pathways. Thus 
caspases represent a proteolytic system, a central component of the execution machinery 
of apoptosis within the cell.
1.5.1.1 Biochemical properties of caspases
With the cloning of ced-3 in C. elegans comes the observation that it encodes a protease 
homologous to the mammalian ICE (now renamed as caspase-1) (Alnemri et al., 1996). 
Together with the finding that apoptosis can be induced in mammalian cells by transient 
expression of caspase-1 (Miura et al., 1993), these studies demonstrate for the first time 
that there exists a conserved family of proteases acting as a critical component of the cell 
death machinery. Thus far there are 13 members of caspase family being identified 
(Table 1). In addition to their sequence similarity to Ced-3, the members of caspase 
family of proteases have several general properties. As indicated by their names, caspases 
are cysteine proteases, each containing a conserved QACRG pentapeptide active-site
— Proform
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Figure 1. Proposed structures of pro- and active-caspase-3
In common with other caspases, caspase-3 is synthesised as an inactive proenzyme and upon activation, is 
cleaved at specific aspartate residues, generating a large and a small subunit, which together form an active 
enzyme in the form of a heterotetramer containing two large and two small subunits. The amino-terminal 
prodomain, which is highly variable in length and sequence, is involved in regulating caspase activation. 
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motif (reviewed by Nicholson, 1996; Cohen, 1997). Caspases are synthesised as 
catalytically inactive proenzymes composed of a variable length amino-terminal 
prodomain, a large subunit (~20 kDa) and a small subunit (~10 kDa) (Fig. 1). Activation 
of caspases requires proteolytic cleavage of the proenzyme at specific aspartate residues 
separating these three domains, thereby resulting in the removal of the prodomain and 
formation of a heterodimer containing one large and one small subunit. Crystallographic 
analyses have shown that the active caspase is a tetramer containing two such 
heterodimers, with two catalytic sites that appear to function independently (Walker et al., 
1994; Wilson et al., 1994; Rotonda et al., 1996). Within each catalytic domain, the large 
and small subunits are closely associated, with both contributing residues necessary for 
substrate binding and catalysis. The amino-terminal prodomain, which is highly variable 
in length (from 23 to 216 amino acids) and sequence, is believed to regulate the activation 
of these enzymes (reviewed by Cryns and Yuan, 1998). Caspases are among the most 
specific of proteases with an unusual and absolute requirement for cleavage after aspartic 
acid (Thomberry et al., 1992; Thomberry and Molineaux, 1995). This distinctive 
substrate specificity, coupled with their necessary proteolytic activation at aspartic 
residues, suggests that autoproteolysis exists in caspases, which may be responsible for 
self-activation and/or activation of other caspases. In addition, efficient catalysis also 
requires four amino acids amino-terminal to the cleavage site of the substrate to serve as 
recognition motif. However, this preferred tetrapeptide recognition motif differs 
significantly among individual caspases, especially the amino acid at P4 position of the 
substrate (Thomberry et al., 1997). This may not only explain the diversity of their 
biological functions, but also suggest that caspases cleave only a set of specific substrates 
with optimal tetrapeptide sequences. The stringent specificity of caspases is consistent 
with the observation that apoptosis is accompanied by the proteolysis of a select set of 
cellular proteins, but not a random protein digestion. Recent studies using a positional 
scanning substrate combinatorial library or synthetic peptides divide caspases into three 
subgroups based on their substrate preferences (Talanian et al., 1997; Thomberry et al.,
1997). The first group comprises of caspases-1, -4, and -5 which prefer bulky 
hydrophobic residues in the P4 position and have the optimal substrate cleavage sequence 
WEXD. The second group consists of caspases-2, -3, and -7 which favour an aspartate 
residue in the P4 position and cleave targets with DEVD sequence. The third group 
contains caspases-6, -8, and -9 which exhibit certain degrees of flexibility in their P4 
preferences with optimal substrate cleavage sequence (L/V)EXD and IEXD. These
18
Chapter 1 Introduction
Table 1. Members of the caspase family of proteases
Name Alternative name References
Caspase-1 ICE Yuan et al., 1993b
Caspase-2 ICH-1, Nedd2 Wang et al., 1994; Kumar 
et al., 1994
Caspase-3 CPP32, Varna, apopain Fernandes-Alnemri et al., 
1994; Tewari et al., 1995b; 
Nicholson et al., 1995
Caspase-4 ICErein, TX, ICH-2 Munday et al., 1995; 
Faucheu et al., 1995; 
Kamens et al., 1995
Caspase-5 ICEreim, TY Munday et al., 1995; 
Faucheu et al., 1996
Caspase-6 Mch2 Femandes-Alnemri et al., 
1995a
Caspase-7 Mch3, ICE-LAP3, CMH-1 F emandes-Alnemri et al., 
1995b; Duan et al., 1996a; 
Lippke et al., 1996
Caspase-8 MACH, FLICE, Mch5 Boldin et al., 1996; Muzio 
et al., 1996; Srinivasula et 
al., 1996a
Caspase-9 ICE-LAP6, Mch6 Duan et al., 1996b; 
Srinivasula et al., 1996b
Caspase-10 Mch4, FLICE2 F emandes-Alnemri et al., 
1996; Vincenz et al., 1997
Caspase-11 ICH-3 S.Wang et al., 1996
Caspase-12 Van de Craen et al., 1997
Caspase-13 ERICE Humke et al., 1998
results are consistent with the cleavage sites of the intracellular proteins known to be 
cleaved by. caspases. For instance, caspase-1 cleaves pro-interleukin-1 (3 at two sites with 
sequences ofFEAD and YVHD (Cerretti et al., 1992; Thomberry et al.,1992). Caspase-3 
cleaves a number of proteins at DXXD sequence during the induction of apoptosis, such 
as PARP containing DEVD motif (Lazebnik et al., 1994; Nicholson et al., 1995), whereas 
caspase-6 cleaves the nuclear envelope protein lamin A at VEID sequence (Takahashi et 
al., 1996). It is important to note, however, that these observations should not be 
interpreted such that one is somewhere near to establish the specific protein substrates of 
the individual caspases in cells undergoing apoptosis. In fact, genetic analysis has thus 
far failed to identify specific substrates of the caspases (reviewed by Villa et al., 1997). 
This may be probably due to the fact that the multiple caspases exist in cells and many of 
them have overlapping cleavage activities as demonstrated by a number of in vitro 
studies. To complicate this further, some intracellular protein substrates may also be
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cleaved by non-caspase proteases during the induction of apoptosis. For example, actin, a 
major component of the cytoskeleton, may be cleaved by caspases (Mashima et al., 1995; 
Kayalar et al., 1996) as well as by non-caspase (Brown et. al., 1997) in cells undergoing 
apoptosis.
1.5.1,2 Role of caspases in apoptosis
Several lines of evidence demonstrate that caspases are critically involved in apoptosis. 
First, early studies have shown that over-expression of caspases-1 (Miura et al., 1993), -2 
(Kumar et al., 1994; Wang et al., 1994), or -3 (Femandez-Alnemri et al., 1994) induces 
apoptosis in various cell systems. Second, several procaspases are proteolytically 
activated early during apoptosis induced by a variety of apoptotic stimuli (Armstrong et 
al., 1996; Duan et al., 1996a; Orth et al., 1996; Shi et al., 1996; Faleiro et al., 1997; H. Li 
et al., 1997; MacFarlane et al., 1997; Medema et al., 1998). Thirdly, as mentioned above, 
many of the proteins being cleaved during apoptosis are cleaved at aspartate residues by 
caspases. Furthermore, specific inhibitors of caspases such as synthetic peptides, viral 
proteins, dominant-negative caspases, and antisense constructs can block apoptosis both 
in vitro and in vivo induced by a diverse proapoptotic stimuli (reviewed by Cohen, 1997; 
Villa et al., 1997; Cryns and Yuan, 1998). The most definitive support for their role in 
apoptosis comes from the in vivo studies with targeted gene knock-out approaches. Mice 
deficient in caspase-3 show a phenotype of decreased apoptosis in the brain and 
premature lethality (Kuida et al., 1996). Recently, it has been shown that mice deficient 
in caspase-9 die perinatally with a markedly enlarged and malformed cerebrum most 
probably caused by reduced apoptosis during brain development (Kuida et al., 1998; 
Hakem et al., 1998). Taken together, these findings suggest unequivocally that caspases 
are essential mediators of apoptosis, although not all caspases play an equally important 
role in apoptosis. For instance, evidence is accumulating that caspase-1 is of greater 
significance in inflammatory response than in apoptosis (reviewed by Chinnaiyan and 
Dixit, 1996; Cohen, 1997; Thomberry and Lazebnik, 1998), despite the fact that it is the 
first identified member of the caspase family of proteases.
How do caspases function in contributing to apoptotic cell death? Although the precise 
relationship of most cellular protein substrates cleaved by caspases to apoptosis is largely 
unknown, careful evaluation of the functions of these substrates may provide some clues. 
From a growing list of substrates that are cleaved by caspases during apoptosis (see Table
20
unapter i mtroaucuon
2), at least four classes of substrates with apparently different functions have emerged 
(reviewed by Villa et al., 1997; Thomberry and Lazebnik, 1998). Class 1 substrates 
include those enzymes whose activation requires caspase cleavage. Typical examples are 
the procaspases themselves, as described earlier. Class 2 substrates are structural 
proteins, as disassembly of cellular structure is an essential event leading to the demise of 
the cell. For example, cleavage of nuclear scaffold protein lamins is often observed in 
cells undergoing apoptosis, which probably contributes to the collapse of the nucleus and 
condensation of chromatin, classical features of apoptosis (Lazebnik et al., 1995; 
Takahashi et al., 1996; Rao et al., 1996). Class 3 substrates are those proteins whose 
function is to prevent cells from undergoing apoptosis. An example is the cleavage of 
DFF45/ICAD (Liu et al., 1997; Enari et al., 1998; Sakahira et al., 1998), an inhibitor of 
the nuclease responsible for DNA fragmentation known as CAD (caspase-activated 
deoxyribonuclease). Other inhibitors of apoptosis cleaved by caspases include Bcl-2 
protein (Cheng et al., 1997). Class 4 substrates represent, however, the majority of the 
proteins whose consequence for apoptosis after caspase cleavage is not fully understood 
yet. These include PARP, DNA-PK, Ul-70kDa and many more. It is speculated that the 
proteolytic disruption of critical homeostatic and repair functions of these proteins may 
facilitate cellular disassembly. Therefore, taken together, these findings clearly 
demonstrate that caspase-mediated proteolysis of many specific intracellular proteins is 
closely associated with the development of many characteristic features of apoptosis. 
Obviously further studies are required to elucidate the functional relationship between 
those known as well as newly discovered caspase substrates and the apoptotic phenotype.
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Table 2. Proteins known to be cleaved by caspases during apoptosis
Proteins Cleavage motif References
Class 1 : enzymes whose activation requires caspase cleavage
procaspases Y/VEX*D, Nicholson and Thomberry, 1997;
DXXD, Cohen, 1997
pro-IL-ip YVHD Thomberry et al., 1992
PKCÔ DMQD Emoto et al., 1995
MEKK-1 DXXD Cardone et al., 1997
PAK2 ? Rudel and Bokoch, 1997
Class 2: components of structural framework
nuclear lamins VEID Lazebnik et al., 1995; Takahashi et 
al., 1996
Gas2 SRVD Brancolini et al., 1995
gelsolin Kothakota et al., 1997
Class 3: inhibitors of apoptotic process
DFF45/ICAD DETD, DAVD Liu et al., 1997; Enari et al., 1998; 
Sakahira et al., 1998
Bcl-2 DAGD Cheng et al., 1997
Bcl-xL ? Clem et al., 1998
Class 4: substrates with unknown consequence for apoptosis
PARP (DNA repair)** DEVD Lazebnik et al., 1994; Nicholson et 
al., 1995
DNA-PK^ (DNA repair) DEVD Casciola-Rosen et al., 1995; Song 
et al., 1996
Ul-70 kDa (component of DGPD Casciola-Rosen et al., 1994;
mRNA splicing complex) Tewari et al., 1995a
SREBPs (sterol regulatory DEPD X.Wang et al., 1996
element binding protein)
heteroribonuclear proteins Cl ? Waterhouse et al., 1996
and C2 (mRNA processing)
DSEB/RF-C140 (subunit of DEVD Ubeda and Habener, 1997
DNA replication complex c)
D4-GDI (regulating Rho DEED Naet al., 1996
GTPases)
fodrin (membrane associated DETD Martin et al., 1995a; Cryns et al.,
cytoskeletal protein) 1996; Vanags et al., 1996
actin (cytoskeletal protein) ? Mashima et al., 1995; Kayalar et 
al., 1996
Rb (cell cycle regulatory DEAD Janicke et al., 1996; Tan et al..
protein) 1997
Huntintin (huntinton disease DXXD Goldberg et al., 1996
gene product)
P-catenin (cell-cell contact) ? Brancolini et al., 1997
presenilins 1 and 2 ? T.Kim et al., 1997; Vito et al.,
______________________________ 1997
* denotes any amino acid residue 
** known functions indicated in bracket
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1,5.1.3 Mechanisms o f caspase activation
As described earlier, caspases are present in cells as inactive proenzymes which require 
activation. Once activated by proteolytic processing at aspartate residues, they are 
capable of activating other caspases as well as cleaving intracellular protein substrates.
But how is the first caspase activated? The available evidence suggests that there exists at 
least two distinct initial caspase activating mechanisms, as outlined in figure 2.
The first of these pathways is initiated in response to apoptotic stimuli such as DNA 
damaging agents that trigger a release of mitochondrial cytochrome c into the cytoplasm, 
where it interacts with other molecules to form a caspase cascade initiating complex. This 
finding was based on an early observation that cytochrome c, a key component of the 
mitochondrial electron transport chain, is required for the activation of caspase-3 in a cell- 
free system (Liu et al., 1996). Further studies show that cytochrome c is rapidly released 
from the mitochondria into the cytoplasm during the induction of apoptosis by diverse 
apoptotic stimuli in several cell systems (Krippner et al., 1996; Yang et al., 1997; Kluck 
et al., 1997). Significantly, cytochrome c release occurs prior to caspase-3 activation and 
DNA fragmentation in cells undergoing apoptosis induced by staurosporine, UV 
irradiation or etoposide (Yang et al., 1997; Kluck et al., 1997; Bossy-Wetzel et al., 1998). 
Cytosolic extracts that have been removed of cytochrome c by immunodepletion are 
unable to activate caspase-3 or induce DNA fragmentation, and re-addition of 
holocytochrome c (containing heme) but not apocytochrome c (without heme) restores 
these activities (Liu et al., 1996). Meanwhile, over-expression of anti-apoptotic Bcl-2 or 
Bcl-xL protein prevents apoptosis as well as translocation of cytochrome c from 
mitochondria to the cytoplasm in cells treated with apoptotic stimuli including DNA 
damaging agents and staurosporine (Yang et al., 1997; Kluck et al., 1997; Vander Heiden 
et al., 1997; Kharbanda et al., 1997). These results clearly indicate that cytochrome c 
release is an early event during the induction of apoptosis, and yet Bcl-2 or Bcl-xL is 
capable of blocking its release thus acting upstream of this event. Recent studies 
demonstrate that, upon its release into the cytoplasm, cytochrome c, together with dATP, 
Apaf-1 (mammalian Ced-4 homologue) and procaspase-9, forms a complex, which results 
in the activation of caspase-9 (P. Li et al., 1997; Zou et al., 1997). Sequence and 
structural analyses show that Apaf-1 contains three functional domains, an amino- 
terminal caspase-recruitment domain (CARD), a conserved nucleotide binding domain in 
the middle and a carboxy-terminal domain with many WD repeats presumably important
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for protein-protein interaction (Zou et al., 1997). Binding of Apaf-1 to caspase-9 through 
their respective amino-terminal CARD domains requires both dATP and cytochrome c, 
suggesting that dATP and cytochrome c may function to alter the conformation of Apaf-1, 
rendering its CARD domain more accessible to caspase-9 (P. Li et al., 1997). dATP 
interacts with the nucleotide domain in Apaf-1 that is conserved in Ced-4, where 
mutations of this region in Ced-4 impair its ability to activate Ced-3 (Chinnaiyan et al. 
1997a; Seshagari and Miller, 1997). Once bound to Apaf-1, caspase-9 undergoes 
autoproteolytic activation which subsequently activates other caspases such as caspase-3 
(P. Li et al., 1997; Srinivasula et al., 1998). Consistent with the role of caspase-9 as an 
apical caspase in this model of caspase activation cascade, over-expression of a 
catalytically inactive caspase-9 mutant fails to activate caspase-3 and attenuate the 
apoptotic response (P. Li et al., 1997). Recently, Bcl-xL has been shown to bind 
specifically to the Ced-4-like domain of Apaf-1 and inhibit Apaf-1-dependent caspase-9 
activation (Hu et al., 1998), whereas pro-apoptotic members of Bcl-2 family proteins Bax 
and Bak can disrupt interaction between Bcl-xL and Apaf-1 (Pan et al., 1998). These 
observations provide further evidence for a role of cytochrome c and dATP-dependent 
formation of Apaf-1/caspase-9 complex in initiating the caspase activation cascade.
The second pathway of initiating caspase activation starts from the cell surface membrane 
with ligand binding to a death receptor. Apoptosis mediated by ligation of death receptor 
CD95, for example, involves the initial formation of a death inducing signalling complex 
(DISC), which is formed following the recruitment of an adaptor molecule, F ADD (F as- 
associating protein with a death domain) (Kischkel et al., 1995). F ADD binds through its 
death effector domain (DED) to one of the two DEDs in the prodomain of caspase-8, 
resulting in its activation (Boldin et al., 1996; Muzio et al., 1996). Once activated, 
caspase-8 then activates other caspases resulting in the apoptotic phenotype. This 
pathway thus provides a direct link between cell death receptors and the caspases. 
Recently, it has been shown that, apart from direct activation of other caspases, active 
caspase-8 can also cleave other cytosolic factor(s), such as Bid (Bcl-2 interacting protein 
with proapoptotic BH3 domain), resulting in a translocation of the cleaved Bid to 
mitochondria where it induces the release of cytochrome c (Li et al., 1998; Luo et al., 
1998). This results in activation of caspase-9, which in turn activates other caspases 
(Srinivasula et.al., 1996a; Scaffidi et al., 1998). Thus, depending on the cell type, 
mitochondria may be initially bypassed in death receptor-mediated apoptosis following
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direct activation of the downstream caspases such as caspases-3 and -7 by caspase-8 
(Scaffidi et al., 1998). The downstream caspases then cleave cellular protein substrates as 
well as disrupt mitochondrial membrane function leading to a release of mitochondrial 
cytochrome c, resulting in a further activation of caspases and the establishment of a self- 
amplification loop (Marzo et al., 1998, Kuwana et al., 1998), so accelerating the apoptotic 
process.
Interestingly, in both pathways the importance of the prodomains of caspases in the 
regulation of their activation has been highlighted by the fact that the prodomains mediate 
protein-protein interactions. The CARD and DED domains in the prodomains of 
caspases-9 and -8, respectively, all function as binding sites between two molecules 
leading to the initiation of caspase activation, These caspases with long prodomains are 
thus also known as initiation caspases, whereas other caspases with no or short 
prodomains such as caspase-3, -6, and -7 are referred to as effector caspases (Cohen,
1997). Therefore the execution of the death programme appears to occur following 
activation of a hierarchy of caspases with caspase-8 and caspase-9 being at the apex of the 
cascades originating at the cell membrane or the mitochondria respectively (Figure 2).
CD95Death stimuli
FADD DD
DED
Bcl-2
Bcl-xi Procaspase-8
Cytosolic 
factors ydATP+Apàf-ï
Active caspase-8
Active caspase-9
Effector caspases, 
G.g. -3, -6, -7
Death substrates ----- ► A p o p to s is
Figure 2. Two distinct pathways that initiate caspase activation cascade
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1.5.1.4 Inhibitors of caspases
The importance of inhibitors in the regulation of complex proteolytic systems in general 
is well recognised, and this is no exception in the control of cell death specific proteases. 
In fact, it has been suggested that the inhibitors can establish a threshold that regulates the 
concentration of active caspases in the cell, thus preventing the undesirable cell death 
resulting from spontaneous activation (Thomberry and Lazebnik, 1998). These inhibitors 
can be subdivided into two groups based on their origins.
As described in section 1.3.1.3, identification of caspase inhibitors has come from the 
work on viruses, which inhibit apoptosis to circumvent the normal host defence to 
infection. These inhibitors include cowpox protein CrmA (Ray et al., 1992), baculovirus 
proteins p35 (Clem et al., 1991; Bump et al., 1995) and a family of LAP (inhibitor of 
apoptosis) (Clem and Miller, 1994; Hawkins et al., 1996). CrmA is a serpin-like protease 
inhibitor and over-expression of CrmA prevents apoptosis in a number of cell systems 
(Miura et al., 1993; Gagliardini et al., 1994). Although CrmA was originally described as 
a specific inhibitor of caspases (Ray et al., 1992), it is now known that it inhibits different 
caspases in a differential manner. It is a potent inhibitor of caspases-1, -4, -6 and -8, but 
less effective in inhibiting caspases-2, -3, -7, and -10 (reviewed by Cohen, 1997), which 
suggests that there is CrmA-sensitive and -resistant pathways present in the cells. 
Consistent with this, CrmA has been shown to block apoptosis induced by CD95, TNFa, 
and growth factor withdrawal, but not cell death induced by DNA damaging agents, 
staurosporine or over-expression of pro-apoptotic member of Bcl-2 family protein Bak 
(reviewed by Cohen, 1997; Villa et al., 1997). The baculovirus p35 protein exhibits 
apdptosis-protective effect in a manner similar to CrmA, but with broader spectrum in 
inhibiting caspases. p35 has been shown to inhibit caspases-1, -2, -3 and -4 in vitro and 
block apoptosis induced by CD95, TNFa, and growth factor withdrawal as well as DNA 
damaging agents (Villa et al., 1997). However, although there is no reported instances of 
p3 5-resistant apoptosis, its selectivity for caspases is not clearly defined yet. The precise 
caspase targets of a newly discovered family of LAP proteins also remain to be elucidated. 
lAPs inhibits caspases-3 and -7 in vitro, suggesting that they block apoptosis by inhibiting 
caspases (Deveraux et al., 1997). In contrast to p35 and CrmA that require peptide bond 
hydrolysis as part of their inhibitory mechanism (Komiyama et al., 1994; Xue and 
Horvitz, 1995), LAPs act as inhibitors not as substrates of the caspases (Roy et al., 1997). 
Future studies obviously need to address the mechanism by which LAPs inhibit caspases.
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Synthetic inhibitors are mainly the peptides which contain a substrate recognition motif 
similar to that found in the endogenous substrates, such as YVAD and DEVD, in order to 
be selective for caspases. There are reversible inhibitors comprising mostly the aldehyde 
derivatives as well as irreversible inhibitors containing chloromethyl, fluoromethyl and 
acyloxymethyl ketone groups (reviewed by Thomberry, 1994; Cohen, 1997; Villa et al.,
1997). However, the specificity of the peptide inhibitors is always subject to dispute. In 
addition, their use is also limited by membrane impermeability in intact cells (reviewed 
by Henkart, 1996). To overcome the pitfall, a tripeptide inhibitor, benzyloxycarbonyl- 
valinyl-alanyl-aspartyl (OMe) fluoromethyl ketone (Z-VAD.FMK) has been developed.
It, at lower micromolar concentration, inhibits the processing of caspase-3 in vitro (Slee et 
al., 1996) and DEVD cleavage activity in lysates from cells pre-treated with apopotic 
stimuli (MacFarlane et al., 1997). This tripeptide is a cell-permeable inhibitor of caspases 
whose permeability is facilitated by the presence of benzyloxycarbonyl and OMe groups 
(Cohen, 1997). It inhibited apoptosis induced by a variety of stimuli in a number of cell 
systems, including rat thymocytes (Feamhead et al., 1995a) and hepatocytes (Cain et al.,
1996), human leukaemic Jurkat T cells (Chow et al., 1995; Armstrong et al., 1996), 
human B-cell lymphoma cell line GM701 and fibroblast cell line SKW6.4 (Jacobson et 
al., 1996) and human monocytic THP.l cells (Zhu et al., 1995). Z-VAD.FMK also blocks 
CD95-induced apoptosis in the fiver of mice (Rodriguez et al., 1996; Chandler et al.,
1998). Thus careful use of synthetic peptide inhibitor is helpful to elucidate the role of 
caspases, particularly in intact cell systems.
1.5.2 Mitochondrial changes
When apoptosis was first described as a unique type of cell death distinct from necrosis, 
the ultrastructure of cytosolic organelles, including mitochondria, appeared to be well 
preserved and the cytoplasm became condensed as a result of overall shrinkage m cells 
undergoing apoptosis (Kerr, 1971; Kerr et al., 1972). Subsequent studies consistently 
show a nearly normal appearance of mitochondria (reviewed by Wyllie et al., 1980; 
Arends and Wyllie, 1991). These morphological findings are further confirmed by a 
recent study investigating changes in mitochondrial function during apoptosis (Krippner 
et al., 1996). The preservation of mitochondrial structure and function is also consistent 
with the observations that a normal supply of ATP provided by intact mitochondria is 
required for an active and controlled apoptotic process to proceed (Leist et al., 1997;
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Eguchi et al., 1997; Stefanelli et al., 1997). However, since the recognition that the anti- 
apoptotic Bcl-2 protein is localised on the mitochondrial membrane (Hockenbery et al., 
1990; Krajewski et al., 1993), many attempts have been made to ascertain a role of 
mitochondria in apoptosis in addition to its primary role in energy production.
1,5.2.1 Bcl-2 family proteins and mitochondria
At least 15 Bcl-2 family proteins have so far been identified in mammalian cells, which 
consist of both cell death promoters and inhibitors, such as the anti-apoptotic proteins 
Bcl-2, BcI-Xl, Mcl-1 and the pro-apoptotic proteins Bax, Bcl-xs, Bak, Bid (reviewed by 
Nunez and Clarke, 1994; Reed, 1997a; Chao and Korsmeyer, 1998; Adams and Cory,
1998). Many of these proteins reside in the outer mitochondrial membrane, anchored by a 
stretch of hydrophobic amino acids located at the carboxyl terminus with the proteins 
oriented towards the cytosol (reviewed by Reed et al., 1998). Thus the obvious 
assumption is that the association of Bcl-2 family proteins with mitochondria may be 
required for their appropriate functions in regulating apoptosis. An early attractive 
hypothesis was that during apoptosis reactive oxygen species (ROS) generated from the 
mitochondrial electron transport chain could provide an apoptotic signal and Bcl-2 could 
function as an antioxidant. This was indeed supported by the observation that over­
expression of Bcl-2 inhibited both the nuclear changes of apoptosis and mitochondrial 
generation of ROS (Hockenbery et al., 1993; Kane et al., 1993). However, cells without 
the functional electron transport chain due to the lack of mitochondrial DNA could still be 
induced to undergo apoptosis (Jacobson et al., 1993; Marchetti et al., 1996a).
Furthermore, when cultured under anaerobic conditions where the generation of ROS is 
limited, cells are able to undergo apoptosis in hypoxia condition alone (Shimizu et al., 
1995) or induced by either ligation of death receptor CD95 or withdrawal of survival 
factor (Jacobson and Raff, 1995), which are all inhibited by Bcl-2. Thus, the oxidant 
signalling hypothesis does not appear to explain a general role of mitochondria in 
apoptosis and Bcl-2 can protect cells against apoptosis by a mechanism independent of 
inhibiting the production and/or effects of ROS.
Currently, there are two major mitochondrial events associated with apoptosis: 1) release 
of apoptogenic proteins from mitochondria into the cytosol; and 2) opening of the 
mitochondrial permeability transition (PT) pore, which results in a reduction in the 
mitochondrial membrane potential (A\|/m)- The Bcl-2 family proteins have, with no
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exception, been implicated in the regulation of these two important events, as described 
below.
1.5.2.2 Release o f apoptogenic proteins from mitochondria
Two proteins have been reported to be capable of inducing nuclear apoptotic changes 
when released from mitochondria into the cytosol, i.e. cytochrome c and apoptosis 
inducing factor (AIF) (Liu et al., 1996; Susin et al., 1996a). As described earlier in 
section 1.5.1.3, cytochrome c, together with dATP, Apaf-1 and procaspase-9, forms a 
complex, which results in the activation of caspase-9 (P. Li et al., 1997; Zou et al., 1997). 
Over-expression of anti-apoptotic Bcl-2 and Bcl-xL proteins prevents translocation of 
cytochrome c from mitochondria to cytoplasm in cells treated with diverse apoptotic 
stimuli (Yang et al., 1997; Kluck et al., 1997; Vander Heiden et al., 1997; Kharbanda et 
al., 1997). Conversely, addition of recombinant Bax protein to isolated mitochondria 
induces cytochrome c release (Jurgensmeier et al., 1998). Although the mechanisms by 
which Bcl-2 prevents and Bax promotes the release of cytochrome c from mitochondria 
are not clear, these observations provide supportive evidence of a link between the 
regulation of apoptosis by Bcl-2 family proteins and mitochondria.
AIF alone, on the other hand, has been shown to directly activate caspases in vitro, 
resulting in proteolytic processing of procaspases and formation of active caspases (Susin 
et al., 1996a). It has, however, been argued that AIF itself is possibly a caspase-like 
protease based on the observation that purified AIF from the supernatants of depolarised 
mitochondria is able to cleave recombinant procaspase-3 through a mechanism that is 
inhibited by a tripeptide caspase inhibitor Z-VAD.FMK (Susin et al., 1997). Over- 
expression of anti-apoptotic Bcl-2 protein prevents the release of AIF from mitochondria 
to the cytoplasm in cells treated with several different apoptotic stimuli (Susin et al., 
1996a and 1997), providing further evidence that Bcl-2 family proteins can regulate 
apoptosis at mitochondria. It, however, has to be noted that, to date, cDNAs encoding 
AIF have not been cloned and thus the molecular identity of the protein still remains to be 
determined,
1.5.2.3 Reduction in mitochondrial membrane potential (Ay/J
During oxidative phosphorylation, the synthesis of ATP is tightly coupled to a flow of 
electrons from NADH or FADH2 to 0 2 by a proton gradient across the inner
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mitochondrial membrane (Nicholls and Ferguson, 1992). Electron flow through three 
asymmetrically oriented transmembrane complexes (also known as respiratory chains) 
results in the pumping of protons out of the mitochondrial matrix into the intermembrane 
space. As a result, a proton-motive force is generated, which consists of a pH gradient 
(cytosolic side acidic) and a membrane potential (cytosolic side positive). The energy 
stored in either the pH gradient or the membrane potential drives the F^F^ATFase (also 
known as ATP synthase) in the inner mitochondrial membrane to synthesise ATP when 
the protons re-enter the mitochondrial matrix. Under physiological situations, 
mammalian mitochondria express this electrochemical gradient mostly as membrane 
potential at about 180 mV and to a less extent as pH gradient equivalent to 60 mV, which 
together yield a total energy of 240 mV (reviewed by Chen, 1988). Thus, the membrane 
potential is essential for mitochondrial production of ATP. The mitochondrial membrane 
potential is also believed to play a vital role in the import of precursor proteins (reviewed 
by Geli and Click, 1990; Bauer et al., 1996), intracellular Ca** homeostasis (reviewed by 
Gunter and Gunter, 1994; Budd and Nicholls, 1996a) and mitochondrial protein synthesis 
(Abou-Khalil et al., 1986).
Reduction in the mitochondrial membrane potential (Avj/hJ  has recently been observed to 
occur early during the induction of apoptosis by a variety of stimuli (Petit et al., 1995; 
Zamzami et al., 1995) and to possibly regulate the aberrant exposure of 
phosphatidylserine on the outer plasma membrane of the cells undergoing apoptosis 
(Castedo et al., 1996). The decrease in Av|/m occurs as a result of the opening of the 
permeability transition (PT) pore or megachannel in the inner mitochondrial membrane 
(reviewed by Petit et al., 1996; Susin et al., 1996b). Although the PT pore has been 
known for more than 20 years (Hunter et al, 1976), to date the structure and composition 
of the PT pore still remain poorly defined and so does its physiological function. It 
appears to be a complex of polypeptides located presumably at inner and outer membrane 
contact sites and is possibly composed of both inner membrane proteins, such as the 
adenine nucleotide translocator (ANT) and cyclophilin D, and outer membrane proteins, 
such as porin (also known as voltage dependent anion channel) which operate in concert 
to create a channel (reviewed by Bemardi et al., 1994). The PT pore thus probably 
represents the channel in which mitochondria operate mainly to release Ca^ and 
participate in the intracellular Ca^ signalling network necessary for many physiological 
functions of the cell and its opening also allows a permeability of the inner mitochondrial
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membrane to solutes of molecular mass less than about 1.5 kDa (reviewed by Zoratti and 
Szabo, 1995). Ca^, Pj, and oxidant chemicals induce the opening of PT pore, whereas 
Mg"1"1", ADP, low pH and high membrane potential oppose the occurrence of PT. The 
rapid change in permeability resulting from the opening of PT pore causes loss of 
membrane potential, uncoupling of oxidative phosphorylation, release of 
intramitochondrial ions and metabolic intermediates, and mitochondrial swelling (Zoratti 
and Szabo, 1995). It has also been shown that the induction of PT in isolated 
mitochondria results in the release of AIF capable of causing isolated nuclei to undergo 
chromatin condensation and DNA fragmentation (Marchetti et al., 1996b). Inhibition of 
PT by pharmacological agents or by over-expression of Bcl-2 prevented apoptosis (Susin 
et al., 1996a and 1997), whereas over-expression of the pro-apoptotic protein Bax induces 
a loss of Avj/m and apoptosis (Xiang et al., 1996). Thus it has been proposed that a 
reduction in mitochondrial membrane potential (Avj/^ ) is a critical event of apoptosis 
(Kroemer et al., 1997).
The observations that over-expression of Bcl-2 and Bcl-xL or Bax proteins prevents or 
promotes the release of apoptogenic proteins from mitochondria and opening of the 
mitochondrial permeability transition (PT) pore during the induction of apoptosis, as 
described above, provide an important insight into the mechanisms whereby Bcl-2 family 
proteins regulate apoptosis in mitochondria. Recent studies have shown, however, that 
Bcl-2 and Bcl-xL also protect against apoptosis in cells microinjected with cytochrome c 
(F. Li et al., 1997; Zhivotovsky et al., 1998). This suggests that Bcl-2 family proteins 
may also utilise other mechanism(s) of action apart from the mitochondrial ones.
Evidence is now accumulating that some Bcl-2 family proteins are multifunctional, 
possessing more than one mechanisms for modulating cell death. These include their 
functions in channel formation and ion movement, action as a chaperone or molecular 
gatekeeper to control movement of proteins such as cytochrome c across the membranes, 
or as an adapter or docking protein to either facilitate or block interaction of proteins 
leading to activation of caspases, and as a protein that preserves integrity of membranes 
(reviewed by Reed, 1997a; Cai et al., 1998; Chao and Korsmeyer, 1998; Reed et al.,
1998).
1.5.3 Cell surface changes leading to recognition and phagocytosis
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One of the key features associated with apoptosis in vivo is the rapid phagocytosis of cells 
undergoing apoptosis by phagocytes (Kerr et al., 1972; Wyllie et al., 1980). This protects 
surrounding tissues from exposure to injurious contents leaking from dying cells, thereby 
preventing the occurrence of inflammation. The speed of phagocytic clearance also 
suggests that phagocytosis is an efficient means of eliminating apoptotic cells. This swift 
phagocytosis can be mediated by macrophages as well as neighbouring epithelial cells 
(reviewed by Savill et al., 1993). Currently, there is, however, only a limited 
understanding of the molecular mechanisms which render apoptotic cells recognisable to 
phagocytes (Savill, 1998). Nevertheless, it is apparent that the surface of cells undergoing 
apoptosis must be different from that of normal cells so that only the dying cells are 
labelled for disposal. In addition, the available data suggest that the cell surface signals 
leading to recognition and phagocytosis are derived from modification of existing plasma 
membrane components of the cell, as will be described below.
1.5.3.1 Carbohydrates changes
One early observation showed that rodent thymocytes undergoing apoptosis induced by 
glucocorticoids exhibits a reduced mobility in a cell micro-electrophoresis assay 
consistent with loss of sialic acids (Morris et al., 1984). Further study showed that mono- 
and disaccharides inhibit recognition of apoptotic thymocytes by macrophages (Duvall et 
al., 1985), suggesting that loss of terminal sialic acid residues from the sugar side chains 
of cell surface glycoproteins of the apoptotic cells may expose normally masked residues 
such as N-acetyl glucosamine, N-acetyl galactosamine and galactose, which are 
recognised by macrophage lectins, one putative mechanism of cellular interaction (Sharon 
and Lis, 1989). These results also imply that, as a consequence of apoptosis, cells 
undergo specific changes in surface carbohydrates. Further support comes from the 
observation that in neonatal rat liver cell cultures the asialoglycoprotein receptor has been 
implicated in the phagocytosis of apoptotic cells by healthy hepatocytes (Dini et al.,
1992). However, specific exposure of such sugars by apoptotic cells has not been 
consistently demonstrated (Morris et al., 1984) and further studies are needed to clarify 
the sites and timing of carbohydrate changes occurring on the surface of apoptotic cells.
1.5.3.2 Thrombospondin binding moiety
Anionic thrombospondin binding sites on the surface of apoptotic cells also appear to be 
important in signalling recognition of apoptotic cells by a number of phagocyte types.
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This is based on the observation that recognition of apoptotic neutrophils by human 
monocyte-derived macrophages is specifically inhibited by aminosugars and amino acids 
in a charge-dependent manner (Savill et al., 1989). Varying the pH at which the 
interaction was performed not only demonstrates a correlation of phagocytosis with pH, 
but also indicates that the inhibitory effects of these small molecules depended on 
carrying a cationic charge. Furthermore, pre-incubation experiments show that 
aminosugars exert their effects at the surface of apoptotic neutrophils, suggesting the 
involvement of particular anionic groups on the neutrophil surface (Savill et al., 1989). 
The inhibitory effects of cationic aminosugars also suggest that these anionic sites might 
bind thrombospondin, a trimeric multifunctional adhesive glycoprotein secreted by many 
cell types (Frazier, 1987). Subsequent studies have indeed shown that apoptotic 
neutrophils exhibit an increased binding to latex beads coated with thrombospondin, 
which could be inhibited by the mouse monoclonal antibodies that also inhibits 
recognition of apoptotic cells by monocyte-derived macrophages (Savill et al., 1992). 
Thus, these observations indicate that thrombospondin acts as a bridge between the 
apoptotic neutrophils and macrophages. Meanwhile, the phagocyte adhesion receptor 
CD36 is found to co-operate with the vitronectin receptor integrins (avP3) to bind 
thrombospondin (Savill et al., 1990; Fadok et al., 1992a). However, it must be pointed 
out that these findings are all obtained from cultured neutrophils undergoing apoptosis 
and thus the significance of the findings needs to be verified in other cell systems. In 
addition, the anionic thrombospondin binding sites on the surface of apoptotic cells 
remain to be further characterised.
1.5.3.3 Externalisation o f phosphatidylserine
Phosphatidylserine (PS), an anionic phospholipid normally confined to the inner leaflet of 
the plasma membrane bilayer by an ATP-dependent aminophospholipid translocase 
(Verhoven et al., 1995; Tang et al., 1996), is currently the best characterised signal for 
recognition. This mechanism was initially suggested by the observation that macrophages 
bind resealed red cell ghosts that apparently lost asymmetry of membrane phospholipids 
(McEvoy et al., 1986). Normally, the distribution of membrane phospholipids is 
asymmetric, with the outer leaflet of the membrane bilayer predominantly containing the 
neutral phospholipids sphingomyelin and phosphatidylcholine, while anionic 
phospholipids such as phosphatidylserine being restricted to the inner leaflet (Op den 
Kamp, 1979). Later, exposure of PS to the external leaflet of the plasma membrane
33
Chapter 1 Introduction
bilayer is observed as a general phenomenon associated with apoptosis regardless of the 
initiating stimulus (Fadok et al., 1992b). Further studies have shown that PS exposure is 
an early feature of apoptosis in a number of systems, serving as a recognition signal for 
yet to be characterised PS receptors on certain phagocyte populations (Fadok et al.,
1992b; Martin et al., 1995b). The mechanisms mediating PS exposure are complex but 
seem to involve both downregulation of the amino phospholipid translocase activity and 
activation of a non-specific lipid scramblase (Verhoven et al., 1995; Bratton et al., 1997). 
Recently, both activation of caspases and loss of mitochondrial membrane potential have 
also been implicated in PS exposure in cells undergoing apoptosis (Vanags et al., 1996; 
Martin et al., 1996; Castedo et al., 1996; Zamzami et al., 1996). However, the precise 
mechanisms of PS exposure still remain elusive.
In summary, one of the key features of apoptosis is that cells undergoing this form of cell 
death are swiftly recognised by phagocytes and ingested while still intact, protecting 
tissues from the potentially harmful consequences of exposure to the contents of the dying 
cells. Therefore a critical event of apoptosis involves the acquisition of plasma membrane 
changes that result in the recognition and engulfinent of dying cells by phagocytes. To 
date, the nature and kinetics of these surface changes, however, remain largely unknown. 
Different membrane changes may lead to recognition and removal of apoptotic cells by 
different types of phagocytes. Similarly, phagocytes may utilise multiple systems for 
recognition of apoptotic cells, as recently indicated (Pradhan et al., 1997). Other signals 
for recognition may also be involved, which may play an important role in phagocytosis 
of the apoptotic cells. Further studies are thus required for elucidating the mechanisms of 
bringing about the signals for recognition as well as revealing their significance in 
clearance of apoptotic cells in vivo.
1.6 Framework of the study
1.6.1 Rationale
Apoptosis, a basic form of cell death which plays a major role in the development and 
homeostasis of multicellular organisms, is also an important form of cell death induced by 
anti-cancer drugs and toxic chemicals (reviewed by Hickman, 1992; Corcoran et al.,
1994; Trump et al., 1997). However, the biochemical mechanisms of chemical-induced 
apoptosis remain largely unknown. In addition, as reviewed above, apoptosis is a 
programmed form of cell death characterised by morphological and biochemical changes
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affecting the nucleus, cytoplasm and plasma membrane. These changes in various 
cellular compartments are widely regarded as mechanistically linked events in a single 
“program”, in which activation of caspases and proteolysis of intracellular substrates 
represent a final common pathway leading to cell death. To date there has, however, been 
very limited knowledge on the temporal relationship between these changes during 
apoptosis, particularly induced by chemicals.
1.6.2 Objectives
To facilitate the understanding of the biochemical mechanisms of apoptosis, I aimed to 
examine the importance of the major biochemical changes, particularly the activation of 
caspases, reduction in mitochondrial membrane potential and externalisation of PS in 
chemical-induced apoptosis. I also wished to study the temporal relationship of these 
biochemical events leading to the morphological and biochemical features of apoptosis. 
Finally, I intended to investigate the role of mitochondria in this model of apoptosis, in 
particular, its role in initial activation of caspases.
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2.1 Materials
RPM I1640 medium and foetal calf serum (PCS) were purchased from Life 
Technologies Ltd. (Paisley, Scotland). N-tosyl-L-phenylalanyl chloromethyl ketone 
(TPCK) was from Boehringer-Mannheim UK (Lewes, England). Benzyloxycarbonyl- 
valinyl-alanyl-aspartyl (OMe) fluoromethyl ketone (Z-VAD.fink) was from Enzyme 
Systems Inc.(Dublin, CA, USA). “AnalaR” zinc acetate dihydrate was from 
BDH/Merck Ltd.(Poole, England). Etoposide, antimycin A, oligomycin (65 % 
oligomycin A), tumour necrosis factor-a (TNF-a) and all other chemicals were 
obtained from Sigma Chemical Company (Poole, England), unless otherwise stated.
2.2 Cell culture
2.2.1 Human monocytic THP.l cells
THP.l cells were obtained from European Collection of Animal Cell Cultures 
(ECACC) (Porton Down, England) and grown as a suspension in the medium 
supplemented with 10 % heat-inactivated PCS and 2 mM L-glutamine in an 
atmosphere of 5% C02 in air at 37°C. Cells were passaged on every third day and the 
cell density was maintained at 0.25-1 x lOVml. Cell growth was assessed by counting 
cell numbers using a Scharfe cell counter with CASYII software. The population 
doubling time was between 32 and 36 hours. Logarithmically growing cells were 
used for all experiments with an average density of 0.5 x 106 cells/ ml.
2.2.2 Human leukaemic U937 cells
U937 cells were obtained from ECACC and maintained as a suspension under the 
same culture condition as THP.l cells. Cells were kept in logarithmic growth by 
allowing each subculture to obtain a population density of about 1 x 106 cells/ml 
before re-seeding at 1 x 105 cells/ml. The population doubling time was between 20 
and 25 hours as assessed by counting cell numbers using a Scharfe cell counter with 
CASY II software. Logarithmically growing cells were used for all experiments with 
an average density of 0.5 x 106 cells/ ml.
2.3 Microscopy
2.3.1 Fluorescence microscopy
37
Chapter 2 Materials and methods
The apoptotic morphological changes were initially examined under the fluorescent 
microscope with ultraviolet (UV) illumination (352 nm) following staining of the cells 
with the membrane permeable DNA binding dye, Hoechst 33342. Cells (1 xlO6 cells/ 
ml) were incubated with 30 pi of Hoechst 33342 (50 pg/ml) for 5 min at 37°C. After 
centrifugation at 200g for 3 min at 4°C, cells were re-suspended in 300 pi of ice cold 
PBS containing 20 pi of propidium iodide (PI, 50 pg/ml). Cells taking up Hoechst 
33342 were stained blue and considered viable, whereas those cells with PI inclusion 
were stained red and considered non-viable. Observed apoptotic changes included 
condensation and fragmentation of the nuclei.
2.3.2 Electron microscopy
The ultrastructural features of apoptosis were also examined under the electron 
microscope. Cells (2 x 106 ) were harvested as a pellet and processed as described 
(Cohen et al., 1992). Duplicate samples were fixed with 2% glutaraldehyde in 0.1 M 
sodium cacodylate buffer (pH 7.4) at 4°C overnight and postfixed with 1% osmium 
tetroxide/1% potassium ferrocyanide overnight at 4°C. After fixation, cells were 
stained en bloc with 5% aqueous uranyl acetate overnight at room temperature, 
dehydrated, and embedded in Agar 100 epoxy resin. Sections, up to 1 pm were 
examined unstained by electron spectroscopic imaging using a Zeiss 902A electron 
microscope. Ultrathin sections were stained with lead citrate and examined in a Jeol 
100-CXn electron microscope equipped with a rotating stage/eucentric goniometer.
2.4 Flow cytometry
2.4.1 Introduction
Flow cytometry is a technique for making rapid measurements on particles or cells as 
they flow in a fluid stream one by one through a sensing point. The feature of the 
technique is that it measures each event individually rather than as average values for 
the whole population. Typically, a flow cytometer consists of a fluidic system, 
detection devices, signal processing and display units (Ormerod, 1990). The fluidic 
system serves the purpose of delivering cells singly to a specific point in space 
intersected by, in most cases, a laser beam. This is achieved by forcing a cell 
suspension, usually with positive air pressure, into an enclosed channel through which 
sheath fluid is flowing. When cells travel as a stream of single particles, they are
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intersected by a laser light. As a result, cells scatter and/or fluoresce depending on the 
method of staining. The scattered and fluorescent light generated by cells passing 
through the laser beam is collected by photodetectors which convert the photon pulses 
into electronic signals. Further electronic and computational processing results in a 
graphic display and quantitative analysis of measurements.
2.4.2 Hoechst 33342 staining
Hoechst 33342 is one of a family of bis-benzimidazoles which stains DNA 
specifically, binding preferentially to repetitive AT sequences in the minor groove of 
the helix. Unlike other DNA binding dyes which do not freely cross an intact plasma 
membrane, Hoechst 33342 is membrane permeable and also actively transported in 
and out of cells. It has been observed that cells undergoing apoptosis fluoresce more 
brightly than normal cells after a brief incubation with Hoechst 33342. Based on this 
observation, a flow cytometric method has been developed in the laboratory to 
separate and quantify viable apoptotic cells (Sun et al., 1992). Further study showed 
that the increased blue fluorescence is due to an increase in cell membrane 
permeability of apoptotic cells (Ormerod et al., 1993).
Briefly, 1x10* cells were incubated with Hoechst 33342 (1.5 pg/ml) in RPM I1640 
medium containing 10 % FCS at 37 °C for 1 min with THP.l or U937 cells. The cells 
were then cooled down on ice for 3 min, centrifuged at 200g for 3 min, re-suspended 
in 1 ml PBS containing 2.5 pg of propidium iodide (PI). Analysis was carried out at a 
flow rate of 200 cells/second on a Becton Dickinson Vantage flow cytometer with 
Lysis II software. Hoechst 33342 and PI were excited using the 352 nm UV line of a 
Krypton laser and resultant blue (420-480 nm) fluorescence with linear amplification 
versus red (~640 nm) fluorescence with logarithmic amplification were recorded. 
Non-viable, red fluorescent cells were gated out. The remaining cells were displayed 
as a cytogram of blue fluorescence against forward light scatter (indicative of cell 
size). Viable cells with high blue fluorescence was determined as apoptotic cells.
2.4.3 Detecting phosphatidylserine with binding of annexin V
One of the key features associated with apoptosis in vivo is the rapid phagocytosis of 
apoptotic cells by phagocytes (Arends and Wyllie, 1991). This protects surrounding
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tissues from exposure to injurious contents leaking from dying cells, thereby 
preventing the occurrence of inflammation. Currently there is only a limited 
understanding of the molecular mechanisms which render apoptotic cells recognisable 
to phagocytes (reviewed by Savill et al., 1993). However, exposure of 
phosphatidylserine (PS) in the external leaflet of the plasma membrane lipid bilayer, a 
general phenomenon of apoptosis regardless of the initiating stimulus, appears to 
serve as a recognition signal for yet to be characterised PS receptors on certain 
phagocyte populations (Fadok et al., 1992a and b; Martin et al., 1995). PS is an 
anionic phospholipid normally confined to the inner leaflet of the membrane bilayer 
(Op den Kamp, 1979) by an ATP-dependent amino phospholipid translocase 
(Verhoven et al., 1995; Tang et al., 1996). The mechanisms mediating PS exposure 
are complex but seem to involve both loss of amino phospholipid translocase activity 
and activation of a non-specific lipid scramblase (Verhoven et al., 1995; Bratton et al.,
1997).
Annexin V, a family member of the calcium and phospholipid binding proteins that 
are expressed in all mammalian cells except red blood cells (Raynal and Pollard, 
1994), has been shown to preferentially bind PS and to inhibit PS-dependent 
procoagulant reactions (Tait et al., 1989; Andree et al., 1990). It has 320 amino acids 
with a MW of 35.8 kDa (Gnmdmann et al., 1988). Although its biological functions 
in vivo remain unknown, in vitro experiments revealed several properties including 
inhibition of phospholipase A2, anticoagulation and formation of ion channels 
(reviewed by Raynal and Polland, 1994; Moss, 1997). The utility of annexin V in 
flow cytometry applications is derived from its selective affinity for negatively 
charged phospholipids. Under defined salt and calcium concentrations, annexin V has 
specificity for PS over other phospholipid species, with K& for its binding to PS 
estimated at 2 x 10'10 M (Andree et al., 1990). The stoichiometry of annexin V 
binding to PS ranges between 4 and 8 annexin V molecules per one PS molecule 
(Meers and Mealy, 1993; Pigault et al., 1994). Based on these properties, a flow 
cytometric method was developed using FITC-labeled annexin V to bind PS on the 
outer leaflet of plasma membrane for quantifying apoptotic cells (Koopman et al., 
1994; Martin et al., 1995b).
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Briefly, 0.5 x 10* cells were pelleted at 200g for 4 min and re-suspended in 1 ml 
Hepes-bufFered saline (10 mM Hepes/NaOH, pH 7.4,150 mM NaCl, 5 mM KC1,1 
mM MgCl2 and 1.8 mM CaCl2 ) and incubated with 2.5pi FITC- labelled annexin V 
(Bender MedSystems, Vienna, Austria) for 8 min at room temperature in the dark. 
After incubation, 2.5 pg PI was added and the sample was analysed in a Becton 
Dickinson FACScan flow cytometer equipped with an Argon laser emitting excitation 
light at 488 nm. The green fluorescence (520 nm) generated from FITC conjugated 
annexin V and red fluorescence resulting from PI were recorded, both with 
logarithmic amplification. Cells, which included PI, were considered non-viable and 
gated-out. The percentage of the remaining, viable cells with high green fluorescence 
was then determined as apoptotic cells.
2.4.4 Measuring Ax¥m using the fluorescent dye, DiOC6(3)
Mitochondrial membrane potential (AT^ was measured by incubating cells (0.5 x 106 
/ml) for 20 min at 37°C with the cationic lipophilic fluorochrome,
3,3'dihexyloxacarbocyanine iodide (DiOC6(3), 50 nM) (Molecular Probes Inc., 
Eugene, OR) which is retained in mitochondria with a normal membrane potential 
(Petit et al., 1990). Control experiments were performed by incubating untreated cells 
for a further 10 min at 37°C with carbonyl cyanide m-chlorophenyl hydrazone (m- 
C1CCP, 50 pM,), an uncoupling agent which abolishes the A^¥m. At the end of 
incubation, 2.5 pg PI was added and the sample was analysed in a Becton Dickinson 
FACScan flow cytometer equipped with an Argon laser emitting excitation light at 
488 nm. The green fluorescence (520 nm) generated from DiOC6(3) and red 
fluorescence resulting from PI were both recorded with logarithmic amplification. 
Cells with PI inclusion were considered non-viable and gated-out. The percentage of 
the remaining, viable cells with low green fluorescence (below the threshold set up by 
using the mitochondrial uncoupler as a positive control) was then determined as cells 
with decreased AT^. Figure 3 was an example of the flow cytometric analysis of the 
AYm after staining with DiOC6(3).
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Figure 3. Flow cytometric analysis of the after staining with DiOC6(3)
The majority of control cells have high mitochondrial Ax¥m ( A). Apoptotic stimuli induced a decrease 
in mitochondrial A'P,,, (C and D). Carbonylcyanide m-chlorophenylhydrazone (mClCCP, 50 pM), a 
mitochondrial uncoupler, was used as a positive control (B).
2.5 Analysis of caspase activation and proteolytic activity
2.5.1 Introduction
Caspases are cysteine proteases, which have an absolute specificity for an aspartic 
acid in the Pt position of the substrate (Thomberry et al., 1992). They exist in cells as 
inactive proenzymes. Upon activation, the procaspases are cleaved at specific 
aspartate residues, generating a large and small subunit, which together form the
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active enzyme (Thomberry and Molineaux, 1995; Kumar and Lavin, 1996; Cohen,
1997). Thus, western blot analysis using antibodies raised against either the large or 
small subunit of a particular caspase has become a commonly used method to measure 
the activation/processing of the caspase during the induction of apoptosis. Once 
activated, caspases cleave many intracellular proteins including lamins and PAKP. 
Although the precise substrate specificity of most caspases is unknown, PARP is 
cleaved at a DEVD>I<G sequence by caspases-3 and -7 (Lazebnik et al., 1994; 
Fernandes-Alnemri et al., 1995b), whereas lamins are preferentially cleaved at a 
VEtDiN sequence by caspase-6 (Orth et al., 1996; Takahashi et al., 1996).
Therefore, the proteolytic activity of particular caspase(s) can be measured 
fluorimetrically using an appropriate substrate. Again, western blot analysis using 
antibodies recognising the respective fragments of the intracellular proteins known to 
be cleaved by caspases during apoptosis is a useful tool for measuring the proteolytic 
activity of caspase(s).
2.5.2 Fluorimetric measurement
2.5,2A Preparation of cytosolic extracts
Isolation of the cytosolic extracts was essentially as described (Bossy-Wetzel et al.,
1998). Briefly, 50 x 10* THP.l cells were washed twice in ice-cold PBS, pH 7.4 and 
centrifuged at 200g for 5 min. The cell pellet was re-suspended in 200 pi of 
extraction buffer (220 mM mannitol, 68 mM sucrose, 50 mM Pipes/KOH, pH 7.5,50 
mM KC1, 5 mM EGTA, 2 mM MgCl2, 1 mM dithiothreitol, 1 mM 
phenylmethylsulfonyl fluoride, 10 pg/ml leupeptin, 10 pg/ml pepstatin A and 10 
pg/ml aprotinin). After 30 min incubation on ice, cells were homogenised using a 
glass Bounce homogeniser, with 40 strokes of the “B” pestle. The homogenates were 
then centrifuged at 14,000g, for 15 min at 4°C, and the resulting supernatants were 
used as the cytosolic extracts for measuring protease activity and stored at -80 °C. The 
protein concentration of the cytosolic extracts was determined by the Bradford assay 
(Bio-Rad Laboratories Ltd., Hemel Hempstead, England).
2.5.2.2 Enzymic assay
The proteolytic activity of caspase(s) in cell lysates was measured using a continuous 
fluorimetric assay initially described by Thomberry (1994), with minor modifications
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(MacFarlane et al., 1997). Liberation of fluorogenic 7-amino-4- 
trifluoromethylcoumarin from Ac-DEVD.AFC (Enzyme Systems Inc.) as a measure 
of caspase-3 like activity was assayed at excitation and emission wavelengths of 400 
and 505 nm, respectively. Lysates were assayed at 37°C in a modified thermostatted 
cuvette holder in 1.25 ml of 100 mM Hepes, pH 7.5, 10 % sucrose, 0.1 % CHAPS, 10 
mM dithiothreitol in an LS50B luminescence fluorimeter (Perkin-Elmer Corp., 
Norwalk, CT). Routinely, the assays contained 50 or 100 pg of lysate protein and 20 
pM substrate. Calibration was carried out with a standard solution of 7-amino-4- 
trifhioromethylcoumarin (0-1.6 pM). The protease activity was expressed as pmol 
AFC/mg protein/min.
2.5.3 W estern blot analysis
2.53.1 SDS-PAGE
SDS-PAGE was performed essentially as described (Harlow and Lane, 1988). Briefly, 
0.2 x 106 cells were prepared and lysed in sample buffer (62.5 mM Tris/HCl, pH 6.8, 
15 % glycerol, 2 % SDS, 10 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, 2.5 % 
P-mercaptoethanol and 0.005 % bromophenol blue). To assist the dissolution of 
DNA, 4 M Urea was added to the sample buffer and samples were sonicated on ice. 
Cellular proteins were then denatured by boiling for 4 min and resolved on SDS- 
polyacrylamide gels using the Mini-PROTEAN H electrophoresis cell (Bio-Rad) with 
the electrophoresis run at 140 volts for approximately an hour.
2.53.2 Immunoblotting
After electrophoresis, proteins were transferred onto nitrocellulose membrane ( 
Hybond-ECL, Amersham, Little Chalfont, England) at 4°C with the electrophoresis 
run at either 30 volts overnight or 100 volts for one hour using the Mini Trans-Blot 
cell (Bio-Rad). After blocking the non specific binding sites with 5 % non-fat milk in 
TBS-T (Tris buffered saline containing 20 mM Tris/HCl, pH 7.5, 150 mM NaCl and 
0.1 % Tween-20), membranes were probed with appropriate antibodies. Intact PARP 
and its 85 kDa fragment were detected using rabbit antiserum (318) (diluted at 1:8,000 
in TBS-T) or mouse monoclonal antibody (C2-10) at a dilution of 1:10,000 (both 
provided by Dr. G.G Poirier, Laval University, Quebec, Canada). Intact lamin B1 and 
its proteolytic fragment were detected with a mouse monoclonal antibody (diluted at
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1:50) (Serotec Ltd., Oxford, England). Pro-caspase-3 and its catalytically active large 
subunit (p i7 fragment) were detected using a rabbit polyclonal antibody directed to 
the pl7 fragment at a dilution of 1:10,000 (provided by Dr. D. Nicholson, Merck 
Frosst, Quebec, Canada). Pro-caspase-7 and its catalytically active large subunit (pi9 
fragment) were detected using a rabbit polyclonal antibody as described (MacFarlane 
et al., 1997). Intact Bid and its cleaved products were detected using an antibody 
provided by Dr. X. Wang as described (Luo et al., 1998). Final detection was 
achieved using the appropriate secondary antibody (goat anti-mouse IgG or goat anti­
rabbit IgG) conjugated with horseradish peroxidase (HRP) together with an enhanced 
chemiluminescence (ECL) kit (Amersham).
For detecting cytochrome c, 30 pg of protein from the cytosolic extracts prepared as 
described in section 2.5.2.1 was separated by SDS-PAGE, transferred to nitrocellulose 
membranes, and probed with a mouse monoclonal antibody recognising human 
cytochrome c (7H8.2C12) (PharMingen, San Diego, CA) at a dilution of 1:2,000.
Final detection was as described above. Parallel samples, containing an equal amount 
of cytosolic protein, were checked by Western blotting for mitochondrial 
contamination of the cytosolic extracts using the 12C4-F12 mouse monoclonal 
antibody (Molecular Probes) to mitochondrial membrane-bound cytochrome c oxidase 
(subunit H) as described by Kluck et al. (1997).
2.6 Analysis of DNA fragmentation
2.6.1 Field inversion gel electrophoresis
Field inversion gel electrophoresis (FIGE) was used to detect large kilobase pair DNA 
fragments as described (Brown et al., 1993). Agarose plugs containing 0.5 x 106 cells 
were prepared and digested with Pronase (1 mg/ml, Boehringer-Mannheim UK) for 
48 h at 50°C in a buffer containing 1 % lauryl sarcosine, 0.5 M EDTA, and 10 mM 
Tris (pH 9.5). Electrophoresis was carried out using a vertical gel chamber at 200 
volts starting with a 15 min continuous forward pulse followed by a 2.4 second 
forward to 0.8 second reverse (3:1 ratio) pulse produced by a PC 750 pulse controller 
(Hoefer Scientific Instruments, San Francisco, CA, USA) for 1 h. Then, a ramp factor 
of 1.5 was applied to increase the forward pulse time to 24 second and reverse phase 
to 8 second, and the gel was run for a further 6 h. Electrophoresis buffer was 0.5 x
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TBE (89 mM Tris, 50 mM boric acid and 2.5 mM EDTA) at pH 8.2. Two sets of 
standards were used: Saccharomytes cerevisiae chromosomes (243-2200 kilobase 
pairs from Clontech (Cambridge, UK) and 0.1-200 kilobase pairs (Sigma). At the end 
of the electrophoresis, the gel was rinsed in de-ionised water and stained with 
ethidium bromide (1 pg/ml) for 30 min and the DNA was visualised under UV light.
2.6.2 Agarose gel electrophoresis
Conventional agarose gel electrophoresis was used to detect intemucleosomal 
fragments of DNA, as described (Sorenson et al., 1990). A 1.8 % agarose gel in 0.5 x 
TBE buffer was prepared as a resolving gel. A digestion gel (0.8 % agarose, 2.5 % 
SDS in 0.5 x TBE buffer) was also prepared to ensure that DNA from intact cells can 
enter the gel, together with the addition of 1.25 mg/ml Proteinase K, which was added 
when the gel has cooled to just below 50°C. The digestion gel was quickly poured 
into a space above the wells previously cut in the resolving gel. 2 xlO6 cells were 
pelleted and resuspended in 20 pi of TE buffer (10 mM Tris/HCl, 1 mM EDTA, pH 
8.0) to which 7 pi of RNase (50 mg/ml) was added. The cells were digested for 20 
min at room temperature before mixing with 5 pi of loading buffer (Sigma) and 
loaded into the wells. 123 base pair DNA ladders (Life Technologies Ltd.) were used 
as standards. Electrophoresis was run in 0.5 x TBE buffer at 20 volts for one hour, 
followed by a further four hours at 100 volts. The DNA fragments were visualised as 
described above.
2.7 Phagocytosis assay
Isolation and culture of mouse macrophages were essentially as described (Fadok et 
al., 1992a) except for minor modifications as follows. Inflammatory macrophages 
were elicited into the peritoneal cavity of 8- to 16-week old Balb/c mice with 2% 
Brewer’s thioglycollate. Peritoneal exudate cells were harvested 4 days later by 
peritoneal lavage with balanced salt solution, plated in 96-well plates at 0.1x106 cells 
per well and cultured overnight in complete medium (DMEM containing 5% FCS, 50 
mM 2-mercaptoethanol, 2 mM L-glutamine, 100 U/ml penicillin and 100 mg/ml 
streptomycin) before use in the phagocytosis assay. Bone marrow was harvested from 
Balb/c mice and plated at O.lxlO6 cells per well in 96-well plates in DMEM 
containing 10% conditioned medium from L929 cells as a source of macrophage-CSF.
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Bone marrow macrophages were used in the phagocytosis assay after being cultured 
for 5 to 7 days. For the phagocytosis assays, macrophage monolayers were washed 
and THP.l cells (0.5 x 10*) in RPMI 1640 containing 5 % FCS added to each well. 
The plates were incubated for 1 h, then washed in ice-cold saline after treatment with 
trypsin to remove adherent macrophages. After cytospinning the macrophages onto 
microscope slides, cells were fixed with 2 % glutaraldehyde and stained with Giemsa 
dye. Phagocytosis was evaluated by counting 500 macrophages per slide of four 
replicate slides in each experiment. Results were expressed as the percentage of 
macrophages that had phagocytosed THP.l cells.
2.8 ATP measurement
Intracellular ATP was determined luminometrieally using a bioluminescent somatic 
cell assay kit (Sigma) according to the manufacturer’s instructions. In principle, ATP 
released from cells is utilised for the oxidation of firefly luciferin by 0 2 in the 
presence of Mg^. This reaction, mediated by firefly luciferase, results in light 
emission (À,^ -565 nm) (Anthony et al., 1985). The amount of light emitted was 
then measured on a Wallac 1450 Microbeta Liquid Scintillation Counter (Wallac OY, 
Turku, Finland).
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3.1 Introduction
Apoptosis is a fundamental form of cell death which plays a major role in the 
development and homeostasis of multicellular organisms (Arends and Wyllie, 1991). 
Disturbances in apoptosis are implicated in cancer, acquired immunodeficiency 
syndrome and some neurodegenerative disorders (Thompson, 1995). Apoptosis is 
also an important form of chemical-induced cell death (Corcoran et al., 1994). 
Apoptotic cell death comprises an initial commitment phase followed by an execution 
phase, which is characterised by a consistent series of distinct morphological changes 
(Eamshaw, 1995), suggesting the existence of a common execution machinery 
(Jacobson et al., 1994). In the nematode C. elegans, the gene ced-3 encodes a protein 
required for developmental cell death (Ellis et al., 1991). Since the recognition that 
CED-3 has sequence homology to the mammalian cysteine protease, interleukin-ip 
converting enzyme (ICE) (Yuan et al., 1993b), a family of at least thirteen related 
ICE-like proteases, now known as caspases (Alnemri et al., 1996), has been identified. 
Caspases are characterised by an absolute specificity for aspartic acid in the P, 
position of the substrate (reviewed by Thomberry and Molineaux, 1995; Kumar and 
Lavin, 1996; Cohen, 1997). They exist in cells as inactive proenzymes and, upon 
activation, are cleaved at specific aspartate residues, generating a large and a small 
subunit, which together form the active enzyme in the form of a heterotetramer 
containing two large and two small subunits (Walker et al., 1994; Wilson et al., 1994). 
Caspases may be divided into “initiator” caspases with long prodomains (e.g. caspase- 
8, -9 and -10), which activate “effector” caspases with short prodomains (e.g. caspase- 
3, -6 and -7), which in turn cleave intracellular proteins, such as poly (ADP-ribose) 
polymerase (PARP) and lamins, so precipitating the dramatic morphological and 
biochemical changes of apoptosis (Cohen, 1997). Thus, caspases appear to play a 
critical role during the execution phase of apoptosis.
Reduction in mitochondrial membrane potential (At|/m) has also been observed to 
occur early during the induction of apoptosis by a variety of stimuli (Zamzami et al., 
1995; Castedo et al., 1996) and possibly to regulate the aberrant exposure of 
phosphatidylserine (PS) on the outer plasma membrane of the cells undergoing 
apoptosis (Castedo et al., 1996). The decrease in Ax|/m probably results from the 
opening of the permeability transition (PT) pore or megachannel in the inner
49
Chapter 3 Major changes in chemical-induced apoptosis
mitochondrial membrane (reviewed by Susin et al., 1996a). The induction of PT in 
isolated mitochondria results in the release of a factor capable of causing isolated 
nuclei to undergo chromatin condensation and DNA fragmentation (Marchetti et al., 
1996b). Inhibition of PT by pharmacological agents or hyperexpression of Bcl-2 
prevented apoptosis (Susin et al., 1996a and 1997) and so mitochondrial permeability 
transition is proposed as a central coordinating event of apoptosis (Kroemer et al., 
1997).
The objective of the present study is to characterise the biochemical and 
morphological features in chemical-induced apoptosis and to investigate the temporal 
relationship of the biochemical events leading to these features using an established 
cell system, human monocytic THP.l cell line. Two chemicals with different modes 
of action were used to induce apoptosis, i.e. etoposide, and N-tosyl-L-phenylalanyl 
chloromethyl ketone (TPCK). TPCK is a chymotrypsin-like serine protease inhibitor 
(Fig. 4). The chloromethyl ketone in the compound functions as an reactive group, 
which alkylates one of the two nitrogen atoms of the imidazole ring of histidine 57 of 
the protease, while its phenylalanyl side chain enables TPCK to bind specifically to 
chymotrypsin, resulting in the irreversible inhibition of the enzymic activity (Shaw, 
1970). Because of this property, TPCK was developed as one of the affinity-labelling 
reagents for the study of the catalytic role of individual residues in functionally- 
related enzymes. It has also been used to study many biological processes including 
fertilization, cell growth, protein synthesis, and diseases such as cancer (reviewed by 
Powers, 1977). However, possibly due to the multiple functions of the chloromethyl 
ketone group, TPCK was shown to inhibit many functionally unrelated enzymes such 
as cAMP-dependent protein kinase (Kupfer et al., 1979) and protein kinase C 
(Solomon et al., 1985), and also to block the activation of nuclear factor (NF)-kappaB 
(Henkel et al., 1993). Recently, TPCK and many other protease inhibitors were used 
to investigate the role of proteases in apoptosis. TPCK has been shown to inhibit 
apoptosis as assessed by intemucleosomal DNA fragmentation (Bruno et al., 1992; 
Weaver et al., 1993). However, studies carried out in this laboratory demonstrated 
that TPCK alone induced both biochemical and morphological changes associated 
with early nuclear changes of apoptosis in thymocytes without the formation of 
intemucleosomal DNA fragments (Feamhead et al., 1995b). This initial observation
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was later confirmed in THP.l cells (Zhu et al., 1997). TPCK was also reported to 
induce apoptosis in HL-60 cells in the absence of DNA ladder formation (Lu and 
Mellgren, 1996). Thus the target(s) of TPCK may not only be engaged in the terminal 
stage of the execution phase, involving intemucleosomal DNA fragmentation but also 
in the regulation of apoptosis at a much earlier stage.
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Figure 4. The structures of TPCK and etoposide
Etoposide (Fig. 4), a semisynthetic derivative of the naturally occurring antimitotic 
agent podophyllotoxin, has been widely used as an anti-cancer drug (reviewed by 
Imbert, 1998). It is believed to act as a specific poison for the cell cycle-regulated 
protein DNA topoisomerase II (Ross et al., 1984). Topoisomerase II is an enzyme 
that unknots, decatenates or relaxes the supercoiled DNA molecules by introducing 
transient double-strand breaks through which the strands of an intact helix can pass 
(reviewed by Berger and Wang, 1996). In order to maintain the integrity of the 
cleaved genetic material during this process, the enzyme forms a proteinaceous bridge 
that spans the nucleic acid break. This bridge is anchored by a covalent 
phosphotyrosyl bond between the active site residues of the homodimeric enzyme and 
the newly created 5’-DNA termini, forming an enzyme-cleaved DNA complex (also 
known as a cleavage complex) (Froelich-Ammon and Osheroff, 1995). As the 
process of forming this cleavage complex is required in a number of critical nuclear 
processes including DNA replication and recombination, as well as chromosome 
segregation (reviewed by Corbett and Osheroff, 1993), topoisomerase II is essential 
for the survival of proliferating eukaryotic cells. Normally, the topoisomerase II-
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cleaved DNA complex is a short-lived intermediate in the catalytic cycle of the 
enzyme and is therefore tolerated by the cell. However, when present in high 
concentrations, the cleavage complexes become potentially toxic, promoting 
permanent double stranded DNA breaks. Etoposide interacts directly with 
topoisomerase II (rather than DNA) and it is this interaction which mediates the drug- 
induced formation of enzyme-DNA cleavage complexes and inhibits DNA religation 
(Burden et al., 1996). DNA is damaged as a result of the formation of permanent 
double stranded breaks. Etoposide has been shown to induce apoptosis in various cell 
systems including human HL-60 and KG1A leukaemic cells (Kaufinann, 1989), 
human colon cancer cell lines HT-29 and COLO 320 (Bertrand et al., 1991), human 
leukaemic U937 cells (Mashima et al., 1995), human breast carcinoma cell line MCF7 
(Benjamin et al., 1998), and primary rat thymocytes (Walker et al„ 1991; Sun et al„ 
1992), as well as human monocytic THP.l cells (Zhu et al., 1995).
3.2 Morphological characterisation of apoptosis
Although both TPCK and etoposide have been shown to induce apoptosis in THP.l 
cells, the biochemical and morphological changes have not been fully characterised.
In particular the relationships between these changes have not been adequately 
investigated. In the present study, several criteria were used to assess apoptosis in an 
attempt to detect different characteristics of the apoptotic phenotype yet with the 
morphological changes as the prime criterion.
3.2.1 Nuclear condensation and fragmentation
It has been shown that incubation of human monocytic THP.l cells with diverse 
stimuli, including etoposide, induced apoptotic cells. Condensed and fragmented 
nuclei are visible by fluorescence microscopy when these cells are stained with the 
membrane permeable DNA binding dye, Hoechst 33342 (Zhu, 1995). Externalisation 
of PS is a general feature of apoptosis, which can be detected using the PS-specific 
binding protein annexin V, labelled with FITC (Tait et al., 1989; Andree et al., 1990). 
Treated cells were therefore examined by confocal microscopy after Hoechst 33342 
staining and FITC-labelled annexin V binding. This technique allowed the 
simultaneous analysis of both nuclear condensation and fragmentation (blue 
fluorescence from Hoechst 33342) and externalised PS (green fluorescence from
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FITC). Treatment with either TPCK (75|iM) or etoposide (25 pM) resulted in the 
induction of apoptotic cells with condensed nuclei which fluoresced more brightly 
than control cells (Fig. 5 compare b and c with a). This increase in Hoechst 
fluoresence resulted from an increased cell permeability of apoptotic cells compared 
with normal cells (Ormerod et al., 1993). The nuclei of the cells treated with either 
TPCK or etoposide also became fragmented (Fig. 5b and c), exhibiting a distinct 
apoptotic morphology. Incubation of cells with either TPCK or etoposide also 
resulted in the increase in green fluorescence in the plasma membrane, indicating the 
binding of annexin V to PS (Fig. 5e and f, respectively), whereas untreated control 
cells showed no increase in green fluorescence (Fig. 5d). Combined image (blue + 
green fluorescence) showed that cells with condensed and fragmented nuclei also 
exhibited a concomitant increase in green fluorescence (Fig. 5h and i). Thus, nuclear 
condensation and fragmentation were co-localised with externalised PS in cells treated 
with either TPCK or etoposide.
Figure 5. Confocal microscopy of co-localisation of nuclear condensation and 
fragmentation with PS externalisation
THP.l cells were incubated for 4h either alone or with TPCK (75 |±M) or with etoposide (25 pM) and 
examined by confocal microscopy after Hoechst 33342 staining (Blue) and FITC-labelled annexin V 
binding (Green). Combined image (Blue + Green) showed that cells with condensed and fragmented 
nuclei exhibited a concomitant increase in green fluorescence. Cells were viewed with a xlOO 
objective.
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3.2.2 Chromatin condensation
The ultrastructure of the treated cells was examined in order to see if they exhibit the 
classical morphology of apoptosis. Untreated THP.l cells appeared to be irregular in 
outline with many microvilli and a multi-lobed nucleus (Fig. 6a). Cells treated with 
etoposide exhibited an increase in cytoplasmic density and chromatin condensation 
into crescentic accumulations against the inner membrane of the nuclear envelope 
(Fig. 6b). These changes were consistent with the characteristic ultrastructural 
features of apoptosis initially described (Kerr et al., 1972). Cells treated with TPCK 
also showed cytoplasmic condensation accompanied by pronounced dilation o f the 
endoplasmic reticulum, with the resulting vacuoles showing signs o f fusion with the 
cell membrane, usually at one pole of the cell (Fig. 6c). The membrane of treated 
cells was largely devoid of microvilli and the cytoplasm contained small 
accumulations of fine granular material. The cytoplasmic changes brought about by 
TPCK treatment were similar to those resulting from etoposide treatment. The degree 
of chromatin condensation was intermediate between control cells (Fig. 6a) and 
etoposide-treated cells (Fig. 6b), in agreement with a previous study (Zhu et ah,
1997). Thus, incubation of THP.l cells for 4 h with either etoposide or TPCK 
induced apoptosis, characterised morphologically by both cytoplasmic and nuclear 
changes.
Figure 6. Etoposide and TPCK induced ultrastructural changes of apoptosis
Induction of apoptosis was as described in legend to figure 5. (a) Control THP.l cells following 
incubation for 4 h in control medium showed normal ultrastructure, (b) Cells incubated with etoposide 
(25 pM) showed perinuclear accumulations of condensed chromatin, (c) Cells treated with TPCK (75 
pM) exhibited dilated endoplasmic reticulum and the accumulation of fine granular material with many 
small clumps of partially condensed chromatin throughout the nucleoplasm [all bar=2.5 pm]
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3.3 DNA fragmentation
The nuclear alterations have often been shown to be associated with the fragmentation 
of DNA. Initially, DNA is cleaved to 200-300 and 30-50 kilobase sized fragments, 
which are then further degraded to form intemucleosomal fragments (Brown et al., 
1993; Cohen et al., 1994). The latter fragments, demonstrated as a DNA ladder by 
agarose gel electrophoresis, were originally considered as a biochemical hallmark of 
apoptosis (Wyllie, 1980). The formation of intemucleosome-sized DNA fragments is 
now considered as a late event in apoptosis, which may be dissociated from early 
more critical changes (G. Cohen et al., 1992). The effect of two proapoptotic stimuli 
on DNA fragmentation was also investigated in the present study. Incubation of 
THP.l cells for 4 h with TPCK induced fragmentation of DNA to large fragments of 
200-300 and 600-700 kilobase pairs in length detected by field inversion gel 
electrophoresis (Fig. 7 lane 2). Treatment with etoposide also resulted in the 
formation of large kilobase pair fragments of DNA, but mainly of 30-50 kilobase pair 
in length (Fig. 7 lane 3). No fragments were observed in untreated control cells (Fig.
7 lane 1). Etoposide also induced the typical ladders of intemucleosomal DNA 
fragments (see Fig. 13 in Chapter 4). The effect of TPCK on intemucleosomal 
cleavage of DNA in THP.l cells has been previously investigated (Zhu et al., 1997). 
TPCK, at the concentrations (50-75 pM) which induced apoptosis, did not induce 
intemucleosomal cleavage of DNA. However, a lower concentration of TPCK (10 
pM) inhibited the intemucleosomal cleavage of DNA induced by many other 
apoptotic stimuli including etoposide (Zhu et al., 1997). Thus, induction of apoptosis 
by TPCK was accompanied by the formation of large kilobase pair fragments of 
DNA, but without intemucleosomal fragments, whereas in etoposide-induced 
apoptosis both large kilobase pair and intemucleosomal fragments of DNA were 
observed, in agreement with previous observations (Zhu et al., 1995 and 1997).
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Figure 7. Apoptosis induced by TPCK or etoposide is accompanied by the 
formation of large kilobase pair fragments of DNA.
Cells were incubated for 4h either alone (Con., lane 1) or with 75 pM TPCK (lane 2) or with 25 pM 
etoposide (Etop., lane 3) and examined for large kilobase pair (kbp) fragments of DNA by field 
inversion gel eletrophoresis as described in Materials and Methods.
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3.4 PS externalisation and reduction in AvFm
As described earlier, exposure of PS is a general phenomenon of apoptosis which can 
be detected by binding of FITC-labelled annexin V and a flow cytometric method has 
been developed to quantify these cells (Koopman et ah, 1994; Martin et ah, 1995). In 
addition, a reduction in AvFm has also been reported to be an early event in the 
induction of apoptosis in many different systems (Zamzami et al., 1995; Castedo et 
al., 1996). Using the membrane potential-sensitive fluorescent dye, DiOC6(3), 
changes in mitochondrial membrane potential can be measured by flow cytometry 
(Petit et al., 1990). Thus, in the present study, apoptosis was quantitated primarily by 
these two flow cytometric methods, measuring the percentage o f cells with 
externalised PS and decreased AT,m. Incubation of THP.l cells with either etoposide 
or TPCK resulted in a time-dependent increase in cells with externalised PS and 
decreased AT^(Fig. 8A and B, respectively). Untreated control cells did not exhibit 
increases in externalised PS or decreased AlPm after 4 h incubation (see below). While 
a decreased AvPm has been proposed to regulate the externalisation of PS (Castedo et 
al., 1996), in the present studies both these changes demonstrated a similar time 
dependence, occurring at 2 h after treatment, irrespective of the apoptotic stimulus 
(Fig. 8). Thus induction of apoptosis in THP.l cells is accompanied by simultaneous 
increases in cells with externalised PS and decreased AT>m.
3.5 Activation of caspases
The results described earlier have shown that incubation of THP.l cells with either 
etoposide or TPCK resulted in the induction of apoptosis, characterised by a series of 
distinct morphological and biochemical alterations. This suggested that there may 
exist a common biochemical execution machinery during the execution phase of 
apoptosis which follows the initial commitment to cell death. In the nematode 
Caenorhabditis elegans, the gene ced-3 encodes a protein which is essential for 
developmental cell death. The protein was later found to bear marked sequence 
similarity to, and identity with, mammalian cysteine protease interleukin-1 (3- 
converting enzyme (ICE) (Yuan et al., 1993b). This finding, together with the 
observation that overexpression of ICE (now known as caspase-1) induces apoptosis 
(Miura et al., 1993), suggests that caspase(s) may play a key role in the execution
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Figure 8. Time-dependent induction of apoptosis by etoposide and TPCK
in THP.l cells
THP. 1 cells were incubated for up to 4 h with either etoposide or TPCK. The percentage o f apoptotic 
cells was then determined flow cytometrically by the number of cells with externalisation of PS or a 
decrease in AT^. The data represent the mean (± sem) of at least three experiments.
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phase of apoptosis. It is therefore important to investigate the role of caspase(s) 
during the induction of apoptosis in this study.
3.5.1 Proteolytic activity of caspases
Caspases are cysteine proteases, which have an absolute specificity for an aspartic 
acid in the P, position of the substrate (Thomberry et al., 1992; Thomberry and 
Molineaux, 1995). In the present study, the proteolytic activity of caspases was 
measured by monitoring the Ac-DEVD.AFC cleavage activity of lysates from cells 
treated with etoposide or TPCK. The substrate Ac-DEVD.AFC was chosen because 
the DEVD tetrapeptide sequences mimic the cleavage site of intracellular protein 
PARP, i.e. DEVD216-G21/ (Lazebnik et al., 1994). In addition, caspase-3 (Nicholson et 
al., 1995), caspases-6 and -7 (Fernandes- Alnemri et al., 1995a and b) all have DEVD 
cleavage activity. The Ac-DEVD.AFC cleaving activity o f lysates obtained from 
control cells was very low after 4 h incubation (Fig. 9). In contrast, incubation of 
THP.l cells with either etoposide or TPCK resulted in a time-dependent increase in 
the Ac-DEVD.AFC cleavage activity (Fig. 9). In lysates prepared from etoposide- 
treated cells, an increase in Ac-DEVD.AFC cleavage activity was first observed at 2 h 
after treatment and continued to rise over a 4 h incubation period (Fig. 9), exhibiting a 
similar time-dependence to the induction of apoptosis as assessed by PS exposure and 
reduction in AT^ (Fig. 8A). The increase in Ac-DEVD.AFC cleavage activity in 
lysates prepared from TPCK-treated cells was similar to that following etoposide 
treatment during the first 2 h of incubation, but then reached a plateau (Fig. 9).
Marked differences were observed in both the level and pattern of proteolytic activity 
in lysates obtained from etoposide- and TPCK-treated cells. Whether the differences 
reflected distinct mechanisms employed by the two stimuli to induce apoptosis or 
were due to the inhibitory effects of TPCK on the proteolytic activity of activated 
caspases remains to be determined. An increase in Ac-DEVD.AFC cleavage activity 
was observed in lysates obtained from either etoposide- or TPCK-treated cells, thus 
providing evidence that caspases are involved in the induction of apoptosis.
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Figure 9. Ac-DEVD.AFC cleavage activity during the induction of apoptosis in
THP.l cells
THP.l cells were incubated for up to 4 h either alone or in the presence of etoposide (25pM) or TPCK 
(75 pM) and lysates were prepared at the indicated time points as described in Materials and Methods. 
Ac-DEVD.AFC cleavage activity was measured as described in Materials and Methods.
3.5.2 Activation of caspases and cleavage of PARP
At least four caspases including caspases-2, -3, -6 and -7 are activated during the 
induction of apoptosis in THP.l cells (MacFarlane et al., 1997, Zhu et al., 1997). 
However, the temporal relationship between activation of caspases and other features 
of apoptosis, such as reduction in and PS exposure has not been investigated. 
Time course studies were carried out to examine the activation of caspases-3 and -7 
and the proteolysis of the intracellular protein substrate PARP using Western blot 
analysis. Untreated control cells showed the presence of the intact -32  kDa proform 
of caspase-3 and —35 kDa pro form of caspase-7 (Figs. 10A and B lane 1, 
respectively). Processing of caspase-3 at A sp"' between the large and small subunits 
yields a p20 fragment, which is further processed at Asp9 and Asp  ^to yield p i9 and 
p 17 fragments, respectively (Nicholson et al., 1995; Fernandes-Alnemri et al., 1996). 
Processing of caspase-7 occurs at Asp158 between the large and small subunits, 
followed by cleavage at Asp"8 to yield the p i9 large subunit (Fernandes-Alnemri et 
al., 1995b). Induction of apoptosis with either etoposide or TPCK was accompanied 
by a time-dependent formation of the catalytically active large subunits of caspases-3
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and -7 (Figs. 10A and B, lanes 2-9 respectively). The initial processing of caspase-7 
occurs at 2 h in cells following incubation with etoposide (Fig. 10B lane 3) and at 1 h 
in cells treated with TPCK (Fig. 10B lane 6), whereas that of caspase-3 was barely 
detectable at 2 h in cells treated etoposide (Fig. 10A lane 3), but clearly detected in 
cells treated with TPCK (Fig. 10A lane 7). These results indicated that activation of 
caspase-7 may precede that of caspase-3. However, because the sensitivities of the 
antibodies used were unknown, caution should be exercised in the interpretation of the 
data. It is of interest to point out that dependent on the apoptotic stimulus, differences 
were observed in the formation of the large subunits of caspase-3 (Fig. 10A), possibly 
suggesting some differences in the mechanisms of activation. Induction of apoptosis 
by either etoposide or TPCK also resulted in a time-dependent loss of intact PARP 
together with formation of its characterisitic signature 85 kDa fragment (Fig. IOC). 
The fragment was first detected at 3 h after treatment with etoposide and at 2 h with 
TPCK treatment, apparently later than the activation of caspase-7 (Fig. I OB). Thus, 
induction of apoptosis in THP.l cells was accompanied by cleavage of PARP and 
activation of caspases-3 and-7, providing further evidence of the involvement of 
caspases during apoptosis. The time-course studies indicated that caspase activation 
appeared to occur prior to PS exposure, reduction in AT^, and cleavage of PARP.
3.6 Discussion
Treatment of THP.l cells with either etoposide or TPCK resulted in the induction of 
apoptosis which was accompanied by an increasesd number o f cells with externalised 
PS and decreased AT^, DNA fragmentation, PARP cleavage and activation of 
caspases. These results suggested that, though the initial cell death inducing 
mechanisms may be different (see below), the two proapoptotic stimuli may utilise a 
similar execution machinery to bring about the morphological and biochemical 
features of apoptosis. The results from the time-course experiments suggested that 
caspases may be the common mediator in this model of apoptosis as caspase 
activation occurred prior to PS exposure and reduction in AT^. However, caution 
must be exercised in the interpretation of these data because of the uncertainties in 
sensitivities of the different antibodies and between individual methods to assess 
apoptosis.
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Figure 10. Apoptosis was accompanied by the activation of caspases-3 and -7
and cleavage of PARP
THP.l cells were incubated for 4 h alone (lane 1), or up to 4 h with either etoposide (25 pM) (lanes 2- 
5) or TPCK (75 pM) (lanes 6-9). At the indicated time points, cells were analyzed by Western blot 
analysis for the cleavage o f (A) 32 kDa pro-caspase-3, and (B) 35 kDa procaspase-7 to their respective 
catalytically active large subunits, as described in Materials and Methods. Cells were also analyzed 
using a mouse monoclonal antibody (C2-10) to detect both intact PARP and its cleaved 85 kDa 
fragment (C).
3.6.1 Mechanisms of apoptosis induced by TPCK
Although many features of apoptosis induced by the two proapoptotic stimuli 
appeared to be similar, marked differences were also observed particularly in the 
ultrastructure, formation of intemucleosomal DNA fragments, Ac-DEVD.AFC 
cleavage activity in cell lysates and activation of caspase-3. Etoposide induced all the 
classical morphological and biochemical changes characteristic of apoptosis, whereas 
in TPCK-treated cells the degree of chromatin condensation was intermediate between 
control and etoposide-treated cells (Fig. 6b and c). TPCK did not induce 
intemucleosomal cleavage o f DNA, a classical hallmark of apoptosis. Rather, it 
inhibited intemucleosomal cleavage of DNA induced by many other apoptotic stimuli 
including etoposide in several different cell systems (Ghibelli et al., 1995; Yoshida et 
al., 1996; Zhu et al., 1997). This suggested that at least two different endonucleases 
were involved in the cleavage of DNA, one responsible for the formation of large
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fragments of 200-300 and 30-50 kilobase pairs, and the other for the intemucleosomal 
fragments, and that a TPCK inhibitable protease(s) may be closely associated with the 
latter endonuclease. The relationship between partial chromatin condensation and 
lack of intemucleosomal cleavage of DNA during TPCK-induced apoptosis in THP.l 
cells has not been investigated, nevertheless these two events were shown to be 
correlated in thymocyte apoptosis (Brown et al., 1993; G. Cohen et al., 1992; 
Feamhead et al., 1995b). Furthermore, the differences in Ac-DEVD.AFC cleavage 
activity in lysates from TPCK- and etoposide-treated cells (Fig. 9) suggested that 
TPCK itself may have some inhibitory effect on activities of caspases after their 
activation. Indeed, TPCK (100 pM) has been shown to inhibit the ability of 
bacterially-expressed recombinant caspases-3 and -7 to cleave PARP (Femandes- 
Alnemri et al., 1995b). Whether the concentration of TPCK required to exhibit 
similar effect could be achieved within intact cells remains to be determined. More 
importantly, the difference in the formation of the large subunits of caspase-3 (Fig.
10A) suggested that different mechanisms of caspase activation may be involved in 
TPCK- and etoposide-induced apoptosis. It has been shown that cells treated with 
TPCK, at the concentration which induced apoptosis, exhibited decreased trypsin-like 
serine protease activity as measured by Boc-Val-Leu-Lys.AMC cleavage activity 
(Zhu et al., 1997). This may represent one of the TPCK targets, possibly a serine 
protease(s), whose inhibition results in apoptosis. The protease responsible for this 
cleavage activity is, however, unknown, and thus the mechanism whereby TPCK 
induces apoptosis is yet to be elucidated.
3.6.2 Mechanisms of apoptosis induced by etoposide
The mechanisms of apoptosis induced by etoposide may be slightly better understood. 
Etoposide is a chemotherapeutic drug used in the treatment of several types of cancer. 
The cytotoxicity of the drug mainly results from its interaction with topoisomerase II, 
which both enhances the enzyme-mediated DNA breakage and inhibits the ability of 
the enzyme to religate cleaved DNA (Froelich-Ammon and Osheroff, 1995; Burden et 
al., 1996), resulting in the formation of permanent breaks. The presence of these 
breaks stimulates DNA recombination/mutation (Han et al., 1993), formation of 
chromosomal abnormalities (Lonn et al., 1989) and eventually triggers cell death by 
apoptosis (Kaufmann, 1989; reviewed by Hickman, 1992). Among the proposed
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mechanisms of apoptosis induced by DNA-damaging agents, such as etoposide, are 
p53-mediated pathways. The tumour suppressor protein p53 is believed to become 
activated as a transcription factor in response to DNA damage and this activation may 
require DNA-dependent protein kinase activity (Woo et ah, 1998). Activated p53 
then induces transcriptional activation of a number of genes (reviewed by Levine, 
1997). One of the genes directly activated by p53 includes bax (Miyashita and Reed,
1995), whose protein product can bind to Bcl-2 and prevent its ability to block 
apoptosis (Oltvai et al., 1993). Bax has also been shown to suppress tumour growth 
by stimulating apoptosis in vivo in a p53-dependent manner (Yin et ah, 1997). Thus, 
transcriptional activation of bax gene by p53 can induce apoptosis. Another pathway 
proposed recently involves reactive oxygen species (ROS) (Polyak et al., 1997).
Upon activation, p53 transcriptionally activates a specific subset of redox-related 
genes, resulting in the production of reactive oxygen species (ROS), which in turn 
damage mitochondria. Leakage of proteinaceous components from damaged 
mitochondria may then activate caspases during the apoptotic process (Kroemer et al., 
1997). p53 has also been shown to have a transcription-independent function in 
apoptosis, as p53-dependent apoptosis proceeded in the absence o f novel mRNA or 
protein synthesis (Gaelics et al., 1994). In addition, mutant p53 protein could induce 
apoptosis without activating promoters of target genes (Haupt et ah, 1995; Chen et al.,
1996). Thus, it seems likely that in p53-mediated apoptosis there exists transcription- 
dependent and -independent pathways and that depending on cell types and stimulus, 
either one pathway or a combination of the two may be involved in committing cells 
to undergo apoptosis. As THP.l cells were shown to express mutant p53 protein 
(Sugimoto et al., 1992), it is possibe that apoptosis induced by etoposide may be 
mediated by a p53 transcription-independent mechanism. However, the observation 
that mitogenically activated T lymphocytes and proliferating lymphoma cells from 
p53-null mice can undergo apoptosis after irradiation (Strasser et al., 1994) suggested 
the existence of a p53-independent mechanism of apoptosis in response to DNA 
damage. Etoposide was also shown to induce apoptosis in immature thymocytes 
obtained from p53-null mice (MacFarlane et ah, 1996). Thus it is conceivable that 
p53-independent pathways also operate in DNA damage-induced apoptosis.
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Recently, it has been shown that in p53-mediated apoptosis, caspase activation is 
required following UV irradiation (Fuchs et ah, 1997) or etoposide treatment 
(Benjamin et ah, 1998). The results described earlier (Fig. 10), together with the 
previous study (MacFarlane et ah, 1997), also demonstrate that caspases are involved 
in etoposide-induced apoptosis in THP.l cells. Moreover, caspases are also activated 
in etoposide-induced apoptosis in a p53 null cell line, HL-60 (Martins et ah, 1997). 
These observations suggested that DNA damage by diverse stimuli can lead to 
caspase activation through p53-dependent and -independent pathways, thus 
supporting the hypothesis that multiple sensors of celluar insults converge on the 
central apoptotic machinery, the caspases (Cohen, 1997). It is therefore imperative to 
understand the biochemical pathways leading to caspase activation during the 
induction of apoptosis in order to gain further insight into the mechanisms of the 
cytotoxicity of DNA damaging agents.
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Dissociation of plasma membrane changes in cells 
undergoing apoptosis from other features of 
the apoptotic program
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4.1 Introduction
In the previous chapter, apoptosis induced by TPCK or etoposide was characterised 
by morphological and biochemical changes affecting the nucleus, cytoplasm and 
plasma membrane. These changes in various cellular compartments are widely 
regarded as mechanistically linked events in a single “program”, in which activation 
of caspases and proteolysis of intracellular substrates represent a final common 
pathway leading to cell death. There has been very limited exploration of the linkage 
of this program to the plasma membrane changes, which bring about swift 
recognition, phagocytosis, and safe degradation of apoptotic cells. In vivo intact cells 
dying by apoptosis are usually swiftly recognised and safely cleared by phagocytes 
(Duvall et ah, 1985; Savill et ah, 1993). This protects surrounding tissues from 
exposure to injurious contents leaking from dying cells, which is inevitable in 
accidental cell death by necrosis. Although there is only limited understanding of the 
molecular mechanisms which render apoptotic cells recognisable to phagocytes 
(Savill, 1998), exposure of phosphatidylserine (PS) appears to serve as a recognition 
signal for yet to be characterised PS receptors on certain phagocyte populations 
(Fadok et ah, 1992a and b; Martin et ah, 1995b; Verhoven et ah, 1995). The 
mechanisms mediating PS exposure are complex but seem to involve activation of 
caspases (Vanags et ah, 1996; Martin et ah, 1996). Another mechanism by which 
phagocytes recognise cells undergoing apoptosis involves the phagocyte adhesion 
receptor CD36 co-operating with the a vP3 vitronectin receptor integrin to bind 
thrombospondin (TSP), which acts as a molecular bridge between the apoptotic cell 
and the macrophage (Savill et ah, 1990; Fadok et ah, 1992a).
Based on the results described in the previous chapter, the apoptotic changes affecting 
the nucleus, cytoplasm and plasma membrane all appear to occur simultaneously 
making it difficult to establish the temporal relationships between these events 
including, particularly, the activation of caspases, reduction in mitochondrial 
membrane potential (AT^J and PS exposure. To test the hypothesis that these 
changes are mechanistically linked events in a single “program” of apoptosis, a 
caspase inhibitor was used. This tripeptide, benzyloxycarbonyl-valinyl-alanyl- 
aspartyl (OMe) fluoromethyl ketone (Z-VAD.fmk), is a cell-permeable irreversible 
inhibitor of caspases whose permeability is facilitated by the presence of
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benzyloxycarbonyl and OMe groups (Cohen, 1997). It inhibited apoptosis induced by 
a variety of stimuli in a number of cell systems, including rat thymocytes (Feamhead 
et ah, 1995a) and hepatocytes (Cain et ah, 1996), human leukaemic Jurkat T cells 
(Chow et ah, 1995; Armstrong et ah, 1996), human B-cell lymphoma cell line GM701 
and fibroblast cell line SKW6.4 (Jacobson et ah, 1996), as well as monocytic THP.l 
cells (Zhu et ah, 1995). Moreover, in order to investigate the possible relationship 
between reduction in mitochondrial AT',,, and other features of apoptosis such as PS 
exposure, two mitochondrial inhibitors antimycin A and oligomycin were also used in 
the study. Antimycin A and oligomycin are inhibitors of the mitochondrial 
respiratory chain and ATP synthase respectively (Nicholls and Ferguson, 1992). Both 
induce apoptosis in several human lymphoblastoid cell lines (Wolvetang et ah, 1994), 
but also inhibit thymocyte apoptosis induced by dexamethasone (Stefanelli et ah,
1997). Nevertheless, these two inhibitors have often been used to modulate the 
changes in AxPni in studies of apoptosis (Zamzami et ah, 1995; Castedo et ah, 1996).
4.2 Activation of caspases occurred upstream of both reduction in 
AXFI11 and externalisation of PS, and also prior to increased Hoechst 
33342 staining
It has been shown that treatment of THP.l cells with etoposide, or TPCK, resulted in 
apoptosis, as assessed flow cytometrically by an increase in Hoechst 33342 
fluorescence (Zhu et ah, 1995 and 1997; MacFarlane et ah, 1997). The increased 
Hoechst 33342 fluorescence is due to an increase in cell membrane permeability of 
apoptotic cells compared with control cells (Ormerod et ah, 1993). In the present 
study, apoptosis was assessed by three independent flow cytometric methods 
measuring increase in Hoechst 33342 fluorescence, externalisation o f PS, and a 
decrease in AT7,,,, respectively. Incubation of THP.l cells for 4 h with either etoposide 
or TPCK induced apoptosis, as assessed by all three flow cytometric methods (Fig.
11A and B). Both antimycin A and oligomycin caused a concentration-dependent 
inhibition of apoptosis induced by the two stimuli, as assessed either by PS exposure 
or Hoechst 33342 staining whereas they had little effect on the decreased Ax¥ m (Fig.
11). Neither antimycin A nor oligomycin alone induced apoptosis as assessed by PS 
exposure, Hoechst 33342 staining or DNA fragmentation (data not shown). Thus
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these experiments dissociated those features of the apoptotic phenotype assessed by 
PS exposure and Hoechst 33342 staining from those measured by the changes in AvFm.
Z-VAD.FMK (50 pM), a broad spectrum inhibitor of caspases, inhibited apoptosis 
induced by both etoposide and TPCK, as assessed by all three methods (Fig.l 1), 
providing further evidence of the involvement of caspases in the execution phase of 
apoptosis in THP.l cells. More importantly, these results, together with the 
observation made in the time-course study described in the previous chapter, 
demonstrated that in this model of apoptosis the activation of caspases occurred 
upstream of both reduction in AxPm and externalisation of PS, and also prior to 
increased Hoechst 33342 staining.
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Figure 11. Antimycin A and oligomycin cause a concentration-dependent 
inhibition of externalisation of PS and increase in Hoechst 33342 fluorescence
but not of the reduction in AvPm
THP.l cells were incubated for 4 h with either (A) etoposide (25 pM) or (B) TPCK (75 pM) either 
alone or in the presence of the indicated concentrations of antimycin A (1 - 30 pM) or oligomycin (0.1 
- 5 pg/ml) or in the presence of Z-VAD.FMK (50 pM). The percentage of apoptotic cells was then 
measured flow cytometrically using either increase in externalisation of PS, or increase in Hoechst 
33342 fluorescence or decrease in AT^. The data represent the mean (± sem) of at least three 
experiments.
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4.3 Dissociation of PS externalisation from activation of caspases-3 
and -7, and cleavage of PARP
During the execution phase of apoptosis, caspases are activated and subsequently 
cleave cellular substrates, such as PARP (Fig. 10 in chapter 3). Questions were 
therefore asked as whether the mitochondrial inhibitors differentially affected the 
activation of caspases and the cleavage of PARP. Using Western blot analysis, 
control cells were shown to contain the intact form of PARP (116 kDa) (Fig. 12A lane 
1). Induction of apoptosis by either TPCK or etoposide was accompanied by the 
cleavage of PARP to its 85 kDa signature fragment (Fig. 12A lanes 2 and 6), which 
was completely blocked by Z-VAD.FMK (50 pM) (Fig. 12A lanes 5 and 9). Neither 
oligomycin nor antimycin A blocked this proteolysis of PARP following incubation 
with either TPCK (Fig. 12A lanes 3 and 4) or etoposide (Fig. 12A lanes 7 and 8). The 
cleavage of PARP to its 85 kDa signature fragment, which occurs at a DEVD^G 
sequence separating the amino terminal DNA binding domain and carboxy terminal 
catalytic domain of the enzyme (Lazebnik et al., 1994), suggested the activation of 
caspase-3 and/or -7, which were examined using antibodies raised against their 
respective large subunits. Control THP.l cells showed the presence of the intact 
pro form of caspase-3 (Fig. 12B lane 1). Induction of apoptosis with either TPCK or 
etoposide was accompanied by loss of the proform of caspase-3 together with 
formation of the catalytically active large subunit (LS) of caspase-3 (Fig. 12B lanes 2 
and 6). Cleavage of caspase-3 was more extensive in response to TPCK compared 
with etoposide, commensurate with the greater induction o f apoptosis by this stimulus 
(Fig. 11). Z-VAD.FMK, which blocked the induction of apoptosis induced by these 
stimuli (Fig. 11), almost totally blocked the formation of the large subunit of caspase- 
3 in cells treated with either TPCK (Fig. 12B lane 5) or etoposide (Fig. 12B lane 9), 
although a small amount of a slightly larger immunoreactive fragment (~ p20) was 
also observed (Fig. 12B lane 9). This fragment was most probably catalytically 
inactive as no cleavage of PARP was detected (Fig. 11A lane 9). Treatment with 
TPCK or etoposide also resulted in the activation of caspase-7 with the formation of a 
catalytically active large subunit (LS) (Fig. 12C lanes 2 and 6), whereas untreated 
control cells retained the intact pro form of caspase-7 (Fig. 12C lane 1). Again, Z- 
VAD.FMK completely blocked the formation of the large subunit of caspase-7 in 
cells treated with either TPCK (Fig. 12C lane 5) or etoposide (Fig. 12C lane 9). Thus,
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these results clearly demonstrated that Z-VAD.FMK inhibited apoptosis by blocking 
the processing/activation o f caspases, in agreement with the previous observations 
(Slee et al., 1996; MacFarlane et al., 1997; Zhu et al., 1997). In contrast, neither 
oligomycin nor antimycin A inhibited the formation of respective large subunits (LS) 
of caspases-3 and -7 after treatment with either TPCK (Fig. 12B and C lanes 3 and 4) 
or etoposide (Fig. 12B and C lanes 7 and 8). Thus oligomycin and antimycin A 
inhibited the externalisation of PS and the increase in cell membrane permeability 
assessed by Hoechst 33342 staining (Fig. 11) but did not inhibit the activation of 
caspases-3 and -7, and cleavage of PARP (Fig. 12).
A
B
Control
kDa
98-
TPCK 
---------------------------------------1 r
Oligo Ant Z-VAD
16-
Etoposide I
Oligo Ant Z-VAD
. -  .   ..
7 8 9
116 kDa
85 kDa 
fragment
‘«c^Proform
*» we*
mm ' F
Proform
Figure 12. Z-VAD.FMK but not antimycin A or oligomycin inhibits PARP 
cleavage and activation of caspases-3 and -7 in THP.l cells.
TH P.l cells were incubated for 4 h with either TPCK (75 pM) or etoposide (25 pM) in the presence or 
absence of oligomycin (Oligo 5 pg/ml), antimycin A (Ant 30 pM) or Z-VAD.FMK (Z-VAD 50 pM). 
To detect the 85 kDa fragment of PARP (A), cellular proteins were resolved on an SDS-7% 
polyacrylamide gel, transferred onto nitrocellulose membrane and probed with rabbit antiserum (318). 
To detect activation of caspases-3 (B) and -7(C), cellular proteins were resolved on an SDS-15% 
polyacrylamide gel. After transferring, the proteins were probed with rabbit polyclonal antibodies 
raised against the large subunits (LS) o f caspase-3 and -7, respectively. Results are representative of 
three experiments.
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4.4 Dissociation of PS externalisation from DNA fragmentation
To further determine whether the treatment with antimycin A or oligomycin had 
interfered with the DNA fragmentation which occurs late in apoptosis, conventional 
agarose gel electrophoresis was carried out to examine the effect of the two inhibitors 
on intemucleosomal cleavage of DNA. Etoposide alone induced intemucleosomal 
DNA cleavage compared with control cells (Fig. 13 compare lanes 1 and 2). Z- 
VAD.FMK but not antimycin A or oligomycin inhibited etoposide-induced 
intemucleosomal cleavage (Fig. 13 lanes 3-5). TPCK alone induced fragmentation of 
DNA to large fragments of 200-300 and 600-700 kilobase pairs in length in the 
absence of intemucleosomal cleavage (Fig. 7 in chapter 3, and Zhu et al., 1997). Z- 
VAD.FMK but not antimcycin A or oligomycin inhibited the formation of these large 
DNA fragments (data not shown). Thus externalisation of PS during apoptosis can 
also be dissociated from DNA fragmentation.
4.5 Cell surface changes resulting in phagocytic recognition can be 
dissociated from other features of the apoptotic phenotype
One of the key features of the apoptotic process is the rapid recognition and 
subsequent phagocytosis of apoptotic cells. As both antimycin A and oligomycin 
inhibited plasma membrane changes, such as externalisation of PS and increased 
Hoechst staining, but not other features of the apoptotic phenotype, the question arose 
as to whether they also interfered with phagocytic recognition of apoptotic THP.l 
cells. Peritoneal and bone marrow macrophages phagocytose apoptotic cells utilising 
receptors for PS (PSRs) or thrombospondin (i.e. a vp3 and CD36) respectively (Savill 
et ah, 1990 and 1993; Fadok et ah, 1992a and b). Exposure of THP.l cells to the two 
pro-apoptotic stimuli, etoposide and TPCK, resulted in an increase in the percentage 
of cells phagocytosed by both peritoneal macrophages and bone marrow-derived 
macrophages (Table 3). Z-VAD.FMK, antimycin A and oligomycin, all inhibited the 
etoposide- and TPCK-induced increases in recognition and phagocytosis by both 
peritoneal and bone marrow-derived macrophages (Table 3). Thus cells displaying 
many features o f apoptosis including reduction in Avj/m, DNA fragmentation, 
processing of caspases-3 and -7, and PARP cleavage do not display characteristic cell
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surface changes, such as PS externalisation, which result in phagocytic recognition 
and engulfment.
Control Etoposide
i---------------------------------------------------------------1
Oligo Ant Z-VAD
1 2 3 4 5
Figure 13. Neither antimcycin A nor oligomycin inhibits intemucleosomal
cleavage of DNA in THP.l cells.
Induction of apoptosis in THP. 1 cells was essentially as described in the legend to Fig. 2. 2 x 106 cells 
were loaded per lane and subjected to conventional agarose gel electrophoresis to detect 
intemucleosomal cleavage of DNA. Results are representative of three experiments.
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Table 3. inhibition of phagocytosis of apoptotic THP.l cells by oligomycin and
antimycin A*
Treatment % Phagocytosis
Peritoneal macrophages Bone-marrow macrophages
Control 3.1 ±0.9 1.7 ±0.5
TPCK 25.6 ±5.3 19.7 ±2.8
TPCK + Z-VAD.FMK 4.4 ± 1.1 3.8 ± 1.1
TPCK + Oligomycin 4.9 ± 1.6 1.1 ±0.5
TPCK + Antimycin A 4.5 ±0.5 2.4 ±0.8
Etoposide 13.0 ±2.3 10.7 ±0.6
Etoposide + Z-VAD.FMK 5.2 ±3 .0 2.2 ±0.3
Etoposide + Oligomycin 3.9 ± 1.6 1.4 ±0.5
Etoposide + Antimycin A 3.8 ±0.5 1.0±0.1
Induction of apoptosis in THP.l cells was essentially as described in the legend to Fig. 12.
Phagocytosis was evaluated by counting 500 macrophages per slide o f four replicate slides in each 
experiment (see Materials and methods). Peritoneal and bone-marrow macrophages phagocytose 
apoptotic cells utilising receptors for PS and thrombospondin respectively. Results were expressed as a 
percentage of macrophages that had phagocytosed THP. 1 cells. The data represent the mean (± sem) 
o f three experiments.
* This work was made possible essentially through the collaboration with Dr. J. Savill 
and his colleagues at the University of Nottingham.
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4.6 Dissociation of cell membrane changes from caspase activation 
during induction of apoptosis in U937 cells
In order to determine whether the phenomenon of dissociation of externalisation of PS 
from other features of the apoptotic phenotype was cell type-specific, the study was 
extended to human leukaemic U937 cells. These cells were treated with two 
commonly used apoptotic stimuli, etoposide (25 pM) or tumour necrosis factor-a 
(TNF-a, 10 ng/ml) in the presence of cycloheximide (0.9 pM) (Vanags et al., 1996). 
Apoptosis was induced by both these stimuli, as assessed by externalisation of PS, 
increase in Hoechst 33342 fluorescence and increase in cells with a decreased AxPm 
(Fig. 14A). Both oligomycin (5 pg/ml) and antimycin A (30 pM) largely blocked the 
apoptotic changes induced by either TNF-a or etoposide as assessed by either PS 
exposure or Hoechst 33342 staining but had little effect on the decreased AT^ ( Fig. 
14A). Z-VAD.FMK (20 pM) inhibited all the apoptotic changes induced by 
etoposide whereas at a concentration of 2 pM it effectively inhibited TNF-a-induced 
apoptosis, as assessed by all three methods (Fig. 14A). It was observed that Z- 
VAD.FMK at the concentrations higher than 2 pM potentiated necrosis in cells treated 
with TNF-a in the presence of cycloheximide (data not shown). Western blot 
analysis showed that control U937 cells contained almost entirely intact PARP (116 
kDa) (Fig. 14B lane 1). Induction of apoptosis by either TNF-a or etoposide was 
accompanied by activation of caspases as assessed by the cleavage of PARP to its 85 
kDa signature fragment (Fig. 14B lanes 2 and 6). This cleavage was completely 
blocked by Z-VAD.FMK (Fig. 14B lanes 5 and 9), providing further evidence for the 
activation of caspases during apoptosis. Apoptosis, as assessed by PS exposure, 
Hoechst 33342 staining or PARP cleavage was not induced by either antimycin A or 
oligomycin alone (data not shown). Neither antimycin A nor oligomycin blocked 
proteolysis of PARP to its 85 kDa fragment following co-incubation with either TNF- 
a  (Fig. 14B lanes 3 and 4) or etoposide (Fig. 14B lanes 7 and 8). Thus, these results 
in U937 cells dissociated those features of the apoptotic phenotype assessed by PS 
exposure and Hoechst 33342 staining from those measured by the changes in AvPmand 
caspase activation.
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Figure 14. Dissociation of PS externalisation from caspase activation in apoptotic
U937 cells.
Apoptosis was induced in U937 cells following incubation for either 3 h with tumour necrosis factor-a 
(TNF-a) (10 ng/ml ) in the presence of cycloheximide (0.9 fiM) (lanes 2-5) or 5 h with etoposide (25 
pM) (lanes 6-9). U937 cells were incubated either alone (lane 1) or with the apoptotic stimuli in the 
presence o f antimycin A (30 pM) (lanes 3 and 7) or oligomycin (5 pg/ml) (lanes 4 and 8). Cells were 
also incubated with the apoptotic stimuli in the presence o f the caspase inhibitor Z-VAD.FMK, the 
concentration o f which was either 2 or 20 pM in the case of TNF-a or etoposide respectively (lanes 5 
and 9). (A) The percentage of apoptotic cells was then measured as described in legend to Fig. 1. The 
data represent the mean (± sem) o f at least three experiments except for which represents the 
mean of two determinations. (B) Cellular proteins were resolved on SDS-10 % polyacrylamide gels, 
transferred onto nitrocellulose membrane and probed with a mouse monoclonal antibody (C2-10) to 
detect both intact PARP (116 kDa) and its cleaved 85 kDa fragment.
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4.7 Discussion
4.7.1 Caspases act upstream of PS externalisation and decrease in AvFm 
Apoptosis induced in both THP.l and U937 cells was assessed by three independent 
flow cytometric methods measuring an increase in PS exposure, increased Hoechst 
33342 fluorescence and an increase in the number of cells with decreased AvPm (Figs.
11 and 14A). The induction of apoptosis in both cell lines was also accompanied by 
the activation of caspases with subsequent cleavage of PARP (Figs. 12 and 14B). Z- 
VAD.FMK inhibited activation of caspases-3 and -7 during the induction of apoptosis 
in THP.l cells and activities of caspases responsible for PARP cleavage in both 
THP.l and U937 cells. This cell membrane permeable inhibitor of caspases also 
inhibited all the biochemical changes associated with apoptosis, including PS 
exposure, increased Hoechst 33342 binding, and decreased AvPm. These results clearly 
demonstrate that caspase activation occurs upstream of reduction in AT^, and also 
prior to externalisation o f PS. This observation is compatible with some recent 
studies (Yang et al., 1997; Kluck et al.,1997; Bossy-Wetzel et al.,1998), but in 
disagreement with others (Shimizu et al., 1996; Hirsch et al., 1997). The discrepancy 
could be due to several reasons. In the study reported by Shimizu et al. (1996), it was 
shown that rat pheochromocytoma PC 12 cells transfected with Bcl-2 and Bcl-xL 
maintained normal mitochondrial AT^ during the induction of apoptosis by 
proapototic stimuli including etoposide and became resistant to cell death. Cells co­
incubated with the caspase inhibitor Ac-YVAD.CHO showed a rapid decrease in AvFm 
and only partial protection against apoptosis, concluding that caspases functions 
downstream of reduction in AT^. However, previous work in this laboratory has 
already shown that Ac-YVAD.CHO, a specific inhibitor of caspase-1 (Thomberry et 
ah, 1992), was incapable of blocking processing of caspases-2 and -3, and thus did not 
inhibit apoptosis induced by cycloheximide in the presence o f trysin-like serine 
protease inhibitor TLCK in THP.l cells, although it inhibited lamin A/B cleavage 
(MacFarlane et ah, 1997). Thus different caspase inhibitors used in the two studies 
may account for the observed difference. In another study, it was concluded that 
caspases were activated after the development of mitochondrial permeability 
transition (PT) as indicated by a decreased AvPm (Hirsch et ah 1997). This conclusion 
was based essentially on experiments of modulating PT by using some 
pharmacological agents, in which PT inducers alone caused the apoptosis and PT
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inhibitors blocked thymocytes apoptosis induced by dexamethasone or etoposide, and 
in which Z-VAD.FMK did not prevent the disruption of induced by the PT 
inducers. Obviously, using pharmacological agents to modulate PT is a useful 
approach to study the role of individual biochemical events in the pathways leading to 
activation of the execution machinery in apoptosis. However, whether and how much 
this approach represents the physiological situation within an intact cell are not clear. 
Added to this, the specificities of modes of action by the pharmacological agents are 
always subject to dispute. Thus particular caution may have to be exercised in the 
interpretation of these results.
4.7.2 Dissociation of phagocytic recognition of cells undergoing apoptosis from 
other features of the apoptotic program
The data presented here also demonstrate the dissociation of phagocyte recognition of 
cells undergoing apoptosis from other features of this programmed form of cell death. 
The mitochondrial inhibitors, antimycin A and oligomycin, not only inhibited surface 
changes o f apoptosis, such as externalisation o f PS recognised by murine peritoneal 
macrophages but also inhibited surface changes recognised by murine bone marrow- 
derived macrophages, which use the CD36/avP3 and thrombospondin recognition 
mechanism (Tables 3). However, antimycin A and oligomycin did not inhibit 
activation o f caspases-3 and -7, cleavage of PARP and DNA degradation (Figs. 12 
and 13), and the reduction in mitochondrial AYm (Fig. 11). These data imply that the 
surface changes of apoptosis relate to an independent pathway of events, which may 
be differentially regulated from the activation of “effector” caspases which are 
believed to trigger the nuclear and some of the cytoplasmic changes of apoptosis. It 
has become a widely held view that PS exposure and associated changes, such as 
increased plasma membrane permeability to Hoechst dye, represent “early” features of 
a single, co-ordinately regulated common pathway leading to cell death, while DNA 
degradation is a “late” feature. However, temporal dissociation of membrane changes 
including PS exposure from other features of apoptosis could also imply that 
mechanisms regulating the ability of dying cells to be recognised by phagocytes are 
part of a parallel process, which may be independent from other features of the 
program. This interpretation of the data is strongly supported by the effects of 
antimycin A and oligomycin reported here. Future studies will need to characterise
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the pathway by which dying cells display “eat me" signals. The effects of Z- 
VAD.FMK reported here support previous data implicating the activation of some 
caspases in the externalisation of PS (Vanags et al., 1996; Martin et al., 1996), 
although “effector" caspases such as caspases-3 and -7 appear not to be involved.
In the present study, PS exposure was also uncoupled from the reduction in AT^. 
There was excellent agreement between the two methods detecting respective 
increases in Hoechst 33342 fluorescence and externalisation of PS, suggesting that 
they may be measuring very similar characteristics of the apoptotic cells. While 
values for the decreased AT^ were generally in reasonable agreement with the other 
measures of apoptosis, there were notable exception in particular with antimycin A 
and oligomycin, where the two inhibitors dissociated those features of the apoptotic 
phenotype assessed by PS exposure and increased Hoechst staining from those 
measured by the changes in AT^. This suggested that the decreased AT% was 
measuring a different characteristic of apoptosis compared with those measured by 
externalisation of PS and increased Hoechst staining. The dissociation of apoptotic 
features described here also provides a cautious note on the methods of assessing 
apoptosis. Externalisation of PS is a commonly used marker of apoptosis. The results 
from this study demonstrated that to assess apoptosis it is preferable to utilise several 
methods, which reflect different characteristics of the apoptotic phenotype, rather than 
using any single method.
4.7.3 Mechanisms of the dissociation of apoptotic features
Although it is possible to dissociate those cell surface changes leading to phagocytic 
recognition and engulfment from other cytoplasmic, mitochondrial and nuclear 
changes of apoptosis, the mechanisms of this dissociation have yet to be understood. 
Under the present experimental conditions, neither antimycin A nor oligomycin alone, 
at the concentrations which inhibit cell surface changes including PS exposure, 
induced a significant reduction in mitochondrial membrane potential (Ax|/m) (Fig.
15 A). Furthermore, both mitochondrial inhibitors alone did not induce a loss of ATP 
in THP.l cells (data not shown) nor did they potentiate the decrease in ATP levels 
during the induction of apoptosis by TPCK (Fig. 15B). These observations raised the 
possibility that the two inhibitors may not be exerting their effects primarily on
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mitochondria to bring about the inhibition of cell surface changes of the apoptotic 
cells. However, it has been reported that the inhibition of electron transport by 
antimycin A or of ATP synthesis by oligomycin alone may not depolarise the 
mitochondria completely provided that a supply of ATP is available through 
glycolysis (Mohr and Fewtrell, 1990; Rizzuto et ah, 1994; Budd and Nicholls, 1996b). 
It was proposed that mitochondria can maintain their membrane potential by running 
the ATP synthase “in reverse”, i.e. by hydrolysing ATP to pump proton out of the 
mitochondrial matrix. Indeed, a recent study showed that several haematopoietic cell 
lines were insensitive to mitochondrial poisons and these cells generated ATP entirely 
by glycolysis, maintaining normal mitochondrial Ax|/m during the induction of 
apoptosis (Garland and Halestrap, 1997). Thus, the results of the present study are 
consistent with the above observations of others. In addition to the fundamental role 
as the cell’s primary energy supplier, mitochondria have become increasingly well 
known in recent years as potent buffers of cytosolic Ca (Rizzuto et al., 1994; Hoth et 
al., 1997). The disturbances of mitochondrial function in intracellular Ca 
homeostasis by the two inhibitors at the concentrations used in the present study have 
been reported (Mohr and Fewtrell, 1990; Budd and Nicholls, 1996b; Hoth et ah,
1997). Therefore the possibility that antimycin A or oligomycin may have modulated 
cytosolic Ca levels which subsequently resulted in the inhibition of cell surface 
changes on apoptotic cells can not be excluded. Neither antimycin A nor oligomycin 
alone directly blocked the binding of annexin V to PS residues on the outer plasma 
membrane o f the apoptotic cells (data not shown). In agreement with a report that 
extracellular Ca4 f is required for efficient PS exposure during apoptosis (Hampton et 
ah, 1996), EGTA (2 mM) inhibited PS exposure, but not activation of caspases, 
during induction of apoptosis by either TPCK or etoposide in THP.l cells (data not 
shown). However, it seems unlikely that antimycin A or oligomycin will have any 
effect on extracellular Ca h
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Figure 15. Both antimycin A and oligomycin alone did not induce a reduction in 
mitochondrial Avpm or potentiate a decrease in intracellular ATP levels during
the induction of apoptosis.
(A) THP.l cells were incubated for 4 h either alone or with etoposide (25 pM) or TPCK (75 pM).
Cells were also incubated with the indicated concentrations of antimycin A (1-30 pM) or oligomycin 
(0.1-5 pg/ml) alone. The percentage of cells with decreased was then determined flow 
cytometrically as described in Materials and Methods. (B) Cells were incubated for up to 4 h either 
alone or with TPCK (75 pM) in the presence or absence of antimycin A (30 pM) or oligomycin (5 
pg/ml). At the indicated time points, relative cellular ATP levels (% of control cells at zero time point) 
were measured as described in Materials and Methods
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It has been reported that PS exposure requires the activation of a Ca -dependent 
scramblase and/or the loss of activity of aminophospholipid translocase (Verhoven et 
al., 1995; Bratton et al., 1997). It is thus conceivable that the mitochondrial inhibitors 
may have suppressed the activity of the scramblase while stabilising the activity of the 
aminophospholipid translocase, so preventing the externalisation of PS. The 
preliminary results showed, however, that the two mitochondrial inhibitors did not 
appear to inhibit either the activation or the activity of the scramblase in human 
peripheral red blood cells (data not shown). Their effects on activity of 
aminophospholipid translocase have not yet been measured. Thus, future work is still 
required to elucidate the mechanisms of this dissociation.
85
Chapter 5 Role of cytochrome c in apoptosis
Chapter 5
Release of mitochondrial cytochrome c occurs upstream of
the activation of caspases
86
Chapter 5 Role of cytochrome c in apoptosis
5.1 Introduction
The data presented in the previous chapters have clearly demonstrated that caspase 
activation occurs prior to the other major biochemical changes characteristic o f the 
apoptotic phenotype, including the reduction in mitochondrial membrane potential 
(AT'hJ  during the induction of apoptosis by etoposide or TPCK in THP.l cells. The 
mechanism initiating the activation of caspases in this model of apoptosis is, however, 
unclear. Recently, release of mitochondrial cytochrome c has been observed as an 
early feature in many models of apoptosis (Liu et al., 1996; Yang et al., 1997; Kluck 
et al., 1997). Further studies show that in the presence of dATP, cytochrome c 
interacts with apoptotic protease activating factor-1 (Apaf-1), resulting in the 
activation of caspase-9, which in turn activates other caspases, such as caspase-3 (Liu 
et ah, 1996; P. Li et ah, 1997; Zou et ah, 1997). Several mechanisms for the release 
of mitochondrial cytochrome c are proposed, including a) opening of a mitochondrial 
permeability transition pore resulting in reduction in AT% and osmotic swelling, b) the 
presence of a specific channel for cytochrome c in the outer membrane or c) 
mitochondrial swelling and rupture of the outer membrane but without loss of 
mitochondrial AT^ (reviewed by Reed, 1997b). However, these mechanisms do not 
appear to be generally applicable, as release of cytochrome c occurs in cells with 
normal mitochondrial membrane potential (Kluck et ah, 1997; Yang et ah, 1997; 
Bossy-Wetzel et ah, 1998). Two recent studies have highlighted another possible 
mechanism for this release, involving Bid, a Bcl-2 interacting protein containing a 
proapoptotic BH3 domain (K. Wang et ah, 1996). Cleavage of Bid by caspase-8 
results in translocation of the cleaved Bid to the mitochondria where it induces the 
release of cytochrome c during cell surface death receptor-mediated apoptosis (Li et 
ah, 1998; Luo et ah, 1998). The BH3 domain of Bid is essential for its ability to 
induce the release of cytochrome c (Luo et ah, 1998).
The primary aim of the present study is to investigate the importance of the release of 
mitochondrial cytochrome c in the induction of apoptosis by etoposide or TPCK. In 
addition, some of the proposed hypotheses for mechanisms of cytochrome c release 
were also investigated in this model of apoptosis in THP.l cells.
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5.2 Release of mitochondrial cytochrome c occurred upstream of the 
reduction in mitochondrial
Incubation with etoposide resulted in a time-dependent induction of apoptosis, as 
assessed flow cytometrically by PS exposure, and decreased AxPm (Fig. 16A). This 
treatment also resulted in a time-dependent cytosolic accumulation o f cytochrome c, 
as detected by Western blot analysis (Fig. 16A lanes 2-6, upper blot). Significant 
changes in all these parameters were clearly observed after 2 h treatment. Z- 
VAD.FMK, the caspase inhibitor, completely blocked the etoposide-induced PS 
exposure. Although Z-VAD.FMK also clearly inhibited the fall in AT^, its effect on 
cytochrome c release was remarkably different (Fig. 16A). Z-VAD.FMK did not 
block the etoposide-induced cytosolic accumulation of cytochrome c (Fig. 16A lane 7, 
upper blot). The absence of cytochrome oxidase (subunit II) in the cytosolic extracts 
confirmed that the samples were free from mitochondrial contamination (Fig. 16A, 
lower blot). Thus Z-VAD.FMK prevented all the biochemical changes of apoptosis 
including PS exposure, and the fall in AT^ except for the release of mitochondrial 
cytochrome c. These data suggested that the release of cytochrome c occurred 
upstream or independent of the reduction in AT%. Further support for this conclusion 
was provided by the data with TPCK, which caused a time-dependent increase in the 
percentage of cells with externalised PS and a reduced AT^ (Fig. 16B lanes 2 - 6).
This increase was prevented by Z-VAD.FMK (Fig. 16B lane 7). TPCK also induced 
a time-dependent release of mitochondrial cytochrome c (Fig. 16B lanes 2 - 6 ,  upper 
blot), which was not blocked by Z-VAD.FMK (Fig. 16B lane 7). In TPCK-induced 
apoptosis the release o f cytochrome c was already evident at Ih, earlier than either the 
externalisation of PS or the reduction in Av|/m(Fig 16B). At 1 h, caspase-7 was also 
processed with the formation of catalytically-active large subunit, whereas cleavage of 
PARP was first observed at 2 h (see Figs. 10B and C in chapter 3). While these data 
did not distinguish whether cytochrome c release preceded the activation of caspase-7, 
results with both apoptotic stimuli demonstrated that the release of cytochrome c 
occurred upstream of the reduction in AT^, during the induction of apoptosis.
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Figure 16. Cytochrome c release is upstream of the decrease in AtPm
(A) Time course o f induction of apoptosis by etoposide (25 pM) was determined by PS exposure and 
decreased AT^ Cells were incubated for the indicated times with etoposide (lanes 2 - 6) or in the 
presence of Z-VAD.FMK (50 pM) (lane 7). Cytosolic extracts were prepared and assessed by Western 
blot analysis for cytochrome c (cyt c) and also for cytochrome oxidase subunit II (cyt oxid), as a 
marker o f mitochondrial contamination of the cytosolic extracts. Purified bovine heart cytochrome c 
(5 ng) (lane 8, upper blot) and 5 pi o f the mitochondrial fraction following removal o f the cytosolic 
extracts were loaded (lane 8, lower blot) as positive controls. (B) The time course o f induction of 
apoptosis by TPCK (75 pM) (lanes 2 - 6) or in the presence o f Z-VAD.FMK (50 pM) (lane 7) was 
determined as described above. Cytosolic extracts were analysed for cytochrome c and cytochrome 
oxidase II. Results were expressed as mean (± sem) of at least three experiments or representative of 
three experiments except for those in lanes 2 and 7 of (B), which represent mean of two experiments.
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5.3 Mitochondrial ultracondensation and outer mitochondrial 
membrane discontinuities in apoptotic cells were inhibited by Z- 
VAD.FMK
Many morphological changes of mitochondria including swelling and rupture of the 
outer membrane have been reported as critical events which result in the release of 
cytochrome c (Vander Heiden et al., 1997). Therefore the ultrastructure of 
mitochondria was examined during the induction of apoptosis. Unlike control cells, 
THP.l cells incubated with etoposide developed many characteristic ultrastructural 
features of apoptosis. Cells treated with TPCK exhibited similar cytoplasmic changes 
but with less clumping and condensation of the heterochromatin (see Fig. 6 in chapter 
3). Particularly striking was the presence of many ultracondensed mitochondria in 
both etoposide- and TPCK-treated cells (Fig. 17a and b). The time-course study 
revealed that a few of these ultracondensed mitochondria were observed as early as 2 
h but were more prevalent by 4 h (data not shown). These mitochondria were defined 
as ultracondensed, based on their marked increase in matrix density and slight dilation 
of the outer compartment/intracristal space despite a marked reduction in volume.
The reduced volume was inferred from their mean diameter (262 ± 58  nm) (mean ± 
sem) in sections, compared with that of controls (474 ± 109 nm). Similar 
ultracondensed mitochondria have been observed in tumour necrosis factor-induced 
apoptosis of a lymphoblastic cell line (Jia et al., 1997). These changes were distinct 
from the commonly described condensed mitochondria, which exhibit increased 
matrix density without any overall reduction in volume and correspond to state 3 
respiration (Hackenbrock, 1968; Laiho and Trump, 1975). Ultracondensed 
mitochondria were invariably present in cells showing the nuclear and cytoplasmic 
changes but they were also found in some cells showing no other morphological signs 
of apoptosis (data not shown). While most mitochondria in the apoptotic cells were 
affected, some remained normal and a few showed condensation of only part of their 
inner compartment (Fig. 17a and b). Discontinuities were observed in the outer 
membrane profile of many of the ultracondensed mitochondria and, although some 
could be attributed to obliquity of the section, many indicated exposure of inner- 
membrane-limited regions of the condensed matrix to the cytosol (Fig. 17a and b).
The contorted shapes of these organelles, together with the electron density of the 
surrounding cytoplasm in apoptotic cells militated against the clear identification of
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discontinuities in ultrathin sections. True discontinuities were, however, recognised 
by tilting these sections during examination. Further evidence was obtained from 0.5- 
1.0 pm sections contrasted en bloc and examined using an integrated energy filter to 
remove inelastically scattered electrons from the image. Z-VAD.FMK inhibited all 
the ultrastructural changes induced by etoposide and TPCK, including the 
mitochondrial and nuclear condensation together with the development of outer 
mitochondrial membrane discontinuities (Figs. 17c and d). These results demonstrate 
that the formation of both ultracondensed mitochondria and discontinuities in the 
outer mitochondrial membrane occurred downstream of the activation o f caspases.
Figure 17. Z-VAD.FMK inhibited the formation of mitochondrial 
ultracondensation and discontinuities during the induction of apoptosis
in THP.l cells.
(a) Cells incubated with etoposide (25 pM) for 4 h showed many ultracondensed mitochondria (solid 
arrows). The increase in matrix density was usually uniform but, in some mitochondria, only restricted 
regions were affected (solid curved arrow), (b) Similar changes were observed after treatment with 
TPCK (75 pM). Apparent discontinuities in the outer membrane of many of these mitochondria could 
be attributed to obliquity of the section (open curved arrows) but several of these organelles also 
showed disruption of this membrane resulting in the exposure of membrane-limited regions of the 
condensed matrix to the cytosol (solid arrows), (c) Co-incubation of THP.l cells with etoposide and Z- 
VAD.FMK (50 pM) for 4 h resulted in complete inhibition of the formation of mitochondrial 
ultracondensation and discontinuities as well as other characteristic ultrastructural features of 
apoptosis. (d) Co-incubation of THP.l cells with TPCK and Z-VAD.FMK (50 pM) for 4 h also 
prevented the formation of mitochondrial discontinuities and the other ultrastructural features of 
apoptosis. [all bars = 1pm]
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5.4 Bid cleavage is inhibited by Z-VAD.FMK
Cleavage of Bid is implicated in the release of mitochondrial cytochrome c in CD95- 
induced apoptosis (Li et ah, 1998; Luo et ah, 1998). This mechanism of cytochrome c 
release was investigated in order to determine whether it is important in chemical- 
induced apoptosis in THP.l cells. Western blot analysis showed that Bid was present 
as an ~26 kDa protein in control cells and was cleaved in cells treated with etoposide 
(Fig. 18A ). It was initially cleaved into two major fragments of ~ 15 and 14 kDa 
(Fig. 18A), most probably following cleavage at LQTD60shG and IEA D '\I/S  (Li et 
ah, 1998; Luo et ah, 1998). Etoposide induced a time-dependent cleavage of Bid in 
THP.l cells with a small amount of fragmentation first being observed at 3 h (Fig.
18A lane 4). Z-VAD.FMK inhibited this cleavage (Fig. 18A lane 6) but it did not 
inhibit etoposide-induced release of cytochrome c (Fig. 16A lane 7). Thus, in 
etoposide-induced apoptosis in THP.l cells, release of mitochondrial cytochrome c 
did not involve the cleavage of Bid. TPCK also induced a time-dependent cleavage of 
Bid with the initial cleavage being observed at 2 h (Fig. 18B lane 3). Again, Z- 
VAD.FMK inhibited this cleavage (Fig. 18B lane 6) but failed to inhibit TPCK- 
induced release o f cytochrome c (Fig. 16B lane 7). Thus, in both etoposide- and 
TPCK-induced cell death in THP.l cells, cleavage of Bid was inhibited by Z- 
VAD.FMK, suggesting that this cleavage was not an essential event required for the 
release of mitochondrial cytochrome c in chemical-induced apoptosis.
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Figure 18. Z-VAD.FMK inhibits cleavage of Bid in both etoposide- and TPCK-
induced apoptosis
THP.l cells were incubated for the indicated times either alone (lane 1) or with (A) etoposide (25 pM) 
or (B) TPCK (75 pM) (lanes 2-5, respectively). Cells were also co-incubated with Z-VAD.FMK (50 
pM) (lane 6). Cells were then analysed by Western blot analysis for Bid and its cleaved products as 
indicated.
5.5 Z-VAD.FMK inhibited TNF-a-mediated but not etoposide- 
induced cytochrome c release in U937 cells
The results described above demonstrated that Bid cleavage was not required for the 
release o f mitochondrial cytochrome c in chemical-induced apoptosis in THP.l cells 
although it may be important for cytochrome c release in cell surface death receptor- 
mediated apoptosis. In order to test this hypothesis, the study was extended to the 
human lymphoid tumour cell line U937. These cells are sensitive to TNF-a, which 
induces apoptosis through death receptor-mediated pathways (reviewed by Nagata, 
1997). Both TNF-ct/cycloheximide and etoposide induced apoptosis in U937 cells, as 
assessed by PS externalisation and decreased (Fig. 19A). Induction of apoptosis 
was accompanied by processing of caspase-3 and cleavage o f PARP, a commonly 
used measure of caspase-3-like enzymic activity (Fig. 19B and C, lanes 2 and 4). Z- 
VAD.FMK completely inhibited TNF-a/cycloheximide-induced apoptosis as assessed
A Etoposide
Time (h)
Z-VAD
B TPCK
Time (h)
1 2 3 4 5 6
Z-VAD
95
Chapter 5 Role of cytochrome c in apoptosis
by all these criteria. In contrast, in etoposide-induced apoptosis Z-VAD.FMK 
completely inhibited PS externalisation, the decrease in and the cleavage of 
PARP but it only partially inhibited processing of caspase-3 (Fig. 19B lane 5). Thus 
Z-VAD.FMK was more effective at blocking the activity rather than the processing of 
caspase-3. Induction of apoptosis by either TNF-a/cycloheximide or etoposide also 
resulted in an increase in cytosolic cytochrome c (Fig. 19D lanes 2 and 4, 
respectively). Interestingly, Z-VAD.FMK blocked the release of cytochrome c from 
mitochondria in TNF-a/cycloheximide-mediated apoptosis but did not inhibit the 
increase in cytosolic cytochrome c in etoposide-induced apoptosis (Fig. 19D lanes 3 
and 5, respectively). Thus, the data from U937 cells supported the hypothesis that Z- 
VAD.FMK inhibits a target upstream of mitochondria in receptor (TNF-a)-mediated 
apoptosis, whereas in etoposide-induced apoptosis the Z-VAD.FMK target is 
downstream of mitochondria. Cleaved Bid has been implicated in mediating the 
release of mitochondrial cytochrome c in receptor (CD95 and TNF-a)-induced 
apoptosis (Li et al., 1998; Luo et al., 1998) and this cleavage is inhibited by Z- 
VAD.FMK in CD95-induced apoptosis in Jurkat T cells (Luo et al., 1998). Thus, it is 
of particular interest to test whether Bid cleavage is also inhibited by Z-VAD.FMK in 
TNF-a-induced apoptosis in U937 cells. Induction of apoptosis by either TNF-a or 
etoposide resulted in the cleavage of Bid (Fig. 19E lanes 2 and 4, respectively). Z- 
VAD.FMK prevented cleavage of Bid induced by both apoptotic stimuli (Fig. 19E 
lanes 3 and 5, respectively). Because Z-VAD.FMK only inhibited cytochrome c 
release in TNF-a- but not in etoposide-induced apoptosis (Fig. 19D lanes 3 and 5, 
respectively), these results effectively ruled out the role of the Bid cleavage in 
cytochrome c release in etoposide-induced apoptosis, although it may play a critical 
role in cytochrome c release in TNF-a-induced apoptosis. Thus in both THP.l and 
U937 cells, cleavage of Bid and loss of mitochondrial cytochrome c accompanied 
chemical-induced apoptosis and Z-VAD.FMK inhibited cleavage of Bid but not the 
loss of cytochrome c, demonstrating that cleavage of Bid is not responsible for the 
release of mitochondrial cytochrome c in chemical-induced apoptosis.
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Figure 19. Z-VAD.FMK inhibits TNF-a- but not etoposide-induced release of 
mitochondrial cytochrome c in U937 cells
U937 cells were incubated for 3 h with TNF-a/cycloheximide (TNF/CHX ) either alone (lane 2) or in 
the presence of Z-VAD.FMK (2 pM) (lane 3). Cells were also incubated for 5 h with etoposide either 
alone (lane 4) or in the presence of Z-VAD.FMK (20 pM) (lane 5). (A) Apoptosis was assessed flow 
cytometrically by PS exposureand decreased AY^ Results were expressed as mean o f at least three 
experiments. Cells were also analysed by Western blot analysis as described in Materials and Methods 
for, (B) processing of caspase-3, (C) cleavage o f PARP (D) cytochrome c and (E) cleavage of Bid. 
Intact PARP (116 kDa) is cleaved by a caspase-3-like enzymic activity to an 89 kDa signature 
fragment. Intact Bid (26 kDa) is cleaved into two fragments o f -15  and 14 kDa.
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5.6 Discussion
5.6.1 Release of cytochrome c is independent of the reduction in A\\jm 
Release of mitochondrial cytochrome c together with caspase-9, Apaf-1 and 
ATP/dATP, forms a complex which then activates “effector” caspases such as 
caspase-3 (P. Li et ah, 1997; Liu et ah, 1996). Several recent studies have also 
highlighted a role for a decrease in Avpm as a key committed step in the induction of 
apoptosis (Zamzami et ah, 1995; Petit et ah, 1996). In the present study, both 
etoposide and TPCK caused a release of mitochondrial cytochrome c and a decrease 
in Av|/m (Fig. 16A). Co-incubation with Z-VAD.FMK abolished the decrease in Av|/m 
but did not affect the release of cytochrome c (Fig. 16 A and B lanes 7, respectively). 
These results demonstrate that the release of cytochrome c occurs upstream of the 
reduction in Av|/m. Further support for this conclusion was provided by the finding 
that TPCK-induced cytochrome c release was clearly observed at 1 h, prior to the 
reduction in Av|/m or the increase in PS exposure (Fig. 16B). Thus, apoptosis induced 
by either etoposide or TPCK resulted in the release of mitochondrial cytochrome c, 
which occurred prior to or independent of the reduction in Ax|/m, a result consistent 
with other studies (Kluck et al., 1997; Yang et al., 1997; Bossy-Wetzel et al.,1998).
5.6.2 Release of mitochondrial cytochrome c is upstream of the formation of 
ultracondensed mitochondria and discontinuities in the outer mitochondrial 
membrane
The transition of mitochondria from an orthodox to a condensed conformation is 
associated with a change from a resting (state 4) to an active (state 3) respiration 
(Hackenbrock, 1968; Lehninger, 1975). The characteristic increase in matrix density 
in the condensed conformation results from a reduction in the volume of the inner 
mitochondrial compartment, which is accompanied by a compensatory increase in the 
outer compartment/intracristal space resulting in little or no reduction in total volume 
of the organelle (Hackenbrock, 1968). The ultracondensed mitochondria described in 
the present study are distinct from the well-described condensed mitochondrial 
conformation and are characterised by a particularly pronounced increase in matrix 
density together with a marked decrease in overall volume (Fig. 17 a and b). The 
ultracondensed mitochondria in THP.l cells exhibit similar features to those observed 
in apoptotic lymphoblastic leukemic cells (Jia et al., 1997), the “pleomorphic
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micromitochondriosis” in apoptotic nodal myocytes (James et al., 1993) and the 
“mitochondrial pyknosis" and “hypercondensation” observed during apoptosis in a 
colon carcinoma cell line (Mancini et ah, 1997). These changes were associated with 
an increased mitochondrial mass but with a decreased A\\im (Mancini et ah, 1997). 
Despite minor differences in the morphology of these examples of highly condensed 
mitochondria, they all share a pronounced increase in matrix density together with a 
marked reduction in the area of their profiles in thin sections. Mitochondria 
resembling the classical condensed form have been described as ultracondensed in 
some instances of cell death (Papadimitriou et ah, 1994). In some systems, there 
appears to be a progression from the condensed to the ultracondensed form followed 
by deletion of the organelle (Jia et ah, 1997; Mancini et ah, 1997). In the present 
study, co-incubation with Z-VAD.FMK resulted in mitochondria of normal 
appearance, with complete inhibition of the formation of ultracondensed mitochondria 
(Fig. 17c and d) without affecting the release of mitochondrial cytochrome c (Fig. 16 
A and B). Thus formation of ultracondensed mitochondria occurred downstream of 
caspase activation.
In apoptotic THP.l cells, many ultracondensed mitochondria showed rupture of the 
outer membrane (Fig. 17a and b) exposing regions of the condensed matrix to the 
cytosol. Mitochondria are susceptible to morphological change during delayed or 
inappropriate processing but control samples were devoid of any such condensation or 
discontinuities. Breaks in the outer mitochondrial membrane occur in the swollen 
mitochondria of apoptotic Jurkat and FL5.12 cells resulting in the redistribution of 
cytochrome c to the cytosol followed by a decrease of Av|/m (Vander Heiden et al., 
1997). These changes are prevented by expression of Bcl-xL suggesting that it 
increases cell survival by modulating electrical and osmotic changes of mitochondria 
(Vander Heiden et al., 1997). In contrast, the present study shows ultracondensation 
rather than swelling of mitochondria in THP.l cells before the development of any 
other morphological features of apoptosis. As Z-VAD.FMK inhibited the formation 
of outer mitochondrial membrane discontinuities (Fig. 17c and d), these changes were 
downstream of caspase activation. Thus our data have excluded two of the major 
hypotheses currently proposed for the release of mitochondrial cytochrome c, i.e. 
formation of outer mitochondrial membrane discontinuities and/ or resulting from a
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decrease in A\j/m. An alternative mechanism for this release may be via a specific 
outer mitochondrial membrane channel. Bax, a proapoptotic member of the Bcl-2 
family, forms channels in lipid membranes (Antonsson et al., 1997; Schlesinger et al., 
1997) and has been proposed as a possible candidate for such a channel (Reed,
1997b). Our data support the hypothesis that an initial mitochondrial perturbation 
results in the release of cytochrome c, which in the presence of Apaf-1 leads to 
activation o f caspases-9 and -3. The activated caspases then cleave cellular proteins 
resulting in mitochondrial damage leading to mitochondrial ultracondensation and 
outer membrane discontinuities.
5.6.3 Cytochrome c release occurs upstream of the activation of caspases 
in chemical-induced apoptosis
Following release from mitochondria, cytochrome c binds to Apaf-1 resulting in the 
activation o f caspase-9, which in turn activates the effector caspases responsible for 
the cleavage of many of the substrates associated with the characteristic biochemical 
and morphological changes of apoptosis (P. Li et al., 1997). In agreement with data 
from chemical- and radiation-induced apoptosis in other cells (Kluck et ah, 1997; 
Yang et ah, 1997; Bossy-Wetzel et ah, 1998), Z-VAD.FMK did not inhibit the release 
of mitochondrial cytochrome c in chemical-induced apoptosis in both THP.l and 
U937 cells. However, Z-VAD.FMK blocked activation of caspases-3 and -7 and 
PARP cleavage (Fig. 19 B and C, and Fig. 12 in chapter 4). These data support the 
hypothesis that the target of Z-VAD.FMK in chemical-induced apoptosis is the 
processing or the activity of caspase-9, the initiator caspase after the release of 
cytochrome c. Recent studies on caspase-9 knockout mice demonstrate that caspase-9 
is a critical upstream activator of a caspase cascade in vivo and in some situations is 
essential for the processing of caspase-3 (Kuida et ah, 1998). Thus cytochrome c 
release occurs upstream of the activation of caspases.
Cleavage o f Bid was observed in the present study in both chemical-induced and 
receptor-mediated apoptosis. Bid is cleaved by low concentrations of caspase-8 but 
can be cleaved by higher concentrations of caspase-3 (Li et ah, 1998). Thus in 
chemical-induced apoptosis, inhibition of Bid cleavage by Z-VAD.FMK may be due 
to inhibition of processing/activity of caspase-3 after release of cytochrome c which,
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in the presence o f dATP and Apaf-1, resulted in the activation of caspase-9. 
Furthermore, in contrast to receptor-mediated apoptosis, Z-VAD.FMK blocked 
cleavage of Bid but not release of cytochrome c in chemical-induced apoptosis (Figs. 
16, 18 and 19) demonstrating that cytochrome c release is a caspase-independent 
event and is not mediated by cleavage of Bid in these two models o f chemical-induced 
apoptosis. Whether the mechanism of mitochondrial cytochrome c release involves 
another proapoptotic BH3 domain-containing member of the Bcl-2 family, such as 
Bik, Hrk, Blk or Bim remains to be seen. Thus in chemical-induced apoptosis, a 
mechanism other than cleavage of Bid is responsible for the release of cytochrome c.
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6.1 Introduction
The data obtained so far have demonstrated that activation of caspases is a key event 
during the execution phase of apoptosis. The cleavage of specific cellular proteins by 
some of the caspases appears to be associated with many of the morphological 
changes characteristic of apoptosis (reviewed by Kumar and Lavin, 1996; Nagata, 
1997; Cohen, 1997). For example, proteolysis of nuclear proteins such as lamins 
(Kaufmann, 1989; Oberhammer et al., 1994), poly (ADP-ribose) polymerase (PARP) 
(Kaufmann, 1989; Kaufmann et al., 1993), DNA-dependent protein kinase (DNA-PK) 
(Casciola-Rosen et al., 1995; Song et al., 1996) and U1 small ribonucleoprotein (U l- 
70 kDa) (Casciola-Rosen et al., 1994; Tewari et al., 1995a) observed in cells 
undergoing apoptosis is believed to contribute to the collapse of the nucleus and 
condensation of the chromatin. Thus the biochemical machinery required to execute 
the apoptotic programme seems to be constitutively present in most mammalian cells, 
but regulation of the process can be modulated by a wide variety of extra- and intra­
cellular factors (Steller, 1995; Wyllie, 1995). The potential role in the modulation of 
apoptosis by Zn has been known for many years (reviewed by Zalewski and Forbes, 
1993; Sunderman, 1995; Fraker and Telford, 1997). B o th 'm vivo and in vitro studies 
have shown that apoptosis is induced during Zn"+ deficiency (Fîmes, 1977; Dinsdale 
and Williams, 1977; Fîmes and Jones, 1980; McCabe et ah, 1993), whereas Zn 
supplementation inhibits apoptosis in a number of cell systems induced by diverse 
stimuli (Cohen and Duke, 1984; Shimuzu et ah, 1991; Takano et ah, 1991; Bicknell et 
al., 1994). Although the precise mechanisms of inhibition in apoptosis by Zn++ are 
largely unknown, several potential targets of Zn+T have been reported including a 
Ca ^/Mg^-dependent endonuclease (Cohen and Duke, 1984; Giannakis et al., 1991) 
and the caspases (Wolf et al., 1997; Perry et al., 1997; Stennicke and Salvesen, 1997). 
However, the inhibitory effect of the cation on apoptosis was almost all observed 
following short time period of incubation. The question of what eventually happens 
to cells that are prevented from undergoing apoptosis has not been adequately 
addressed. In human monocytic THP.l cells, the role of Zn in apoptosis has not 
been characterised. In the present study, the effects of Zn on apoptosis induced by 
either etoposide or TPCK were examined with particular interest in its effect after 
longer incubation.
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6.2 Concentration-dependent inhibition of apoptosis by Zn^
Incubation of THP.l cells for 4 h with either etoposide (25 p M ) or TPCK (75 p M ) 
resulted in the induction of apoptosis, as assessed by the externalisation of PS (Fig.20 
A). Zn 1 (0.1 mM) had no inhibitory effect on the PS externalisation in cells treated 
with etoposide but partly inhibited that in cells treated with TPCK. Zn 1 (0.5 and 1.0 
mM) completely inhibited the PS externalisation in cells treated with either etoposide 
or TPCK. Thus Zn" inhibited, in a concentration-dependent manner, the induction of 
apoptosis induced by either agent (Fig. 20A). Zn* alone at all three concentrations 
did not induce PS externalisation (Fig. 20A, lanes 12-14). Z-VAD.FMK (50 pM ), the 
inhibitor of caspases, also inhibited apoptosis induced by the two apoptotic stimuli 
(Fig. 20A). The induction of apoptosis by either etoposide or TPCK was 
accompanied by the activation of caspases together with ensuing proteolysis of PARP 
and lamins (Fig. 10 in chapter 3, and MacFarlane et ah, 1997; Zhu et ah, 1997). This 
proteolysis together with the cleavage of DNA by etoposide or TPCK was prevented 
by the treatment with Z-VAD.FMK (Figs. 12 and 13 in chapter 4; and MacFarlane et 
ah, 1997; Zhu et ah, 1997). The effect of Zn on these changes associated with the 
induction of apoptosis was therefore investigated in THP.l cells.
First, the effect of Zn '  on the intemucleosomal cleavage of DNA induced by 
etoposide was examined using conventional agarose gel electrophoresis, and Zn ^  
exhibited a concentration-dependent inhibition on the formation of intemucleosomal 
fragments o f DNA (data not shown). The effects of Zn*' on the activities of caspases, 
including cleavage of PARP and lamin B1 was then examined using Western blot 
analysis. Figure. 20 B and C showed that control cells (lane 1) contained only intact 
PARP (116 kDa) and lamin B1 (-67 kDa) respectively. Induction of apoptosis by 
either etoposide or TPCK was accompanied by the cleavage of PARP to its 85 kDa 
fragment (Fig. 20 B lanes 2 and 7) and of lamin B1 to its -46  kDa fragment (Fig. 20 C 
lanes 2 and 7), respectively, which were all completely blocked by Z-VAD.FMK (Fig. 
20 B and Fig. 20 C lanes 6 and 11, respectively). Zn+* inhibited, in a concentration- 
dependent fashion, the cleavage of PARP and lamin B1 (Figs. 20 B and C, lane 3-5 
and 8-10 ) in cells treated with either apoptotic stimulus whilst Zn* alone at all three 
concentrations did not induce the cleavage of either PARP (Fig. 20 B lanes 12-14) or 
lamin B1 (Fig. 20 C lanes 12-14). It was noted that 1 mM Zn , while clearly
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preventing the cleavage of PARP after etoposide treatment (Fig. 20 B lane 5), did not 
completely block that after TPCK treatment (Fig.20 B lane 10).
The cleavage of PARP to its 85 kDa signature fragment suggested the activation of 
caspases-3 and/or -7 whereas that of lamin B1 indicated the activation of caspase-6. 
As it has been shown that Zn r inhibited the cleavage activity of caspase-6 (Takahashi 
et ah, 1996), it was decided to determine if Zn had any inhibitory effect on the 
activation of caspases-3 and -7. Untreated control cells showed the presence of the 
intact pro forms of caspase-3 (Fig. 20 D lane 1) and caspase-7 (Fig. 20 E lane 1). 
Induction of apoptosis with either etoposide or TPCK was accompanied by a decrease 
in the proforms of caspases-3 and -7 together with the formation of their respective 
catalytically active large subunits (LS) (Figs. 20 D and E, lanes 2 and 7, respectively). 
Zn+" (0.1 mM) showed no inhibitory effect on the formation of LS of caspase-3 in 
cells treated with either etoposide (Fig. 20 D lane 3) or TPCK (Fig. 20 D lane 8). Zn 
(0.5 mM) almost completely inhibited the formation of LS of caspase-3 in etoposide- 
treated cells (Fig. 20 D lane 4), but only partly inhibited the formation of LS of 
caspase-3 in TPCK-treated cells (Fig. 20 D lane 9). Zn"" (1.0 mM) completely 
inhibited the formation of LS of caspase-3 in cells treated with etoposide (Fig. 20 D 
lane 5) and largely inhibited that in cells treated with TPCK (Fig. 20 D lane 10). Zn" 
showed a similar inhibitory pattern in the formation of LS of caspase-7 following 
treatment with either apoptotic stimulus (Fig. 20 E). Thus Zn"+ inhibited, in a 
concentration-dependent manner, the formation of LSs of caspases-3 and -7 in cells 
treated with either etoposide or TPCK. Zn " alone, at all three concentrations, did not 
induce the formation of LS of either caspase-3 (Fig. 20 D lanes 12-14) or caspase-7 
(Fig. 20 E, lanes 12-14). Z-VAD.FMK clearly blocked the formation of LSs of 
caspase-3 and -7 after treatment with either etoposide or TPCK (Figs. 20 D and E, 
lanes 6 and 11, respectively). Taken together, these results suggested that Zn " 
inhibited apoptosis by blocking the processing of both caspase-3 and -7 to form their 
respective catalytically active large subunits. While this work was in progress, it was 
reported that Zn" was a potent inhibitor of caspase-3 as it inhibited both 
processing/activation and activity of the protease (Wolf et al., 1997 and Perry et al., 
1997). Further study showed that Zn" was a general inhibitor of caspases, although
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their sensitivities to Zn++ vary significantly (Stennicke and Salvesen, 1997). Thus the 
data from this study are in good agreement with these observations.
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Figure 20. Z-VAD.FMK and Zn^ inhibit PS exposure, cleavage of PARP and 
lamin B1 and processing of caspases-3 and -7
THP.l cells were incubated for 4 h either alone ( lane 1), or with etoposide (25 pM) (lanes 2 - 6) or 
TPCK (75 pM) (lanes 7 - 11) in the presence of Z-VAD.FMK (50 pM) ( lanes 6 and 11) or Z n ^  (0.1- 
1 mM) (lanes 3 - 5  and 8 -10) as indicated. Cells were also incubated with Z n ^  alone (0.1-1 mM) 
(lanes 12-14). (A) The induction of apoptosis was assessed by externalisation o f PS as described in 
Materials and Methods. Cells were examined by Western blot analysis using antibodies to detect the 
cleavage o f (B) PARP and (C) lamin B l. Cells were also analysed for the cleavage o f the (D) 32-kDa 
procaspase-3 and (E) 35-kDa procaspase-7 to their respective catalytically active large subunits (LS). 
Results were expressed as mean ± sem o f at least three experiments or representative of three 
experiments.
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6.3 Zn^ inhibited the release of cytochrome c in etoposide- but not 
TPCK-induced apoptosis
It has previously been shown that cytochrome c is released from mitochondria during 
the induction o f apoptosis by either apoptotic stimulus (see Fig. 16 in chapter 5). A 
reduction in mitochondrial membrane potential has also been observed as an
event associated with apoptosis (see Fig. 8 in chapter 3). Experiments were therefore 
performed to investigate whether Zn" could inhibit the release of cytochrome c and 
reduction in AlFm as well. Incubation with etoposide resulted in a time-dependent 
accumulation of cytochrome c in cytosolic extracts, detected by western blot analysis 
(Fig. 21 lanes 2-6, upper blot). Whilst Z-VAD.FMK did not block cytochrome c 
release induced by etoposide, Zn " (1 mM) blocked its release into cytosol (Fig. 21 
compare lanes 8 with 7, upper blot). Zn++ (1 mM) alone did not cause the release of 
cytochrome c (see below). Zn' also caused a concentration-dependent inhibition of 
the reduction in AvFm when co-incubated with etoposide whereas it alone at all three 
concentrations had no effect on AY^ (Table 4). Thus these data have shown that Zn' 
inhibited several features of apoptosis including the release of cytochrome c and 
reduction in AlFm following treatment with etoposide. However, further experiments 
showed that neither Zn’h (1 mM) nor Z-VAD.FMK blocked the release of cytochrome 
c during the induction o f apoptosis by TPCK (Fig. 21 lanes 7 and 8, lower blot), 
although they both inhibited the reduction in AT^ (Table 4). These data thus showed 
that Z n" inhibited etoposide- but not TPCK-induced release of cytochrome c during 
induction of apoptosis.
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Figure 21. Zn^ inhibited the release of cytochrome c in etoposide-induced
apoptosis
Cells were incubated for the indicated times either alone (lane 1) or with etoposide (25 pM) or TPCK 
(75 pM) (lanes 2 - 6). Cells were also co-incubated with Z-VAD.FMK (50 pM) (lane 7) or Zn"" (1 
mM) (lane 8). Cytosolic extracts were prepared and assessed by Western blot analysis for cytochrome 
c as described in Material and Methods. No detectable cytochrome oxidase subunit II, a marker of 
mitochondrial contamination, was observed in these samples (data not shown).
Table 4. Zn^ and Z-VAD.FMK inhibit the decrease of during 
the induction of apoptosis
Treatment Zn++ (mM) % cells with low AT^
Control - 6.1 ± 0.8
Etoposide - 24.4 ± 1.2
Etoposide 0.1 23.4 ± 2.5
Etoposide 0.5 11.4 ±4.7
Etoposide 1.0 00+1
Etoposide + Z-VAD.FMK - 3.9 ± 0.7
TPCK - 44.2 ± 4.6
TPCK 1.0 9.5 ± 1.7
TPCK + Z-VAD.FMK - 5.6 ± 1.1
Zn~ 0.1 6.4 ± 1.7
Zn++ 0.5 5.9 ± 1.2
Zn++ 1.0 8.2 ± 2.7
Z-VAD.FMK - 2.6*
m-ClCCP - 79.8 ± 2.9
THP.l cells were incubated with etoposide (25 pM) or TPCK (75 pM) for 4 h either alone or in the 
presence of the indicated concentrations of Zn"" or Z-VAD.FMK (50 pM). The percentage o f cells 
with decreased mitochondrial membrane potential (AT^ ) was determined by flow cytometry. Cells 
were also incubated with the mitochondrial uncoupler, carbonyl cyanide m-chlorophenyl hydrazone 
(m-ClCCP, 50 pM) as a positive control. The results are expressed as the mean ± sem o f at least three 
separate experiments except for * , which was the average of two experiments.
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6.4 Zn^ did not prevent subsequent cell death despite inhibition of 
apoptotic pathways
Early work in this laboratory has shown that, in the presence of Zn++, apoptosis 
proceeded without the intemucleosomal cleavage of DNA in thymocytes following 4 
h incubation with either etoposide or dexamethasone (G. Cohen et ah, 1992; Brown et 
ah, 1993; Sun et ah, 1994), but was inhibited in human leukaemic U937 cells during a 
7 h incubation with actinomycin D (Bicknell et ah, 1994). To answer the question 
whether Zn” prevents or merely delays apoptosis in THP.l cells, the incubation time 
was extended to 24 h and cells were then examined for the activation of caspase-7 and 
PARP cleavage in cells treated with etoposide. Figure 22 A showed that at 24 h 
control cells retained the intact caspase-7 proform (lane 1) whilst cells treated with 
etoposide (25 pM) had a lower amount of proform with the formation of a 
corresponding catalytically active large fragment (lane 2). Z n” still inhibited the 
activation of caspase-7 in a concentration-dependent manner whereas it alone at all 
three concentrations did not induce the formation of large fragment (Fig. 22 A lanes 
7-9). Z-VAD.FMK (50 pM) effectively blocked the activation of caspase-7 (Fig. 22 
A lane 6) whilst it alone had no effect (Fig. 22 A lane 10). Control cells contained 
only the intact form of PARP (Fig. 22 B lane 1) whereas etoposide-treated cells 
almost completely lost the intact form with the subsequent formation of the 85 kDa 
fragment (Fig. 22 B lane 2). Zn+" also inhibited the PARP cleavage induced by 
etoposide in a concentration-dependent manner whereas Zn ' alone at all three 
concentrations had no effect (Fig. 22 B). Z-VAD.FMK clearly inhibited the cleavage 
of PARP (Fig. 22B lane 6) whereas it alone showed no effect (Fig. 22 B lane 10).
Thus the data indicated that Zn still effectively blocked the activation of caspase-7 
and the proteolytic activities of caspases responsible for PARP cleavage after 24 h co­
incubation with etoposide. However, when the cell viability was examined at 24 h, 
by trypan blue staining, most of the cells treated with etoposide and those co- 
incubated with Zn++ had lost their viability (Fig. 22 C). Surprisingly, cells treated 
with Zn ' alone also showed a concentration-dependent loss of viability. Partial loss 
of viability was also observed in cells co-incubated with etoposide and Z-VAD.FMK. 
Only control cells and those treated with either 0.1 mM Zn+ or 50 pM Z-VAD.FMK 
alone maintained greater than 95 % viability (Fig. 22 C). These results suggested that 
cells were still undergoing cell death when co-incubated with etoposide and Zn++,
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even though caspase-7 activation and PARP cleavage were inhibited. They also 
indicated that Zn itself might exhibit a cytotoxic effect at the concentrations which 
inhibited apoptosis. More importantly, these data showed that Z n^ did not protect 
cells from subsequent cell death.
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Figure 22. Zn^ did not prevent subsequent cell death despite inhibition of
apoptotic pathways
THP.l cells were incubated for 24 h either alone (lane 1), or with etoposide (25 pM) (lanes 2 - 6) in the 
presence of Z-VAD.FMK (50 pM) ( lanes 6) or Zn~ (0.1-1 mM) (lanes 3-5). Cells were also 
incubated with Z n^ alone (0.1-1 mM) (lanes 7-9) or Z-VAD.FMK alone (lane 10). Cells were then 
analysed by Western blot analysis using antibodies to (A) 35-kDa pro-caspase-7 and its catalytically 
active large subunits (LS), and (B) intact PARP and cleaved fragment. (C) Cell viability at 24 h was 
examined by trypan blue staining. Results were expressed as mean ± sem o f at least three experiments 
or representative of three experiments.
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6.5 Longer incubation with Zn^ alone resulted in necrosis
In order to characterise the cell death caused by Zn ", time-course experiments were 
carried out in cells treated with Zn alone within the range of concentrations that 
inhibit apoptosis. Since the cells dying after 24 h incubation with Zn showed no 
sign of either caspase-7 activation or PARP cleavage (Fig. 22 A and 3B), it was 
assumed that the cell death caused by Zn " was most probably by necrosis. It was 
therefore decided to monitor the intracellular ATP levels and the cell viability, the 
latter being assessed by the cell’s uptake of propidium iodide. Zn (0.1 mM) had no 
effect on the intracellular ATP levels compared with control (Fig. 23 A) . Zn " (0.5 
mM) induced a decrease in the intracellular ATP levels at 8 h and showed a 
continuing time-dependent decrease (Fig. 23 A). The decrease in ATP levels caused 
by Zn+r (1.0 mM) also occurred after 4 h incubation and became more pronounced 
with time and by 24 h ATP levels dropped to lower than 5 % compared with that at 
the start o f treatment (Fig. 23 A). Correlating well with the decrease in ATP levels 
was the loss of cell viability. Zn" (0.5 mM) caused a loss of cell viability at 12 h and 
in a time-dependent manner thereafter (Fig. 23 B) and with Zn+r (1.0 mM) the loss of 
cell viability was apparent after 8 h and by 24 h more than 70 % of the cells lost their 
viability. In contrast, cells treated with 0.1 mM Zn " showed almost identical viability 
to control cells (Fig. 23 B). Thus the results demonstrated that Zn alone at 
concentrations that inhibit apoptosis can cause cell death over a 24 h incubation 
period, which can be characterised by the decrease in intracellular ATP levels and the 
loss of cell viability. Ultrastructural studies revealed no signs of injury at 4 h (data 
not shown) whereas at 8 h cells were swollen. This was accompanied by a reduction 
in the density of the cytoplasm together with slight swelling of the lysosomes, 
endoplasmic reticulum and nuclei (Fig. 23 C). A few of these cells showed the 
development of flocculent densities within their mitochondria (Fig. 23 C). At 12 h 
these changes were more widespread and accompanied by chromatolysis or the 
clumping o f heterochromatin into complex, densely-staining structures which were 
generally isolated from the inner membrane of the nuclear envelope (Fig. 23 D). By 
24 h most cells were clearly in the late stages of necrosis exhibiting flocculent 
densities in the mitochondrial matrix, chromatolysis and lysis of many organelles 
(data not shown). Thus the necrotic cells observed 24 h after treatment with Zn " 
have died by oncosis, a process distinct from apoptosis (Majno and Joris 1995).
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Oncosis is characterised by a loss of cellular ATP and cellular swelling leading to the 
formation of necrotic cells. In order to determine at what stage these cells were 
irreversibly committed to die, cells were incubated with Zn " (1 mM) for short periods 
of time and then transferred to a Zn r - free medium. At 24 h no loss of viability was 
observed when Zn was removed after 2 h incubation, whereas 50 % of cells died 
when Zn was removed after 4 h incubation (see below). Thus cells were irreversibly 
committed to die as early as 4 h after exposure to Zn"+, prior to the development of 
detectable ultrastructural changes.
Figure 23. Zn4^  caused time- and concentration-dependent depletion of ATP, 
loss of viability and ultrastructural changes of necrosis.
THP. 1 cells were incubated for up to 24 h either alone (-0-), or with Zn++ at the concentrations of 0.1 
mM ( -• - )  or 0.5 mM ( - A - )  or 1.0 mM (-■-)• (A) relative ATP levels were measured at the indicated 
time points as described in Materials and methods. The level of ATP in the control cells at zero time 
was 9.0 ± 0.6 nmoles / 106 cells. (B) % loss of viability was measured by uptake of propidium iodide 
by flow cytometry. Results are expressed as the mean ± sem of at least three experiments. The data 
were analysed by Student’s t  test and differences between control and treatment of p<0.05 were 
considered significant (*). (C) Incubation with Zn++ (1 mM) for 8 h, resulted in a slight reduction in 
cytoplasmic density, swelling of lysosomes, endoplasmic reticulum and nuclei together with the 
clumping of heterochromatin and the development of flocculent densities within mitochondria (fine 
arrows). (D) Incubation with Zn++ (1 mM) for 12 h, resulted in a marked increase in the density of the 
clumped chromatin, reduction in cytoplasmic density, discontinuities in the cell membrane (solid 
arrow) and lysis of many of the organelles, including mitochondria, [all bars = 1 pm)
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6.6 Cytochrome c release was a late event in non-apoptotic cell death
While many recent studies have concentrated on a possible role o f cytochrome c 
release in apoptosis, few if any have investigated a possible relationship between this 
release and other forms of cell death. As Zn"+ (ImM) caused cell death by oncosis 
over a 24 h incubation period, it was o f interest to determine when cytochrome c was 
released in this non-apoptotic form of cell death. Zn^ (ImM) alone induced a time 
dependent increase in cytosolic accumulation o f cytochrome c, which was first 
observed at 12 h (Fig. 24), after the loss of intracellular ATP (Fig. 23 A) and 
ultrastructural changes which were observed at 8 h (Fig. 23 C). Thus release of 
mitochondrial cytochrome c was a late event in oncosis and does not play a significant 
role in this non-apoptotic form of cell death.
T im e (h) 0 4 8 12 16
cyt C * 4
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Figure 24. Cytochrome c release is a late event in necrosis
Cells were incubated with Zn++ (Im M ) for up to 24 h. Cytosolic extracts were prepared at the 
indicated time points and assessed for cytochrome c (cyt c) by western blot analysis as described in 
Materials and methods.
6.7 Discussion
6.7.1 Zn^ is a potent inhibitor of caspases
The data presented in this study demonstrate the inhibitory effects of Z n^ on 
apoptosis characterised by the activation of caspases and their proteolytic activity, PS 
exposure, reduction in Ai|/m, and DNA fragmentation. The broad spectrum of 
inhibition suggest the possible existence of multiple sites o f action by Zn"+ on the 
apoptotic pathways, including some early events during the execution phase. The data 
and that of others have clearly shown that Zn" is a potent inhibitor o f caspases (Wolf 
et ah, 1997; Perry et a l, 1997; Stennicke and Salvesen, 1997). It has been reported 
that cytochrome c is required for the activation o f caspases (Liu et al., 1996) and the 
finding from the present study that Zn++ blocked the release of cytochrome c into the
20 24
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cytosol in etoposide-induced apoptosis also suggested that Zn may interfere with the 
initial activation of caspases so preventing the progression of apoptotic protease 
cascade. Thus these results are consistent with the observation that cytochrome c is 
an essential component of the complex which initiates this cascade (Li et ah, 1997). 
The possibility that Zn interferes with the transduction of the apoptotic signal prior 
to the release of cytochrome c may not be ruled out, but it is unlikely as Zn does not 
block the release of cytochrome c during TPCK-induced apoptosis although it inhibits 
all the other apoptotic features. The mechanism by which Zn" blocks the release of 
cytochrome c in etoposide- but not in TPCK-induced apoptosis is still unresolved. As 
Zn inhibits both the activation of caspases and decrease in Ax|/m but does not block 
the release of cytochrome c in TPCK-induced apoptosis ( Table 4 and Fig. 21, lower 
blot), it provides further evidence that release of cytochrome c occurs upstream of the 
activation of caspases and also prior to the decrease in
6.7.2 Mechanism of non-apoptotic cell death induced by Zn^
Zn" alone induces a non-apoptotic cell death, consistent with the process of cell death 
normally referred to as oncosis (Majno and Joris, 1995; Trump et al., 1997). 
Irreversible commitment of these cells to die occurs at 4 h, prior to the release of 
cytochrome c. Thus this release is a late event in the oncotic death of THP.l cells.
The characteristic depletion of ATP in oncotic cells may preclude the activation of 
caspases, whereas in apoptotic cells, early release of mitochondrial cytochrome c 
following interaction with Apaf-1 and dATP results in the activation of caspases, so 
precipitating the biochemical and morphological features of apoptosis. The mode of 
cytotoxicity of Z n "  appears to be non-specific because it does not cause immediate 
disruption of cellular function as the intracellular ATP levels during the first 4h 
incubation were similar to that of control cells (Fig. 23 A). Also, when cells were 
incubated with Zn+ (1 mM) for up to 2h, then washed to remove excess Zn" and re­
suspended in fresh Z iv-free medium they maintained normal growth showing neither 
reduction in intracellular ATP levels nor decrease in cell viability at 24h (Fig. 25). 
Only those cells being exposed to Zn" for 4 h exhibited significant losses in both 
intracellular ATP levels and cell viability, suggesting that cells became irreversibly 
committed to die at between 2 h and 4 h following exposure to Zn"+. The potential 
targets of Zn + in the cytotoxic action includes calcium antagonism, zinc finger
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proteins, microtubules and disruption in mitotic phase of cell cycle (reviewed by 
Zalewski and Forbes, 1993). Thus, depending on the cell type, Zn may exert 
divergent effects from inhibiting apoptotic pathways to inducing cell death.
Therefore, in THP.l cells Zn does not prevent cell death, a result consistent with the 
previous observation in this laboratory (G. Cohen et al., 1992) and those of others 
(Barbieri et ah, 1992; McCabe et ah, 1993). In addition, Zn alone at the 
concentration that inhibits apoptosis causes necrosis, in agreement with a finding of 
the other study (McGowan et ah, 1994).
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Figure 25. Short exposure (up to 2 h) to Zn^ caused neither decrease in 
intracellular ATP levels nor loss of cell viability at 24 h
THP.l cells were incubated either alone or with Zn ' (1.0 mM) for the indicated time periods and then 
washed to remove excess Zn"T and re-suspended in Zn++-free medium for continued incubation for up 
to 24 h. At 24 h, (A) relative intracellular ATP levels (% of control cells at zero time point) were 
determined as described in Materials and methods. (B) Cell viability at 24 h was also measured by 
trypan blue staining.
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The observation that ZnT+ alone at the concentration that inhibited apoptosis caused 
necrosis over an extended incubation period certainly poses a dilemma to the attempt 
o f using Zn for therapeutic gain. It also provides a cautious note on studies of 
apoptosis using inhibitors. These studies should not only look at the effect of 
inhibition of apoptosis in a short time period but also examine the effect of the 
inhibitor on cell survival over an extended time period and also investigate whether 
inhibitor itself induces cell death. This is to ensure that inhibitor of apoptosis 
provides cells with long-term protection but not just a temporary blockade of certain 
changes associated with apoptotic phenotype. Theoretically, inhibitors of apoptosis 
should allow cells to survive and proliferate in particular if they are to be used 
therapeutically to inhibit the apoptotic process.
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7.1 Caspases act upstream of the reduction in Av|/m
In this study, apoptosis was induced in THP.l cells by two chemicals, the anti-cancer 
drug, etoposide, and the serine protease inhibitor, TPCK. Apoptosis, characterised 
morphologically by the condensation of the cytoplasm and the nucleus as well as 
chromatin fragmentation, was accompanied by activation of caspases-3 and -7 
together with the cleavage of PARP and lamins, reduction in Avgm, PS externalisation 
and DNA fragmentation. Several recent studies have highlighted a role for a decrease 
in Ax|/m as a key committed step in the induction of apoptosis (Zamzami et al., 1995; 
Castedo et al., 1996). However, several lines of evidence obtained from the present 
study support the notion that caspases act upstream of the reduction in Av|/m. Firstly, 
the time-eourse experiments demonstrated that during the induction of apoptosis 
activation of caspase-7 was evident at 1 h whereas both reduction in Avj/m and 
increased PS exposure were first observed at 2 h after treatment with TPCK (compare 
Fig. 10 B with Fig. 8 B in chapter 3). Secondly, Z-VAD.FMK, the broad spectrum 
caspase inhibitor, blocked the activation of caspases, PS exposure and reduction in 
Av|/m during the induction of apoptosis by either etoposide or TPCK in THP.l cells 
(Figs. 11 and 12 in chapter 4). It also inhibited the activation of caspases, PS 
exposure and reduction in Av|/m during the induction of apoptosis by TNF-a or 
etoposide in U937 cells (Figs. 15 in chapter 4 and 19 in chapter 5). Therefore, in 
these models of apoptosis, activation of caspases occurs upstream of a decrease in 
ARm. This observation is consistent with some recent studies of apoptosis induced by 
staurosporine, UV irradiation or etoposide in several different cell systems (Yang et 
ah, 1997; Kluck et ah, 1997; Bossy-Wetzel et ah, 1998), supporting the role of 
caspases as the key execution machinery in apoptosis. In addition, the data from this 
study and others suggest that the reduction in Av|/m may be a consequence o f caspase 
activity and regulated by the caspases. Caspases have been shown to be able to 
directly induce the disruption in A\\/m in either isolated mitochondria (Susin et ah, 
1997; Marzo et ah, 1998a) or the PT pore complex reconstituted in liposomes (Marzo 
et ah, 1998b). In some cases where apoptosis is induced through the engagement of 
the death receptors (e.g. CD95), expression of Bcl-2 inhibits the mitochondrial 
changes including the reduction in Avj/m, but it fails to inhibit apoptosis and activation 
of caspases in certain cell systems (Scaffidi et ah, 1998). Further evidence supporting 
this hypothesis comes from the studies using some specific genes knock-out mice.
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Both Apaf-1 and caspase-9 are implicated in the initial activation of a caspase cascade 
(P. Li et al., 1997; Zou et al., 1997). Thymocytes from the Apaf-1 ~A null-mutant mice 
are resistant to apoptotic cell death and maintain normal Avj/m in response to a number 
of apoptotic stimuli including etoposide, dexamethasone, staurosporine and y- 
irradiation (Yoshida et al., 1998). Thymocytes from the caspase-9 deficient mice also 
show resistance to apoptosis and retain their Av|/m when treated with dexamethasone 
(Hakem et al., 1998). These studies demonstrate that the Apaf-T7" and caspase-9 A 
thymocytes are protected not only from apoptotic cell death but also from the 
mitochondrial changes, providing evidence that both Apaf-1 and caspase-9 lie 
upstream of the changes in Ax|/m. Taken together, the results from the present study 
and studies of others support the idea that Apaf-1, in concert with cytochrome c and 
dATP, functions by activating caspases, which in turn cause the disruption in
Reduction in Ai|/m during the induction of apoptosis is believed to be mediated by the 
opening of the mitochondrial permeability transition (PT) pore (reviewed by Kroemer 
et al., 1997). However, to date the structure and composition of the PT pore still 
remain poorly defined, so does its physiological functions (reviewed by Green and 
Reed, 1998; Remasters et ah, 1998). It appears to be a complex of polypeptides 
located presumably at inner and outer membrane contact sites and possibly composed 
of both inner membrane proteins, such as the adenine nucleotide translocator (ANT), 
and outer membrane proteins, such as porin (Green and Reed, 1998). PT probably 
represents an abrupt increase of permeability o f the mitochondrial inner membrane to 
solutes of molecular mass less than about 1.5 kDa (Zoratti and Szabo, 1995). C a +, Pj, 
and oxidant chemicals induce the opening of PT pore, whereas Mg++, ADP, low pH 
and high membrane potential oppose the occurrence of PT. The rapid change in 
permeability resulting from the opening of PT pore causes loss of membrane 
potential, uncoupling of oxidative phosphorylation, release of intramitochondrial ions 
and metabolic intermediates, and mitochondrial swelling (Zoratti and Szabo, 1995). 
Recently, it has been reported that opening of PT pore does not occur exclusively 
during apoptosis and, in fact, it is a common mechanism for cell death by either 
necrosis or apoptosis (Remasters et ah, 1998). Therefore, these observations suggest 
that change in Av|/m is not a key step in the apoptotic process. This, however, does not 
exclude the possibility that it may be critical for apoptosis in some cases. For
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example, in apoptosis induced by some proapoptotic proteins such as BAX, 
mitochondrial changes including loss of A\j/m are observed even when caspases are 
inhibited (Xiang et ah, 1996).
7.2 Mechanisms regulating cell surface changes of cells undergoing 
apoptosis may not directly involve the activity of caspases
Apoptosis is a programmed form of cell death characterised by a series of biochemical 
and morphological changes affecting the nucleus, cytoplasm and plasma membrane. 
These changes in various cellular compartments are widely regarded as 
mechanistically linked events in a single “program”, in which activation of caspases 
and proteolysis of intracellular substrates represent a final common pathway leading 
to cell death. In this study, using the mitochondrial inhibitors, antimycin A and 
oligomycin, the plasma membrane changes in cells undergoing apoptosis are 
dissociated from other features of the apoptotic phenotype, as described in chapter 4.
In THP.l cells triggered into apoptosis by etoposide or TPCK, these inhibitors 
blocked increased plasma membrane permeability, externalisation of PS and 
recognition by two classes of phagocytes utilising their respective receptors for PS 
and thrombospondin, but not activation of caspases-3 and -7, cleavage of P ARP and 
DNA fragmentation. Similarly, externalisation of PS in apoptotic human leukaemic 
U937 cells is dissociated from activation of caspases. Z-VAD.FMK, on the other 
hand, inhibited all the above features of apoptosis. These findings could have at least 
two significant indications.
First, these data demonstrated for the first time that the surface changes of apoptosis 
relate to an independent pathway of events, which may be differentially regulated 
from the activation of “effector” caspases which are believed to trigger the nuclear 
and some o f the cytoplasmic changes of apoptosis. Although these changes may 
occur simultaneously as part of a parallel process, mechanisms underlying these 
changes are potentially independent from each other. The effects of Z-VAD.FMK 
described here were in agreement with previous observations that activation of 
caspases is implicated in the externalisation of PS (Vanags et al., 1996; Martin et al., 
1996). However, in the present study the “effector” caspases such as caspases-3 and - 
7 are clearly not involved, whereas in their studies they appear to be required. The
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discrepancy in these findings may be reconciled by the observations that a loss of 
phospholipid asymmetry in the plasma membrane is often correlated with disruption 
or degradation of the cytomembrane network of spectrin, actin, and associated 
proteins (Williamson et al., 1987). The spectrin is capable of interacting directly 
with, in particular, the anionic phospholipids including PS that are concentrated in the 
inner leaflet of the membrane (reviewed by Schlegel and Williamson, 1987). Loss of 
the association with the proteins of the cytoskeleton results in an increased 
transbilayer movement of the aminophospholipids (Vermeulen et al., 1995). These 
results suggest that the membrane skeleton proteins are not only responsible for 
maintaining cell shape but also upholding the membrane phospholipid asymmetry. 
During the induction of apoptosis, cleavage of a subset of the membrane skeleton 
proteins was observed, including actin (Mashima et al., 1995; Kay alar et al., 1996; 
Brown et al., 1997), fodrin (non-erythroid spectrin) (Martin et ah, 1995a; Cryns et ah, 
1996; Vanags et ah, 1996) and Gas2 protein, a component of the microfilament 
system (Brancolini et ah, 1995). Most, if not all, o f these proteins are cleaved by 
various members of caspases. Thus it appears likely that the involvement of caspases 
in the PS exposure in apoptosis is probably through the proteolysis of some of these 
membrane skeleton proteins, which in turn result in a loss of phospholipid asymmetry 
in the membrane, leading to PS exposure. Future work will need to determine 
whether the two mitochondrial inhibitors block the cleavage of these proteins, which 
may shed light to the understanding of the mechanisms of their inhibition on the 
membrane changes including PS exposure during the induction of apoptosis. In 
addition, it has been reported that expression of Bcl-2 in neutrophils inhibits their 
apoptosis as assessed by a loss of viability and intemucleosomal DNA fragmentation, 
but not engulfment by macrophages (Lagasse and Weissman, 1994). This suggests 
that mechanism(s) triggering phagocytosis of aging neutrophils is independent from 
the process of apoptosis regulated by Bcl-2. It will be interesting to see whether 
activation of caspases is also inhibited in these neutrophils, thus further testing the 
hypothesis of caspase-independent pathway(s) of cell surface changes leading to 
recognition and phagocytosis.
Secondly, this finding of dissociation could have very important consequences for 
attempts to manipulate apoptosis for therapeutic gain. In disorders characterised by
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unscheduled cell loss by apoptosis, such as neurodegenerative disease, potential 
therapies will not only need to block intracellular pathways leading to engagement of 
effector enzymes but will also need to interfere with those governing recognition, in 
case potentially rescued cells are undesirably removed by phagocytes. Conversely, 
there may be potential for selective triggering of the surface changes of apoptosis in 
“undesirable” cells (such as cancer cells) so that these are removed by innate 
mechanisms.
It is of interest that the dissociation of the cell surface changes from the other changes 
of the apoptotic phenotype was accomplished using antimycin A and oligomycin, two 
agents which interfere with mitochondrial functions. The blockade of this putative 
‘recognition pathway’ by the two mitochondrial inhibitors provides important clues 
for its further dissection. A critical role for the mitochondrial release of proteins, such 
as apoptosis inducing factor (AIF) and cytochrome c, has been proposed in initiating 
the apoptotic program including DNA fragmentation and activation of caspase-3 
(Susin et al., 1996a; Liu et ah, 1996). Bcl-2 may prevent apoptosis in part by 
blocking the mitochondrial release of both AIF and/or cytochrome c (Susin et ah, 
1996a; Yang et ah, 1997; Kluck et ah, 1997). Although antimycin A and oligomycin 
may affect targets other than their known mitochondrial ones, it is possible that two 
mitochondrial inhibitors may have interfered with mitochondrial function, so 
preventing the mitochondrial release of some factor(s), other than cytochrome c or 
AIF, which directly or indirectly results in exposure of PS.
In addition, the finding of the dissociation of the cell surface changes including PS 
exposure from the other changes of the apoptotic phenotype appears to be analogous 
to a clinical condition known as Scott syndrome. Scott syndrome is a rare inherited 
bleeding disorder characterised by the inability of blood platelets and other cells 
including erythrocytes to expose PS in response to activation by Ca % resulting in 
deficient procoagulant activity (Sims et ah, 1989; Weiss, 1994). This disorder is 
generally believed to be related to a defective gene that selectively affects membrane 
phospholipid scrambling (Bevers et ah, 1992; Toti et ah, 1996). Recent studies show, 
however, that the scramblase isolated from detergent-solubilised Scott erythrocytes 
exhibits normal phospholipid scrambling activity (Stout et ah, 1997). Scott
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lymphoblasts also expressed normal levels of phospholipid scramblase mRNA and 
protein (Zhou et al., 1998). These results suggest that the defect in Scott syndrome is 
related to an aberrant posttranscriptional processing of the scramblase polypeptide 
preventing its interaction with Ca' in situ, or alternatively, due to the presence of a 
detergent-dissociable inhibitor in the Scott cells. If true, it may be possible that the 
mitochondrial inhibitors either interact with the enzyme or enhance the binding of the 
inhibitor to it, thus blocking the access of Ca' to its binding sites in phospholipid 
scramblase. There may also be the possibility that the mitochondrial inhibitors block 
the upstream signal(s) leading to the activation of the scramblase.
7.3 Cytochrome c release represents the commitment point of cell 
death in chemical-induced apoptosis
The data obtained from this study strongly support the view that caspases are the 
major biochemical execution machinery during the induction of the apoptosis by 
etoposide or TPCK. Activation of caspases occurred early with the subsequent 
cleavage of intracellular proteins such as PARP and lamins, which precipitated the 
dramatic morphological and other biochemical changes of apoptosis. Inhibition of 
caspase activation by the tripeptide inhibitor, Z-VAD.FMK, blocked all the changes 
characteristic of apoptosis. This appears to indicate that activation of caspases may be 
an irreversible commitment o f cells to death in chemical-induced apoptosis.
However, two pieces of evidence from the present study argue against this 
proposition. First, Z-VAD.FMK did not block the release o f cytochrome c during the 
induction of apoptosis by either etoposide or TPCK in THP.l cells, as described in 
chapter 5, (Fig. 16 A and B lanes 7), nor did it block this release during the induction 
o f apoptosis by etoposide in U937 cells (Fig. 19 D lane 5) although it blocked that in 
TNF-a-mediated apoptosis (Fig. 19 D lane 3). Secondly and more importantly, in 
THP.l cells incubated with etoposide in the presence of Z-VAD.FMK for 24 h, over 
one third of total cell population lost their viability, as assessed by trypan blue dye 
inclusion even though the activation of caspases was still inhibited (Fig. 22 lane 6 in 
chapter 6). The latter observation suggests that these cells are not fully protected from 
subsequent cell death even when caspases are inactivated. It further implies that cells 
become irreversibly committed to cell death before the activation of caspases 
following treatment with etoposide. This notion is compatible with an earlier
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observation that inhibition of caspases does not prevent cell death induced by 
oncogenes , DNA damage and Bak, a proapoptotic member of the Bcl-2 family in rat 
fibroblasts (McCarthy et ah, 1997). In this study, it is also shown that cells treated 
with various apoptotic stimuli in the presence of Z-VAD.FMK have no clonogenic 
potential and can not be rescued by the addition of antiapoptotic survival factors. 
Another recent study show that Jurkat cells co-incubated with etoposide or 
actinomycin D or staurosporine and Z-VAD.FMK are incapable of proliferating as 
determined by lack of clonogenic potential and they subsequently die by necrosis 
(Amarante-Mendes et al., 1998). These studies suggest that activation of caspases 
follows an event that commits cells to die under these circumstances.
There is an increasing evidence suggesting that release of mitochondrial cytochrome c 
represents the commitment point of cell death in chemical-induced apoptosis. In the 
present study, while a direct temporal relationship between cytochrome c release and 
activation of caspases had not been established in intact cells, release o f cytochrome c 
was observed as an early event during the induction of apoptosis by etoposide or 
TPCK, occurring prior to both the reduction in AvPm and PS exposure (Fig. 16 in 
chapter 5). The observation that Z-VAD.FMK did not block the release of 
cytochrome c in chemical-induced apoptosis in both TF1P.1 and U937 cells 
demonstrated that this release was upstream of the activation of caspases.
Cytochrome c has been shown to complex with Apaf-1, in the presence o f dATP, 
activating caspase-9, so initiating the caspase cascade (Liu et ah, 1996; P. Li et al. 
1997; Zou et ah, 1997). These results suggest that release of cytochrome c is a critical 
event, involved in triggering caspase activation which subsequently brings about the 
caspase-dependent apoptotic changes. This notion is supported by many observations 
of other studies in the literature. Release of cytochrome c is observed in apoptosis 
induced by a variety of stimuli including UV irradiation, staurosporine, actinomycin 
D, etoposide, ara-C, hydrogen peroxide, and ligation of the death receptor (e.g. CD 
95) (Krippner et ah, 1996; Liu et ah, 1996; C. Kim et ah, 1997; Kluck et ah, 1997; 
Yang et ah, 1997; Bossy-Wetzel et ah, 1998; Scaffidi et ah, 1998; Vander Heiden et 
ah, 1998). Immunocytochemistry confirms the translocation of cytochrome c from 
the mitochondria to the cytoplasm following stimulation with UV irradiation in HeLa 
cells (Bossy-Wetzel et ah, 1998) and in embryonic stem cells (Hakem et ah, 1998) or
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with etoposide, staurosporine and UV irradiation in embryonic fibroblast cells 
(Yoshida et ah, 1998). These results suggest that the release of cytochrome c is a 
common event in apoptosis, which acts as a converging point from diverse apoptotic 
signal-transducing pathways. As Z-VAD.FMK inhibits cytochrome c release and cell 
death in CD95 receptor-mediated apoptotsis in Jurkat cells (Vander Heiden et ah, 
1998; Amarante-Mendes et ah, 1998) and protects cells against CD95-induced 
apoptosis in mice (Rodriguez et ah, 1996; Chandler et ah, 1998), it appears that the 
commitment to cell death is caspase-dependent in death receptor-mediated apoptosis. 
Release of cytochrome c is thus not an essential event in these cases. However, Z- 
VAD.FMK does not block cytochrome c release in chemical-induced apoptosis, as 
described here, and in apoptosis induced by UV irradiation or staurosporine in human 
T lymphoblastoid CEM cells (Kluck et ah, 1997; Bossy-Wetzel et ah, 1998) and in 
Jurkat cells (Vander Heiden et ah, 1998). These results suggest that Z-VAD.FMK 
does not inhibit the commitment to cell death but rather inhibits all the biochemical 
changes associated with caspase activation. Further evidence is provided by several 
gene knock-out studies. Cytochrome c has been shown to interact with Apaf-1, 
activating caspase-9, which in turn activates the effector caspases such as caspase-3 
(Liu et ah, 1996; P. Li et ah 1997; Zou et ah, 1997), suggesting that Apaf-1 and 
caspase-9 are the important components in cytochrome c-mediated caspase-activating 
pathways. Thymocytes from caspase-9 deficient mice are resistant to cell death 
induced by many different stimuli including dexamethasone, etoposide and y 
irradiation, but not to apoptosis by engaging the death receptors with CD95 and TNF- 
a  (Hakem et ah, 1998; Kuida et ah, 1998). In A paf-1thym ocytes and embryonic 
fibroblasts, resistance to cell death induced by apoptotic stimuli such as etoposide, 
dexamethasone and staurosporine is observed, but not in CD95-induced apoptosis 
(Cecconi et ah, 1998; Yoshida et ah, 1998). These results demonstrate that Apaf-1 
and caspase-9 are required in the induction of apoptosis by a mechanism other than 
the death receptor-mediated one. Because the release of cytochrome c is observed 
during the induction of cell death in both caspase-9" " cells (Hakem et ah, 1998) and 
Apaf-1 "A cells (Yoshida et ah, 1998), it suggests that both Apaf-1 and caspase-9 act 
downstream of cytochrome c release. Thus, taken together, these results clearly 
demonstrate that release of cytochrome c is a central event in chemical-induced 
apoptosis, involved in the commitment of cells to die. Caspase activation occurs after
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commitment to cell death and is primarily responsible for those stereotypic 
biochemical and morphological changes commonly associated with the apoptotic 
phenotype. In this model of apoptosis, therefore, caspases act solely as the 
executioners. Meanwhile, Z-VAD.FMK inhibits apoptosis downstream of cell death 
commitment by inhibiting the initiator caspase-9 and the resultant postmitochondrial 
activation of effector caspases. This interpretation may have some clinical 
implications for the use of caspase inhibitors as potential therapeutic agents. Cells, 
which are committed to die but with caspases inhibited, may die more slowly and with 
a different morphology from cells dying with characteristic apoptotic morphology, as 
demonstrated by recent reports describing a caspase-independent cell death, such as 
Bax- or Bak-induced cell death (Xiang et ah, 1996; McCarthy et ah, 1997).
7.4 Molecular ordering of the cell death pathways in chemical- 
induced apoptosis
A model o f apoptosis in which the release of cytochrome c represents the commitment 
point of cell death is proposed (Fig. 26). Diverse cell death-transducing signals 
converge on mitochondria to induce the release of cytochrome c. The mechanisms of 
this release in chemical-induced apoptosis is not yet clear. Cytochrome c release has 
been reported to be prevented by anti-apoptotic proteins, Bcl-2 or Bcl-xL (C. Kim et 
ah, 1997; Kluck et ah, 1997; Yang et ah,1997; Vender Heiden et ah 1997; Bossy- 
Wetzel, 1998). Once released, in the presence of dATP, cytochrome c interacts with 
apoptotic protease activating factor-1 (Apaf-1), resulting in activation of caspase-9, 
which in turn activates downstream effector caspases such as caspase-3 (Liu et ah, 
1996; P. Li et ah 1997; Zou et ah, 1997). Activated caspases then cleave a subset of 
important intracellular protein substrates, which are believed to be associated with the 
stereotypic biochemical and morphological changes of the apoptotic phenotype. Z- 
VAD.FMK inhibits the activation of the initiator caspase-9 and the effector caspases. 
Caspases can also act on mitochondria to induce an opening of the mitochondrial PT 
pore. As a result, A4/m becomes dissipated with subsequent generation of reactive 
oxygen species (ROS) and release of apoptosis-inducing factor (AIF) from 
mitochondria, which further accelerate the death process. The plasma membrane 
changes such as PS exposure in apoptotic cells serve as signals for phagocytic 
recognition and clearance of the dying cells (Savill et ah, 1993; Pradhan et ah, 1997;
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Savill, 1998). These membrane changes may be inhibited by the mitochondrial 
inhibitors antimycin A and oligomycin by a yet unknown mechanism(s).
Etoposide/TPCK
9
Bcl-2
Bcl-x,
Cyt. c
dATP & Apaf-1
ROS r
Antimycin A 
Oligomycin
Z-VAD.FMK
AIF
Caspase-3/-7
Death substrates PS exposure
Apoptosis
Phagocytosis
Figure 26. Schematic diagram of the caspase activation pathways in 
chemical-induced apoptosis
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